Document_and_Entity_Informatio
Document and Entity Information Document (USD $) | 12 Months Ended | ||
Aug. 28, 2014 | Oct. 16, 2014 | Feb. 27, 2014 | |
Entity Information [Line Items] | ' | ' | ' |
Entity Registrant Name | 'MICRON TECHNOLOGY INC | ' | ' |
Entity Central Index Key | '0000723125 | ' | ' |
Current Fiscal Year End Date | '--08-28 | ' | ' |
Entity Filer Category | 'Large Accelerated Filer | ' | ' |
Document Type | '10-K | ' | ' |
Document Period End Date | 28-Aug-14 | ' | ' |
Document Fiscal Year Focus | '2014 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Amendment Flag | 'false | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 1,073,455,204 | ' |
Entity Well-known Seasoned Issuer | 'Yes | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Public Float | ' | ' | $21,300,000,000 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 12 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Income Statement [Abstract] | ' | ' | ' |
Net sales | $16,358 | $9,073 | $8,234 |
Cost of goods sold | 10,921 | 7,226 | 7,266 |
Gross margin | 5,437 | 1,847 | 968 |
Selling, general and administrative | 707 | 562 | 620 |
Research and development | 1,371 | 931 | 918 |
Restructure and asset impairments | 40 | 126 | 10 |
Other operating (income) expense, net | 232 | -8 | 32 |
Operating income (loss) | 3,087 | 236 | -612 |
Adjustment to gain on MMJ Acquisition | -33 | ' | ' |
Gain on MMJ Acquisition | ' | 1,484 | 0 |
Interest income | 23 | 14 | 8 |
Interest expense | -352 | -231 | -179 |
Other non-operating income (expense), net | 8 | -218 | 29 |
Income (loss) before income taxes, net income attributable to noncontrolling interests and equity in net income (loss) of equity method investees: | 2,733 | 1,285 | -754 |
Income tax (provision) benefit | -128 | -8 | 17 |
Equity in net income (loss) of equity method investees | 474 | -83 | -294 |
Net income (loss) | 3,079 | 1,194 | -1,031 |
Net income attributable to noncontrolling interests | -34 | -4 | -1 |
Net income (loss) attributable to Micron | $3,045 | $1,190 | ($1,032) |
Earnings (loss) per share: | ' | ' | ' |
Basic (in dollars per share) | $2.87 | $1.16 | ($1.04) |
Diluted (in dollars per share) | $2.54 | $1.13 | ($1.04) |
Number of shares used in per share calculations: | ' | ' | ' |
Basic (in shares) | 1,060 | 1,022 | 991 |
Diluted (in shares) | 1,198 | 1,057 | 991 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Net income (loss) | $3,079 | $1,194 | ($1,031) |
Other comprehensive income (loss), net of tax | ' | ' | ' |
Gain (loss) on derivatives, net | -9 | -9 | -18 |
Foreign currency translation adjustments | -2 | -5 | -16 |
Pension liability adjustments | 3 | -1 | 0 |
Gain (loss) on investments, net | 1 | -1 | -24 |
Other comprehensive income (loss) | -7 | -16 | -58 |
Total comprehensive income (loss) | 3,072 | 1,178 | -1,089 |
Comprehensive (income) loss attributable to noncontrolling interests | -34 | -5 | 5 |
Comprehensive income (loss) attributable to Micron | $3,038 | $1,173 | ($1,084) |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Assets | ' | ' |
Cash and equivalents | $4,150 | $2,880 |
Short-term investments | 384 | 221 |
Receivables | 2,906 | 2,329 |
Inventories | 2,455 | 2,649 |
Restricted cash | 0 | 556 |
Other current assets | 350 | 276 |
Total current assets | 10,245 | 8,911 |
Long-term marketable investments | 819 | 499 |
Property, plant and equipment, net | 8,682 | 7,626 |
Equity method investments | 971 | 396 |
Intangible assets, net | 468 | 386 |
Deferred tax assets | 816 | 861 |
Other noncurrent assets | 497 | 439 |
Total assets | 22,498 | 19,118 |
Liabilities and equity | ' | ' |
Accounts payable and accrued expenses | 2,698 | 2,115 |
Deferred income | 309 | 243 |
Equipment purchase contracts | 166 | 182 |
Current debt | 1,638 | 1,585 |
Total current liabilities | 4,811 | 4,125 |
Long-term debt | 4,955 | 4,452 |
Other noncurrent liabilities | 1,102 | 535 |
Total liabilities | 10,868 | 9,112 |
Commitments and contingencies | ' | ' |
Redeemable convertible notes | 57 | 0 |
Micron shareholders' equity: | ' | ' |
Common stock, $0.10 par value, 3,000 shares authorized, 1,073 shares issued and outstanding (1,044 as of August 29, 2013) | 107 | 104 |
Additional capital | 7,879 | 9,187 |
Retained earnings (accumulated deficit) | 2,729 | -212 |
Accumulated other comprehensive income | 56 | 63 |
Total Micron shareholders' equity | 10,771 | 9,142 |
Noncontrolling interests in subsidiaries | 802 | 864 |
Total equity | 11,573 | 10,006 |
Total liabilities and equity | $22,498 | $19,118 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, except Per Share data, unless otherwise specified | ||
Liabilities and equity | ' | ' |
Common stock, par value (in dollars per share) | $0.10 | $0.10 |
Common Stock, authorized shares (in shares) | 3,000 | 3,000 |
Common Stock, issued (in shares) | 1,073 | 1,044 |
Common Stock, outstanding (in shares) | 1,073 | 1,044 |
STATEMENT_OF_CHANGES_IN_EQUITY
STATEMENT OF CHANGES IN EQUITY (USD $) | Total | Common Stock [Member] | Additional Capital [Member] | Retained Earnings (Accumulated Deficit) [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Total Micron Shareholders' Equity [Member] | Noncontrolling Interests in Subsidiaries [Member] |
In Millions, unless otherwise specified | |||||||
Balance at Sep. 01, 2011 | $9,852 | $98 | $8,610 | ($370) | $132 | $8,470 | $1,382 |
Common Stock, outstanding (in shares) at Sep. 01, 2011 | ' | 984 | ' | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Net income (loss) | -1,031 | ' | ' | -1,032 | ' | -1,032 | 1 |
Other comprehensive income (loss) | -58 | ' | ' | ' | -52 | -52 | -6 |
Contributions from noncontrolling interests | 197 | ' | ' | ' | ' | 0 | 197 |
Issuance and repurchase of convertible notes | 191 | ' | 191 | ' | ' | 191 | ' |
Conversion of 2013 notes | 138 | 3 | 135 | ' | ' | 138 | ' |
Conversion of 2013 Notes (in shares) | ' | 27 | ' | ' | ' | ' | ' |
Stock-based compensation expense | 87 | ' | 87 | ' | ' | 87 | ' |
Stock issued under stock plans | 6 | 1 | 5 | ' | ' | 6 | ' |
Stock issued under stock plans (in shares) | ' | 8 | ' | ' | ' | ' | ' |
Acquisition of noncontrolling interests | -466 | ' | ' | ' | ' | 0 | -466 |
Distributions to noncontrolling interests | -391 | ' | ' | ' | ' | 0 | -391 |
Purchase and settlement of capped calls | -102 | ' | -102 | ' | ' | -102 | ' |
Repurchase and retirement of common stock | -6 | 0 | -6 | 0 | ' | -6 | ' |
Repurchase and retirement of common stock (in shares) | ' | -1 | ' | ' | ' | ' | ' |
Balance at Aug. 30, 2012 | 8,417 | 102 | 8,920 | -1,402 | 80 | 7,700 | 717 |
Balance (in shares) at Aug. 30, 2012 | ' | 1,018 | ' | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Net income (loss) | 1,194 | ' | ' | 1,190 | ' | 1,190 | 4 |
Other comprehensive income (loss) | -16 | ' | ' | ' | -17 | -17 | 1 |
Contributions from noncontrolling interests | 11 | ' | ' | ' | ' | 0 | 11 |
MMJ Acquisition | 168 | ' | ' | ' | ' | 0 | 168 |
Stock-based compensation expense | 91 | ' | 91 | ' | ' | 91 | ' |
Stock issued under stock plans | 150 | 2 | 148 | ' | ' | 150 | ' |
Stock issued under stock plans (in shares) | ' | 27 | ' | ' | ' | ' | ' |
Distributions to noncontrolling interests | -37 | ' | ' | ' | ' | 0 | -37 |
Purchase and settlement of capped calls | -24 | ' | -24 | ' | ' | -24 | ' |
Exchange, issuance and repurchase of convertible notes impact on to additional paid in capital | 57 | ' | 57 | ' | ' | 57 | ' |
Repurchase and retirement of common stock | -5 | 0 | -5 | 0 | ' | -5 | ' |
Repurchase and retirement of common stock (in shares) | ' | -1 | ' | ' | ' | ' | ' |
Balance at Aug. 29, 2013 | 10,006 | 104 | 9,187 | -212 | 63 | 9,142 | 864 |
Balance (in shares) at Aug. 29, 2013 | 1,044 | 1,044 | ' | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Net income (loss) | 3,079 | ' | ' | 3,045 | ' | 3,045 | 34 |
Other comprehensive income (loss) | -7 | ' | ' | ' | -7 | -7 | ' |
Contributions from noncontrolling interests | 102 | ' | ' | ' | ' | 0 | 102 |
Stock-based compensation expense | 115 | ' | 115 | ' | ' | 115 | ' |
Stock issued under stock plans | 266 | 4 | 262 | ' | ' | 266 | ' |
Stock issued under stock plans (in shares) | ' | 36 | ' | ' | ' | ' | ' |
Acquisition of noncontrolling interests | -146 | ' | 34 | ' | ' | 34 | -180 |
Distributions to noncontrolling interests | -18 | ' | ' | ' | ' | 0 | -18 |
Purchase and settlement of capped calls | 86 | ' | 86 | ' | ' | 86 | ' |
Exchange, issuance and repurchase of convertible notes impact on to additional paid in capital | -1,691 | ' | -1,691 | ' | ' | -1,691 | ' |
Redeemable convertible notes | -57 | ' | -57 | ' | ' | -57 | ' |
Repurchase and retirement of common stock | -162 | -1 | -57 | -104 | ' | -162 | ' |
Repurchase and retirement of common stock (in shares) | ' | -7 | ' | ' | ' | ' | ' |
Balance at Aug. 28, 2014 | $11,573 | $107 | $7,879 | $2,729 | $56 | $10,771 | $802 |
Balance (in shares) at Aug. 28, 2014 | 1,073 | 1,073 | ' | ' | ' | ' | ' |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Cash flows from operating activities | ' | ' | ' |
Net income (loss) | $3,079 | $1,194 | ($1,031) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ' | ' | ' |
Depreciation expense and amortization of intangible assets | 2,103 | 1,804 | 2,141 |
Amortization of debt discount and other costs | 167 | 122 | 81 |
Loss on restructure of debt | 195 | 31 | 0 |
Stock-based compensation | 115 | 91 | 87 |
Adjustment to gain on MMJ Acquisition | 33 | ' | ' |
(Gain) on MMJ Acquisition | ' | -1,484 | 0 |
(Gains) losses from currency hedges, net | 27 | 222 | 19 |
Equity in net (income) loss of equity method investees | -474 | 83 | 294 |
Gain from disposition of interest in Aptina | -119 | 0 | 0 |
Gain from Inotera issuance of shares | -97 | -48 | 0 |
Noncash restructure and asset impairments | -17 | 112 | -6 |
Change in operating assets and liabilities: | ' | ' | ' |
Receivables | -518 | -409 | 238 |
Inventories | 194 | 83 | 258 |
Accounts payable and accrued expenses | 671 | 22 | 182 |
Deferred income taxes, net | 68 | -7 | 3 |
Other noncurrent liabilities | 243 | -15 | -89 |
Other | 29 | 10 | -63 |
Net cash provided by operating activities | 5,699 | 1,811 | 2,114 |
Cash flows from investing activities | ' | ' | ' |
Expenditures for property, plant and equipment | -2,658 | -1,244 | -1,699 |
Purchases of available-for-sale securities | -1,063 | -924 | -564 |
Payments to settle hedging activities | -26 | -253 | -62 |
Additions to equity method investments | 0 | 0 | -187 |
Proceeds from sales and maturities of available-for-sale securities | 557 | 678 | 152 |
Decrease in restricted cash | 536 | 0 | 5 |
Cash received from disposition of interest in Aptina | 105 | 0 | 0 |
Other | 96 | 31 | 43 |
Net cash used for investing activities | -2,453 | -1,712 | -2,312 |
Cash flows from financing activities | ' | ' | ' |
Repayments of debt | -3,843 | -743 | -203 |
Payments on equipment purchase contracts | -479 | -214 | -172 |
Cash paid to purchase common stock under equity plans | -76 | -5 | -6 |
Acquisition of noncontrolling interests | -18 | 0 | -466 |
Distributions to noncontrolling interests | -10 | -37 | -391 |
Proceeds from issuance of debt | 2,212 | 1,121 | 1,065 |
Proceeds from issuance of common stock under equity plans | 265 | 150 | 5 |
Cash received from noncontrolling interests | 102 | 11 | 197 |
Proceeds from equipment sale-leaseback transactions | 14 | 126 | 609 |
Other | -115 | -87 | -141 |
Net cash provided by (used for) financing activities | -1,948 | 322 | 497 |
Effect of changes in currency exchange rates on cash and equivalents | -28 | 0 | 0 |
Net increase (decrease) in cash and equivalents | 1,270 | 421 | 299 |
Cash and equivalents at beginning of period | 2,880 | 2,459 | 2,160 |
Cash and equivalents at end of period | 4,150 | 2,880 | 2,459 |
Supplemental disclosures | ' | ' | ' |
Income taxes refunded (paid), net | -43 | 4 | 13 |
Interest paid, net of amounts capitalized | -163 | -107 | -72 |
Noncash investing and financing activities: | ' | ' | ' |
Exchange of convertible notes | 756 | 0 | 0 |
Equipment acquisitions on contracts payable and capital leases | 587 | 443 | 897 |
Acquisition of noncontrolling interest | 127 | 0 | 0 |
Conversion of notes to stock, net of unamortized issuance cost | $0 | $0 | $138 |
Significant_Accounting_Policie
Significant Accounting Policies | 12 Months Ended |
Aug. 28, 2014 | |
Accounting Policies [Abstract] | ' |
Significant Accounting Policies | ' |
Significant Accounting Policies | |
Basis of Presentation: We are one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and its consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. | |
Certain reclassifications have been made to prior period amounts to conform to current period presentation. Certain deferred tax assets in prior years were corrected with corresponding changes in the valuation allowance, resulting in no change to net deferred tax assets. Changes in these items were not material for any period presented. | |
Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2014, 2013 and 2012 each contained 52 weeks. Fiscal year 2015 will contain 53 weeks, and the first quarter of fiscal 2015 will contain 14 weeks. All period references are to our fiscal periods unless otherwise indicated. | |
Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates. | |
Product Warranty: We generally provide a limited warranty that our products are in compliance with our specifications existing at the time of delivery. Under our general terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our general terms and conditions. Our warranty obligations are not significant. | |
Revenue Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable and collectability is reasonably assured. If we are unable to reasonably estimate returns or the price is not fixed or determinable, sales made under agreements allowing rights of return or price protection are deferred until customers have resold the product. | |
Research and Development: Costs related to the conceptual formulation and design of products and processes are expensed as research and development as incurred. Determining when product development is complete requires judgment. Development of a product is deemed complete once the product has been thoroughly reviewed and has passed tests for performance and reliability. Subsequent to product qualification, product costs are valued in inventory. Product design and other research and development costs for certain technologies are shared with our joint venture partners. Amounts receivable from cost-sharing arrangements are reflected as a reduction of research and development expense. (See "Equity Method Investments" and "Equity – Noncontrolling Interests in Subsidiaries" notes.) | |
Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We issue new shares upon the exercise of stock options or conversion of share units. (See "Equity Plans" note.) | |
Stock Repurchases: When we repurchase and retire our common stock, any excess of the repurchase price paid over par value is allocated between paid-in capital and retained earnings. | |
Functional Currency: The U.S. dollar is the functional currency for all of our consolidated operations. | |
Financial Instruments: Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. Investments with maturities greater than three months and less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. | |
Derivative and Hedging Instruments: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities or future cash flows and to reduce the volatility that changes in interest rates on variable-rate debt have on our earnings. Our currency derivatives have consisted of forward and option contracts and interest rate swap contracts. We do not use derivative instruments for trading or speculative purposes. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated as hedges for accounting purpose, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash-flow hedges, the effective portion of the gain or loss is included as a component of other comprehensive income (loss), and the ineffective or excluded portion of the gain or loss is included in other non-operating income (expense). The amounts in accumulated other comprehensive income (loss) for these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. Effectiveness is measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the forecasted cash flows of the hedged item. For the effectiveness assessment of our cash-flow hedges, changes in the time value are excluded for forward contracts. | |
We seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty under these arrangements have been presented in our consolidated balance sheet on a net basis. | |
(See "Derivative Instruments" note.) | |
Inventories: Inventories are stated at the lower of average cost or market value. Cost includes depreciation, labor, material and overhead costs, including product and process technology costs. Determining market values of inventories involves numerous judgments, including projecting future average selling prices, sales volumes and costs to complete products in work in process inventories. When market values are below costs, we record a charge to cost of goods sold to write down inventories to their estimated market value in advance of when the inventories are actually sold. Inventories are primarily categorized as memory (including DRAM, NAND Flash and NOR Flash) for purposes of determining lower of average cost or market. The major characteristics considered in determining inventory categories for purposes of determining the lower of cost or market value are product type and markets. We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis. | |
Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology and (3) maintain patent technology are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical and projected patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. | |
Property, Plant and Equipment: Property, plant and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, generally 5 to 7 years for equipment and generally 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in our results of operations. | |
We capitalize interest on borrowings during the active construction period of capital projects. Capitalized interest is added to the cost of the underlying assets and amortized over the useful lives of the assets. |
Variable_Interest_Entities
Variable Interest Entities | 12 Months Ended |
Aug. 28, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Variable Interest Entities | ' |
Variable Interest Entities | |
We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. | |
Unconsolidated Variable Interest Entities | |
Inotera: Inotera is a VIE because its equity is not sufficient to permit it to finance its activities without additional support from its shareholders. We have determined that we do not have the power to direct the activities of Inotera that most significantly impact its economic performance, primarily due to (1) limitations on our governance rights that require the consent of other parties for key operating decisions and (2) Inotera's dependence on Nanya for financing and the ability of Inotera to operate in Taiwan. Therefore, we do not consolidate Inotera and we account for our interest under the equity method. See "Equity Method Investments – Inotera" note. | |
EQUVO Entities: EQUVO HK Limited and EQUVA Capital 1 Pte. Ltd. (together, the "EQUVO Entities") are special purpose entities created to facilitate equipment sale-leaseback financing transactions between us and a consortium of financial institutions. Neither we nor the financing entities have an equity interest in the EQUVO Entities. The EQUVO Entities are VIEs because their equity is not sufficient to permit them to finance their activities without additional support from the financing entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangements with the EQUVO Entities are merely financing vehicles and we do not bear any significant risks from variable interests with the EQUVO Entities. Therefore, we have determined that we do not have the power to direct the activities of the EQUVO Entities that most significantly impact their economic performance and we do not consolidate the EQUVO Entities. | |
SC Hiroshima Energy Corporation: SC Hiroshima Energy Corporation ("SCHE") is an entity created to construct and operate a cogeneration, electrical power plant to support our wafer manufacturing facility in Hiroshima, Japan. SCHE is a VIE due to the nature of its tolling agreements with us and our purchase and call options for SCHE's assets. We do not have an equity ownership interest in SCHE. We do not control the operation and maintenance of the plant, which we have determined are the activities of SCHE that most significantly impact its economic performance. Therefore, we do not consolidate SCHE. | |
Consolidated Variable Interest Entities | |
IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and IMFT is dependent upon us or Intel for any additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. In addition, IMFT manufactures certain products exclusively for us using our technology. We also determined that we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. As a result, we have determined that we have the power to direct the activities of IMFT that most significantly impact its economic performance and, therefore, we consolidate IMFT. | |
IMFS: Prior to April 6, 2012, IMFS was a VIE because all of its costs were passed to us and its other member, Intel, through product purchase agreements and IMFS was dependent upon us or Intel for any additional cash requirements. Prior to April 6, 2012, we determined that we had the power to direct the activities of IMFS that most significantly impacted its economic performance. Therefore, we consolidated IMFS. On April 6, 2012, we acquired Intel's remaining interests in IMFS and it ceased to be a VIE. | |
MP Mask: MP Mask is a VIE because substantially all of its costs are passed to us and its other member, Photronics, through product purchase agreements and MP Mask is dependent upon us or Photronics for any additional cash requirements. We have tie-breaking voting rights over key operating decisions and nearly all key MP Mask activities are driven by our supply needs. We also determined that we have the obligation to absorb losses and the right to receive benefits from MP Mask that could potentially be significant to it. As a result, we have determined that we have the power to direct the activities of MP Mask that most significantly impact its economic performance and, therefore, we consolidate MP Mask. | |
(See "Equity – Noncontrolling Interests in Subsidiaries" note.) |
Recently_Issued_Accounting_Sta
Recently Issued Accounting Standards | 12 Months Ended |
Aug. 28, 2014 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
Recently Issued Accounting Standards | ' |
Recently Issued Accounting Standards | |
In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09 – Revenue from Contracts with Customers, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principal of this ASU is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This ASU will be effective for us in our first quarter of 2018. Early adoption is not permitted. The ASU allows for either full retrospective or modified retrospective adoption. We are evaluating the transition method that will be elected and the potential effects of the adoption of this ASU on our financial statements. |
Micron_Memory_Japan_Inc
Micron Memory Japan, Inc. (MMJ Acquisition [Member]) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
MMJ Acquisition [Member] | ' | ||||||||
Business Acquisition [Line Items] | ' | ||||||||
Micron Memory Japan, Inc. | ' | ||||||||
Micron Memory Japan, Inc. | |||||||||
On July 31, 2013, we acquired Elpida, now known as MMJ, and a controlling interest in Rexchip, now known as MMT, for an aggregate of $949 million in cash (collectively, "the MMJ Acquisition"). The MMJ Acquisition included (1) the acquisition of MMJ, including its 65% interest in MMT and (2) the acquisition of an additional 24% interest in MMT from Powerchip Technology Corporation (the "MMT Share Purchase"). The MMJ Acquisition was treated as a single business combination because: (1) the two transactions were entered into and closed contemporaneously, and (2) the MMT Share Purchase was negotiated in contemplation of the acquisition of MMJ and its completion was contingent on the closing of the acquisition of MMJ. | |||||||||
In 2014, we purchased additional interests in MMT, increasing our ownership interest to 99.5%. (See "Equity – Noncontrolling Interest in Subsidiaries – MMT" note.) | |||||||||
The MMJ Acquisition included a 300mm DRAM wafer fabrication facility located in Hiroshima, Japan, a 300mm DRAM wafer fabrication facility located in Taichung City, Taiwan and an assembly and test facility located in Akita, Japan. The operations from the MMJ Acquisition, which are included primarily in our MBU and CNBU segments, include the manufacture of Mobile DRAM targeted to mobile phones and tablets and computing DRAM targeted to desktop PCs, servers, notebooks and workstations. | |||||||||
We estimated the provisional fair values of the assets and liabilities of the MMJ Group as of the July 31, 2013 acquisition date using an in-use model, which reflects its value through its use in combination with other assets as a group. In the second quarter of 2014, the provisional amounts recorded in connection with the MMJ Acquisition were adjusted, primarily for pre-petition liabilities, and we recognized a charge in 2014 for these measurement period adjustments. The valuation of assets acquired and liabilities assumed were as follows: | |||||||||
Assets acquired and liabilities assumed: | |||||||||
Cash and equivalents | $ | 999 | |||||||
Receivables | 697 | ||||||||
Inventories | 962 | ||||||||
Restricted cash | 557 | ||||||||
Other current assets | 142 | ||||||||
Property, plant and equipment | 935 | ||||||||
Equity method investment | 40 | ||||||||
Intangible assets | 10 | ||||||||
Deferred tax assets | 811 | ||||||||
Other noncurrent assets | 66 | ||||||||
Accounts payable and accrued expenses | (387 | ) | |||||||
Equipment purchase contracts | (22 | ) | |||||||
Current portion of long-term debt | (673 | ) | |||||||
Long-term debt | (1,461 | ) | |||||||
Other noncurrent liabilities | (75 | ) | |||||||
Total net assets acquired | 2,601 | ||||||||
Noncontrolling interests in MMJ | 168 | ||||||||
Consideration | 949 | ||||||||
Preliminary gain on acquisition recognized in 2013 | 1,484 | ||||||||
Adjustment for primarily pre-petition liabilities | (33 | ) | |||||||
Final gain on acquisition | $ | 1,451 | |||||||
Our results of operations for 2013 include $355 million of net sales and $46 million of operating income from the MMJ Group's operations after the July 31, 2013 acquisition date. Included in the selling, general and administrative expenses in results of operations for 2013 are transaction costs of $50 million incurred in connection with the MMJ Acquisition. | |||||||||
The acquisition of MMJ was pursuant to the terms and conditions of an Agreement on Support for Reorganization Companies (as amended, the "Sponsor Agreement") that we entered into in July 2012 with the trustees of the MMJ Companies pursuant to and in connection with the MMJ Companies' corporate reorganization proceedings under the Corporate Reorganization Act of Japan. As a result of the Japan Proceedings, for so long as such proceedings are continuing, the MMJ Companies are subject to certain restrictions on dividends, loans and advances. The plans of reorganization of the MMJ Companies prohibit the MMJ Companies from paying dividends, including any cash dividends, to us and require that excess earnings be used in their businesses or to fund the MMJ Companies' installment payments. These prohibitions would also effectively prevent the subsidiaries of the MMJ Companies from paying cash dividends to us as any such dividends would have to be first paid to the MMJ Companies which are prohibited from repaying those amounts to us as dividends under the plans of reorganization. In addition, pursuant to an order of the Japan Court, the MMJ Companies cannot make loans or advances, other than certain ordinary course advances, to us without the consent of the Japan Court. Moreover, loans or advances by subsidiaries of the MMJ Companies may be considered outside the ordinary course of business and may require consent of MMJ's trustees or, in certain cases, approval by the Japan Court. As a result, the assets of the MMJ Companies, while available to satisfy the MMJ Companies' installment payments and other obligations, capital expenditures and other operating needs of the MMJ Companies, are not available for use by us in our other operations. Certain uses of the assets of the MMJ Companies, including investments in certain capital expenditures and in MMT, may require consent of MMJ's trustees or, in certain cases, approval by the Japan Court. Disposition of certain assets of the MMJ Companies may also require consent of one or more of the secured creditors. | |||||||||
Unaudited Pro Forma Financial Information | |||||||||
The following unaudited pro forma financial information presents the combined results of operations as if the MMJ Acquisition had occurred on September 2, 2011. The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities. The historical results of operations of the MMJ Group for the eleven months ended May 31, 2013 included a gain of $1.69 billion for the forgiveness of debt related to liabilities subject to compromise upon approval of the bankruptcy by the creditors and the Japan Court and, for the year ended June 30, 2012, included a $2.83 billion loss for impairment of long-lived assets. No adjustments were made to the unaudited pro forma financial information for these items, consistent with the requirements for preparation of the pro forma financial information. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the MMJ Acquisition occurred on September 2, 2011. | |||||||||
For the year ended | 2013 | 2012 | |||||||
Net sales | $ | 12,494 | $ | 11,492 | |||||
Net income (loss) | 3,825 | (4,439 | ) | ||||||
Net income (loss) attributable to Micron | 3,770 | (4,471 | ) | ||||||
Earnings (loss) per share: | |||||||||
Basic | $ | 3.69 | $ | (4.51 | ) | ||||
Diluted | 3.57 | (4.51 | ) | ||||||
The unaudited pro forma financial information for 2013 includes our results for the year ended August 29, 2013, which includes one month of results from the MMJ Group following the closing of the MMJ Acquisition, and the results of the MMJ Group, including the adjustments described above, for the eleven months ended May 31, 2013. The pro forma information for 2012 includes our results for the year ended August 30, 2012 and the results of the MMJ Group, including the adjustments described above, for the year ended June 30, 2012. |
Investments
Investments | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Investments [Abstract] | ' | ||||||||
Investments [Text Block] | ' | ||||||||
Investments | |||||||||
The fair values of available-for-sale investments, which approximated amortized costs, were as follows: | |||||||||
As of | 2014 | 2013 | |||||||
Money market funds | $ | 1,281 | $ | 1,188 | |||||
Corporate bonds | 561 | 414 | |||||||
Certificates of deposit | 437 | 349 | |||||||
Government securities | 420 | 168 | |||||||
Asset-backed securities | 128 | 97 | |||||||
Commercial paper | 107 | 61 | |||||||
Marketable equity securities | 1 | 6 | |||||||
$ | 2,935 | $ | 2,283 | ||||||
The table below presents the fair value of available-for-sale debt securities by contractual maturity: | |||||||||
As of | 2014 | ||||||||
Money market funds | $ | 1,281 | |||||||
Due in 1 year or less | 835 | ||||||||
Due in 1 - 2 years | 438 | ||||||||
Due in 2 - 4 years | 351 | ||||||||
Due after 4 years | 29 | ||||||||
$ | 2,934 | ||||||||
Net unrealized holding gains reclassified out of accumulated other comprehensive income from sales of available-for-sale securities were $31 million for 2012 and were not significant for any other period presented. Proceeds from sales of available-for-sale securities for 2014, 2013 and 2012 were $355 million, $526 million and $149 million, respectively. Gross realized gains from sales of available-for-sale securities were $34 million for 2012 and gross realized gains and losses for all other periods presented were not significant. |
Receivables
Receivables | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Receivables [Abstract] | ' | ||||||||
Receivables | ' | ||||||||
Receivables | |||||||||
As of | 2014 | 2013 | |||||||
Trade receivables (net of allowance for doubtful accounts of $3 and $5, respectively) | $ | 2,524 | $ | 2,069 | |||||
Income and other taxes | 104 | 74 | |||||||
Other | 278 | 186 | |||||||
$ | 2,906 | $ | 2,329 | ||||||
As of August 28, 2014 and August 29, 2013, other receivables included $70 million and $34 million, respectively, due from Intel for amounts related to product design and process development activities under cost-sharing agreements for NAND Flash and certain emerging memory technologies. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.) |
Inventories
Inventories | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Inventory Disclosure [Abstract] | ' | ||||||||
Inventories | ' | ||||||||
Inventories | |||||||||
As of | 2014 | 2013 | |||||||
Finished goods | $ | 898 | $ | 796 | |||||
Work in process | 1,372 | 1,719 | |||||||
Raw materials and supplies | 185 | 134 | |||||||
$ | 2,455 | $ | 2,649 | ||||||
Property_Plant_and_Equipment
Property, Plant and Equipment | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property, Plant and Equipment | ' | ||||||||
Property, Plant and Equipment | |||||||||
As of | 2014 | 2013 | |||||||
Land | $ | 86 | $ | 86 | |||||
Buildings (includes $289 and $209, respectively, from capital leases) | 5,093 | 4,835 | |||||||
Equipment (includes $1,108 and $1,305, respectively, from capital leases) | 17,781 | 15,600 | |||||||
Construction in progress | 114 | 84 | |||||||
Software | 358 | 315 | |||||||
23,432 | 20,920 | ||||||||
Accumulated depreciation (includes $693 and $463, respectively, from capital leases) | (14,750 | ) | (13,294 | ) | |||||
$ | 8,682 | $ | 7,626 | ||||||
Depreciation expense was $1,993 million, $1,721 million and $2,053 million for 2014, 2013 and 2012, respectively. Other noncurrent assets included land held for development of $57 million as of August 28, 2014 and $54 million as of August 29, 2013. | |||||||||
As of August 28, 2014, production equipment and buildings with carrying values of $476 million and land with a carrying value of $43 million were pledged as collateral under various notes payable. (See "Debt – Other Notes Payable" note.) |
Equity_Method_Investments
Equity Method Investments | 12 Months Ended | ||||||||||||||
Aug. 28, 2014 | |||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | ' | ||||||||||||||
Equity Method Investments | ' | ||||||||||||||
Equity Method Investments | |||||||||||||||
As of | 2014 | 2013 | |||||||||||||
Investment Balance | Ownership Percentage | Investment Balance | Ownership Percentage | ||||||||||||
Inotera(1) | $ | 914 | 33 | % | $ | 344 | 35 | % | |||||||
Tera Probe | 48 | 40 | % | 40 | 40 | % | |||||||||
Other | 9 | Various | 12 | Various | |||||||||||
$ | 971 | $ | 396 | ||||||||||||
(1) Entity is a variable interest entity. | |||||||||||||||
As of August 28, 2014, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was the $914 million carrying value of our investment in Inotera. We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera. | |||||||||||||||
We recognize our share of earnings or losses from our equity method investees generally on a two-month lag. Equity in net income (loss) of equity method investees, net of tax, included the following: | |||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||
Inotera | $ | 465 | $ | (79 | ) | $ | (189 | ) | |||||||
Tera Probe | 11 | — | — | ||||||||||||
Other | (2 | ) | (4 | ) | (105 | ) | |||||||||
$ | 474 | $ | (83 | ) | $ | (294 | ) | ||||||||
The summarized financial information in the tables below reflects aggregate amounts for all of our equity method investees. Financial information is presented for equity method investments as of the respective dates and for the periods through which we recorded our proportionate share of each investee's results of operations. Summarized results of operations are presented only for the periods subsequent to the acquisition or through the disposition of our ownership interests. | |||||||||||||||
As of | 2014 | 2013 | |||||||||||||
Current assets | $ | 2,233 | $ | 1,018 | |||||||||||
Noncurrent assets | 2,502 | 2,634 | |||||||||||||
Current liabilities | 1,417 | 1,912 | |||||||||||||
Noncurrent liabilities | 254 | 435 | |||||||||||||
For the years ended | 2014 | 2013 | 2012 | ||||||||||||
Net sales | $ | 3,382 | $ | 1,788 | $ | 1,798 | |||||||||
Gross margin | 1,576 | 1 | (451 | ) | |||||||||||
Operating income (loss) | 1,371 | (203 | ) | (751 | ) | ||||||||||
Net income (loss) | 1,339 | (188 | ) | (793 | ) | ||||||||||
Inotera | |||||||||||||||
We have partnered with Nanya in Inotera, a Taiwan DRAM memory company, since 2009. In 2012, we contributed $170 million to Inotera, which increased our ownership percentage to 40%. In 2013, Inotera issued 634 million common shares to Nanya and certain of its affiliates in a private placement at a price equal to 9.47 New Taiwan dollars per share, which was in excess of our carrying value per share. As a result of the issuance, our ownership interest decreased from 40% to 35% and we recognized a non-operating gain of $48 million in 2013. On May 15, 2014, Inotera issued 400 million common shares in a public offering at a price equal to 31.50 New Taiwan dollars per share, which was in excess of our carrying value per share. As a result of the issuance, our ownership interest decreased from 35% to 33% and we recognized a non-operating gain of $93 million in 2014. As of August 28, 2014, we held a 33% ownership interest in Inotera, Nanya and certain of its affiliates held a 33% ownership interest and the remaining ownership interest in Inotera was publicly held. | |||||||||||||||
As of August 28, 2014, the market value of our equity interest in Inotera was $3.72 billion based on the closing trading price of 51.90 New Taiwan dollars per share in an active market. As of August 28, 2014 and August 29, 2013, there were gains of $44 million and $44 million, respectively, in accumulated other comprehensive income (loss) for cumulative translation adjustments from our equity investment in Inotera. | |||||||||||||||
The net carrying value of our initial and subsequent investments was less than our proportionate share of Inotera's equity at the time of those investments. These differences are being amortized as a net credit to our earnings through equity in net income (loss) of equity method investees (the "Inotera Amortization"). For 2012, we recognized $48 million of Inotera Amortization and as of August 30, 2012, the remaining amount of unrecognized Inotera Amortization was not significant. | |||||||||||||||
Through December 2012, we purchased 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. Since January 2013, we have purchased substantially all of Inotera's DRAM output at a discount from market prices for our comparable components under a new supply agreement (the "Inotera Supply Agreement"). Our costs for supply from Inotera increased in 2014 from 2013 due to changes in average selling prices for our DRAM products and the changes in the pricing terms. The Inotera Supply Agreement has a three-year term (currently through December 2016) that contemplates annual negotiations with respect to potential successive one-year extensions. If the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. In the event of a wind-down, our share of Inotera's capacity would decline over the wind-down period. In 2014, our cost of products purchased from Inotera was significantly higher than our cost of similar products manufactured in our wholly-owned facilities. We are currently in negotiations regarding the extension of the Inotera Supply Agreement. There can be no assurance that we will be able to reach an agreement. Under the Inotera supply agreements, we purchased $2.68 billion, $1.26 billion and $646 million of DRAM products in 2014, 2013 and 2012 respectively. | |||||||||||||||
Pursuant to a DRAM R&D joint development program with Nanya, which was effective through December 31, 2012, our R&D costs were reduced by $19 million and $138 million in 2013 and 2012, respectively. Nanya ceased participating in the DRAM joint development program after December 31, 2012. | |||||||||||||||
Tera Probe | |||||||||||||||
In 2013, as part of the MMJ Acquisition, we acquired a 40% interest in Tera Probe, which provides semiconductor wafer testing and probe services to us and others. The initial net carrying value of our investment was less than our proportionate share of Tera Probe's equity and the difference is being amortized as a credit to our earnings through equity in net income (loss) of equity method investees (the "Tera Probe Amortization"). As of August 28, 2014, the remaining balance of the Tera Probe Amortization was $26 million and is expected to be amortized over a weighted-average period of 6 years. | |||||||||||||||
As of August 28, 2014, the market value of our equity interest in Tera Probe was $39 million based on the closing trading price of 1,087 yen per share in an active market and was $9 million below our carrying value. We evaluated our investment in Tera Probe and concluded that the decline in the market value below our carrying value was not an other-than-temporary impairment primarily because of the limited amount of time the fair value was below the carrying value and historical volatility of Tera Probe's stock price. | |||||||||||||||
We incurred manufacturing costs for 2014 and 2013 of $117 million and $13 million, respectively, for services performed by Tera Probe. | |||||||||||||||
Other | |||||||||||||||
Transform: In 2010, we acquired a 50% interest in Transform, a developer, manufacturer and marketer of photovoltaic technology and solar panels, from Origin. As of August 28, 2014, we and Origin each held a 50% ownership interest in Transform. In 2012, the Board of Directors of Transform approved a liquidation plan and as a result, we recognized a charge of $69 million in 2012. As of August 30, 2012, Transform's operations were substantially discontinued. | |||||||||||||||
Aptina: We held an equity interest in Aptina until August 15, 2014. On August 15, 2014, ON Semiconductor Corporation acquired Aptina for approximately $433 million and we recognized a non-operating gain of $119 million based on our diluted ownership interest of approximately 27%. The gain approximated our share of the consideration because the carrying value of our investment had been reduced to zero in the second quarter of 2012, at which time we ceased recognizing our proportionate share of Aptina's losses. | |||||||||||||||
Through May 3, 2013, we manufactured components for Complementary Metal-Oxide Semiconductor ("CMOS") image sensors for Aptina under a wafer supply agreement. Subsequent to May 3, 2013, we provided various services for Aptina under a service agreement. For 2014, 2013 and 2012, we recognized net sales of $43 million, $182 million and $372 million, respectively, from products sold to and services performed for Aptina, and cost of goods sold of $37 million, $219 million and $395 million, respectively. In 2013, we assigned to LFoundry Marsica L.r.l. ("LFoundry") our supply agreement with Aptina to manufacture components for image sensors at our 200mm Avezzano facility. (See "Restructure and Asset Impairments" note.) | |||||||||||||||
In connection with the sale of our 200mm Avezzano facility to LFoundry in 2013, we entered into a short-term, interest-free, unsecured loan agreement with Aptina. As of August 29, 2013, other current assets included $45 million for amounts due under the loan agreement, which was repaid in 2014. |
Intangible_Assets
Intangible Assets | 12 Months Ended | ||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ||||||||||||||||
Intangible Assets | ' | ||||||||||||||||
Intangible Assets | |||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||
Gross | Accumulated | Gross | Accumulated | ||||||||||||||
Amount | Amortization | Amount | Amortization | ||||||||||||||
Product and process technology | $ | 809 | $ | (341 | ) | $ | 642 | $ | (269 | ) | |||||||
Customer relationships | 1 | (1 | ) | 127 | (114 | ) | |||||||||||
$ | 810 | $ | (342 | ) | $ | 769 | $ | (383 | ) | ||||||||
During 2014 and 2013, we capitalized $177 million and $100 million, respectively, for product and process technology with weighted-average useful lives of 6 years and 7 years, respectively. Amortization expense was $110 million, $83 million and $88 million for 2014, 2013 and 2012, respectively. Annual amortization expense is estimated to be $112 million for 2015, $98 million for 2016, $88 million for 2017, $77 million for 2018 and $31 million for 2019. | |||||||||||||||||
Accounts_Payable_and_Accrued_E
Accounts Payable and Accrued Expenses | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Payables and Accruals [Abstract] | ' | ||||||||
Accounts Payable and Accrued Liabilities Disclosure | ' | ||||||||
Accounts Payable and Accrued Expenses | |||||||||
As of | 2014 | 2013 | |||||||
Accounts payable | $ | 1,119 | $ | 1,048 | |||||
Related party payables | 673 | 374 | |||||||
Salaries, wages and benefits | 456 | 267 | |||||||
Customer advances | 98 | 140 | |||||||
Income and other taxes | 71 | 47 | |||||||
Other | 281 | 239 | |||||||
$ | 2,698 | $ | 2,115 | ||||||
As of August 28, 2014 and August 29, 2013, related party payables included $660 million and $345 million, respectively, due to Inotera primarily for the purchase of DRAM products under the Inotera Supply Agreement. As of August 28, 2014 and August 29, 2013, related party payables also included $13 million and $29 million, respectively, due to Tera Probe for probe services performed. (See "Equity Method Investments" note.) | |||||||||
As of August 28, 2014, customer advances included $90 million for amounts received from a customer in 2014 under a DRAM supply agreement to be applied to purchases at market pricing through September 2016. As of August 28, 2014, other noncurrent liabilities included $90 million from this DRAM supply agreement. As of August 29, 2013, customer advances included $134 million for amounts received from Intel, all of which was applied to Intel's purchases of NAND Flash in 2014 under a supply agreement. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.) | |||||||||
Debt
Debt | 12 Months Ended | ||||||||||||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ' | ||||||||||||||||||||||||||||||
Debt | ' | ||||||||||||||||||||||||||||||
Debt | |||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
MMJ creditor installment payments | N/A | 6.25 | % | $ | 192 | $ | 939 | $ | 1,131 | $ | 527 | $ | 1,117 | $ | 1,644 | ||||||||||||||||
Capital lease obligations(2) | N/A | N/A | 323 | 588 | 911 | 407 | 845 | 1,252 | |||||||||||||||||||||||
2014 convertible senior notes | 1.875 | % | 7.88 | % | — | — | — | 465 | — | 465 | |||||||||||||||||||||
2019 senior notes | 1.258 | % | 1.97 | % | 92 | 324 | 416 | — | — | — | |||||||||||||||||||||
2022 senior notes | 5.875 | % | 6.14 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
2025 senior notes | 5.5 | % | 5.56 | % | — | 1,150 | 1,150 | — | — | — | |||||||||||||||||||||
2027 convertible senior notes | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
2031A convertible senior notes | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
2031B convertible senior notes(3) | 1.875 | % | 6.98 | % | 362 | — | 362 | — | 253 | 253 | |||||||||||||||||||||
2032C convertible senior notes(4) | 2.375 | % | 5.95 | % | — | 314 | 314 | — | 463 | 463 | |||||||||||||||||||||
2032D convertible senior notes(4) | 3.125 | % | 6.33 | % | — | 288 | 288 | — | 369 | 369 | |||||||||||||||||||||
2033E convertible senior notes(4)(5) | 1.625 | % | 4.5 | % | 278 | — | 278 | — | 272 | 272 | |||||||||||||||||||||
2033F convertible senior notes(4)(5) | 2.125 | % | 4.93 | % | 265 | — | 265 | — | 260 | 260 | |||||||||||||||||||||
2043G convertible senior notes | 3 | % | 6.76 | % | — | 636 | 636 | — | — | — | |||||||||||||||||||||
Other notes payable | 2.289 | % | 3.4 | % | 126 | 116 | 242 | 186 | 449 | 635 | |||||||||||||||||||||
$ | 1,638 | $ | 4,955 | $ | 6,593 | $ | 1,585 | $ | 4,452 | $ | 6,037 | ||||||||||||||||||||
(1) | We have either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||
(2) Weighted-average imputed rate of 4.3% and 4.1% as of August 28, 2014 and August 29, 2013, respectively. | |||||||||||||||||||||||||||||||
(3) | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||
(4) | Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||
(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Our senior notes are unsecured obligations ranking equally in right of payment with all of our other existing and future unsecured indebtedness, and are effectively subordinated to all of our other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness. Our parent company, MTI, has $3.89 billion of debt including all of our convertible notes, the 2022 Notes and the 2025 Notes, which are structurally subordinated to $1.57 billion of capital lease obligations and notes payable of its subsidiaries. MTI guarantees certain debt obligations of its subsidiaries. MTI does not guarantee the MMJ creditor installment payments. MTI's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of MTI's other existing and future unsecured indebtedness. | |||||||||||||||||||||||||||||||
2014 Debt Restructure | |||||||||||||||||||||||||||||||
In 2014, we initiated a series of actions to restructure our debt, including exchanges, conversions and settlements, repurchases, issuances and early repayments. The following table presents the net effect of each of the actions: | |||||||||||||||||||||||||||||||
Increase (Decrease) in Principal | Increase (Decrease) in Carrying Value | Increase (Decrease) in Cash | (Decrease) in Equity | Loss(1) | |||||||||||||||||||||||||||
Exchanges | $ | 585 | $ | 282 | $ | — | $ | (238 | ) | $ | 49 | ||||||||||||||||||||
Conversions and settlements | (770 | ) | (437 | ) | (1,446 | ) | (886 | ) | 130 | ||||||||||||||||||||||
Repurchases | (320 | ) | (269 | ) | (857 | ) | (567 | ) | 23 | ||||||||||||||||||||||
Issuances | 2,212 | 2,212 | 2,157 | — | — | ||||||||||||||||||||||||||
Early repayments | (336 | ) | (334 | ) | (339 | ) | — | 3 | |||||||||||||||||||||||
$ | 1,371 | $ | 1,454 | $ | (485 | ) | $ | (1,691 | ) | $ | 205 | ||||||||||||||||||||
(1) | The loss on 2014 debt restructure activities was recorded as $184 million in other non-operating expense and $21 million in interest expense in 2014. | ||||||||||||||||||||||||||||||
• | Exchanges: Exchanged $440 million in aggregate principal amount of our 2027 Notes, 2031A Notes and 2031B Notes into $1.03 billion principal amount at maturity of 2043G Notes. | ||||||||||||||||||||||||||||||
• | Conversions and Settlements: Holders of substantially all of our remaining 2014 Notes, 2027 Notes and 2031A Notes (with an aggregate principal amount of $770 million) converted their notes and we settled the conversions in cash for $1.45 billion. | ||||||||||||||||||||||||||||||
• | Repurchases: Repurchased $320 million in aggregate principal amount of our 2031B Notes, 2032C Notes and 2032D Notes in privately-negotiated transactions for an aggregate of $857 million in cash. | ||||||||||||||||||||||||||||||
• | Issuances: Issued $600 million in principal amount of 5.875% senior notes due February 2022 and $1.15 billion in principal amount of 5.500% senior notes due February 2025. Issued $462 million in principal amount of 1.258% senior notes due 2019 Notes, payable in 10 semi-annual installments commencing in July 2014. | ||||||||||||||||||||||||||||||
• | Early Repayments: Repaid $334 million of notes and capital leases prior to their scheduled maturities. (See "Other Notes Payable" below.) | ||||||||||||||||||||||||||||||
Subsequent to 2014, we settled an aggregate principal amount of $114 million of our remaining 2031B Notes for $389 million in cash and repaid a $120 million note prior to its scheduled maturity. (See "Other Notes Payable" below.) | |||||||||||||||||||||||||||||||
The following discussion provides further details of our 2014 debt restructure activities: | |||||||||||||||||||||||||||||||
Exchanges: During 2014, in a series of separate non-cash transactions, we exchanged portions of our 2027 Notes, 2031A Notes and 2031B Notes (collectively, the "Exchanged Notes") into 2043G Notes (collectively, the "Exchange Transactions"). In connection with the Exchange Transactions, which were accounted for as extinguishments, we issued to holders of the Exchanged Notes new 2043G Notes with an aggregate principal amount at issuance of $820 million, which accrete up to a principal amount at maturity of $1.03 billion (see further discussion in "2043G Notes" below). The liability and equity components of the Exchanged Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, our accounting for the Exchanged Notes affected debt and equity. In connection with the Exchange Transactions, we recognized a loss of $49 million based primarily on the difference between the carrying values and the fair values of the debt components of the Exchanged Notes, of which $38 million was included in other non-operating expense for 2014. The fair value of the debt component of each of the Exchanged Notes was determined as if they were stand-alone instruments using interest rates for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (based on Level 2 fair value measurements). The table below summarizes the Exchange Transactions: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
Amounts reduced in connection with the Exchanged Notes: | |||||||||||||||||||||||||||||||
2027 Notes | $ | 80 | $ | 68 | $ | 51 | |||||||||||||||||||||||||
2031A Notes | 155 | 125 | 148 | ||||||||||||||||||||||||||||
2031B Notes | 205 | 152 | 212 | ||||||||||||||||||||||||||||
440 | 345 | 411 | |||||||||||||||||||||||||||||
Amounts added in connection with the issued notes: | |||||||||||||||||||||||||||||||
2043G Notes | 1,025 | 627 | 173 | ||||||||||||||||||||||||||||
Net increase (decrease) as a result of the Exchange Transactions | $ | 585 | $ | 282 | $ | (238 | ) | ||||||||||||||||||||||||
Conversions and Settlements: During 2014, we initiated a series of actions resulting in a number of debt conversions and settlements. Those actions included the following: | |||||||||||||||||||||||||||||||
Termination of Conversion Rights of our 2027 Notes – On November 7, 2013, we announced the termination of the conversion rights for our remaining 2027 Notes, effective on December 13, 2013. Prior to such effective date, substantially all of the holders of our 2027 Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. | |||||||||||||||||||||||||||||||
Redemption of our 2031A Notes – On November 7, 2013, we called for the redemption of our remaining 2031A Notes effective on December 7, 2013. Prior to such effective date, substantially all of the holders of our 2031A Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. | |||||||||||||||||||||||||||||||
Redemption of our 2014 Notes – On January 31, 2014, we called for the redemption of our remaining 2014 Notes effective on March 3, 2014. Prior to such effective date, substantially all of the holders of our 2014 Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. | |||||||||||||||||||||||||||||||
Redemption of our 2031B Notes – On July 23, 2014, we called for the redemption of our remaining 2031B Notes with a principal amount of $114 million effective on August 22, 2014. Prior to such effective date, substantially all of the holders of our 2031B Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. All conversions of the 2031B Notes were settled in the first quarter of 2015. | |||||||||||||||||||||||||||||||
As a result of our elections to settle the conversion amounts in cash, each of the settlement obligations became derivative debt liabilities subject to mark-to-market accounting treatment. Under the terms of the indentures for the above notes, cash settlement amounts for these derivative debt liabilities were determined based on the shares underlying the converted notes multiplied by the volume-weighted-average price of our common stock over a period of 20 consecutive trading days, beginning three days after the holder's election to convert their notes. Therefore, we reclassified the fair values of the equity components of each of the converted notes from additional capital to derivative debt liabilities within current debt in our consolidated balance sheet. In connection with the above, we used an aggregate of $1.45 billion in cash in 2014 and $389 million in 2015 to settle conversion activities. A summary of the conversion activities for these notes is as follows: | |||||||||||||||||||||||||||||||
Debt Principal | (Increase) Decrease in Carrying Value of Debt | Equity Component Reclassified To Debt(1) | Loss(2) | ||||||||||||||||||||||||||||
2014 Notes | $ | 485 | $ | 478 | $ | 341 | $ | 9 | |||||||||||||||||||||||
2027 Notes | 95 | 80 | 58 | 42 | |||||||||||||||||||||||||||
2031A Notes | 190 | 154 | 217 | 70 | |||||||||||||||||||||||||||
2031B Notes(3) | — | (275 | ) | 270 | 9 | ||||||||||||||||||||||||||
$ | 770 | $ | 437 | $ | 886 | $ | 130 | ||||||||||||||||||||||||
(1) Based on Level 2 fair value measurements. | |||||||||||||||||||||||||||||||
(2) The loss on conversion and settlement activities was recorded as $120 million in other non-operating expense and $10 million in interest expense in 2014. | |||||||||||||||||||||||||||||||
(3) In the first quarter of 2015, we used an aggregate of $389 million in cash to settle the remaining 2031B Notes. In connection therewith, we incurred an additional charge of $24 million for the settlement of the 2031B Notes in the first quarter of 2015. | |||||||||||||||||||||||||||||||
Repurchases: During 2014, we repurchased $320 million in aggregate principal amount of our 2031B Notes, 2032C Notes and 2032D Notes in privately-negotiated transactions for an aggregate of $857 million in cash, collectively referred to herein as the "Repurchased Notes." In connection with the Repurchased Notes, we recognized losses (based on Level 2 fair value measurements) of $23 million in 2014, which were included in other non-operating expense. | |||||||||||||||||||||||||||||||
The liability and equity components of the Repurchased Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, our accounting for the Repurchased Notes affect debt and equity. The table below summarizes amounts reduced in 2014 in connection with the Repurchased Notes: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
2031B Notes | $ | 26 | $ | 19 | $ | 43 | |||||||||||||||||||||||||
2032C Notes | 188 | 161 | 316 | ||||||||||||||||||||||||||||
2032D Notes | 106 | 89 | 208 | ||||||||||||||||||||||||||||
$ | 320 | $ | 269 | $ | 567 | ||||||||||||||||||||||||||
Issuances: During 2014, as part of our debt restructure activities, we issued the following senior notes: | |||||||||||||||||||||||||||||||
5.875% Senior Notes due February 2022: On February 10, 2014, we issued $600 million in principal amount of the 2022 Notes. Issuance costs for the 2022 Notes totaled $14 million. | |||||||||||||||||||||||||||||||
The 2022 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur or guarantee certain additional secured indebtedness and unsecured indebtedness of certain of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions and qualifications. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: Prior to February 15, 2017, we may redeem the 2022 Notes, in whole or in part, at a price equal to the principal amount of the 2022 Notes to be redeemed plus a make-whole premium as described in the indenture governing the 2022 Notes, together with accrued and unpaid interest. On or after February 15, 2017, we may redeem the 2022 Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. Additionally, prior to February 15, 2017, we may use the net cash proceeds of one or more equity offerings to redeem up to 35% of the aggregate principal amount of the 2022 Notes at a price equal to 105.875% of the principal amount together with accrued and unpaid interest. | |||||||||||||||||||||||||||||||
5.500% Senior Notes due February 2025: On July 28, 2014, we issued $1.15 billion in principal amount of the 2025 Notes. Issuance costs for the 2025 Notes totaled $13 million. | |||||||||||||||||||||||||||||||
The 2025 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur or guarantee certain additional secured indebtedness and unsecured indebtedness of certain of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions and qualifications. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: Prior to August 1, 2019, we may redeem the 2025 Notes, in whole or in part, at a price equal to the principal amount of the 2025 Notes to be redeemed plus a make-whole premium as described in the indenture governing the 2025 Notes, together with accrued and unpaid interest. On or after August 1, 2019, we may redeem the 2025 Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. Additionally, prior to August 1, 2017, we may use the net cash proceeds of one or more equity offerings to redeem up to 35% of the aggregate principal amount of the 2025 Notes at a price equal to 105.5% of the principal amount together with accrued and unpaid interest. | |||||||||||||||||||||||||||||||
2013 Debt Restructure | |||||||||||||||||||||||||||||||
During 2013, we repurchased $464 million of aggregate principal amount of our 2014 Notes for $477 million in cash in privately negotiated transactions. The liability and equity components of the 2014 Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, the repurchase resulted in the derecognition of $431 million in debt for the principal amount (net of $33 million of debt discount) and $15 million in additional capital for the equity component. We recognized a loss of $31 million (based on Level 2 fair value measurements) in 2013, which was included in other non-operating expense. | |||||||||||||||||||||||||||||||
MMJ Creditor Installment Payments | |||||||||||||||||||||||||||||||
Under the MMJ Companies' plans of reorganization, which set forth the treatment of the MMJ Companies' pre-petition creditors and their claims, the MMJ Companies were required to pay 200 billion yen, less certain expenses of the reorganization proceedings and other items, to their secured and unsecured creditors in seven annual installment payments (the "MMJ Creditor Installment Payments"). The MMJ Creditor Installment Payments do not provide for interest and were recorded at fair value in the MMJ Acquisition. The fair-value discount is accreted to interest expense over the term of the installment payments. | |||||||||||||||||||||||||||||||
Under the MMJ Companies' corporate reorganization proceedings, the secured creditors of MMJ will recover 100% of their amount of their fixed claims in 6 annual installment payments through December 2018 and the unsecured creditors will recover at least 17.4% of the amount of their fixed claims in 7 annual installment payments through December 2019. In October 2013, we paid the first installment payment of 51 billion yen to the reorganization creditors of the MMJ Companies. The secured creditors of MAI were paid in full with a portion of the first installment payment made in October 2013, while the unsecured creditors of MAI will recover at least 19% of the amount of their claims in 7 installment payments through December 2019. The remaining portion of the unsecured claims of the creditors of the MMJ Companies not recovered pursuant to the Reorganization Proceedings will be discharged, without payment, through December 2019. | |||||||||||||||||||||||||||||||
The following table presents the remaining amounts of MMJ Creditor Installment Payments (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount as of August 28, 2014: | |||||||||||||||||||||||||||||||
MMJ Creditor Installment Payments | |||||||||||||||||||||||||||||||
2015 | ¥ | 20,330 | $ | 196 | |||||||||||||||||||||||||||
2016 | 20,197 | 194 | |||||||||||||||||||||||||||||
2017 | 20,063 | 193 | |||||||||||||||||||||||||||||
2018 | 19,928 | 192 | |||||||||||||||||||||||||||||
2019 | 28,674 | 276 | |||||||||||||||||||||||||||||
2020 | 33,024 | 318 | |||||||||||||||||||||||||||||
142,216 | 1,369 | ||||||||||||||||||||||||||||||
Less unamortized discount | (24,700 | ) | (238 | ) | |||||||||||||||||||||||||||
MMJ Creditor Installment Payments | ¥ | 117,516 | $ | 1,131 | |||||||||||||||||||||||||||
Pursuant to the terms of the Sponsor Agreement, we entered into a series of agreements with the MMJ Companies, including supply agreements, research and development services agreements and general services agreements, which are intended to generate operating cash flows to meet the requirements of the MMJ Companies' businesses, including the funding of the MMJ Creditor Installment Payments. | |||||||||||||||||||||||||||||||
Capital Lease Obligations | |||||||||||||||||||||||||||||||
We have various capital lease obligations due in periodic installments with a weighted-average remaining term of 4.1 years as of August 28, 2014. In 2013, we received $126 million in proceeds from equipment sale-leaseback transactions and as a result recorded capital lease obligations aggregating $126 million at a weighted-average effective interest rate of 4.3%, payable in periodic installments through July 2017. | |||||||||||||||||||||||||||||||
Convertible Notes With Debt and Equity Components | |||||||||||||||||||||||||||||||
Accounting standards for convertible debt instruments that may be fully or partially settled in cash upon conversion require the debt and equity components to be separately accounted for in a manner that reflects a nonconvertible borrowing rate when interest expense is recognized in subsequent periods. The amount initially recorded as debt is based on the fair value of the debt component as a standalone instrument, determined using an interest rate for similar nonconvertible debt issued by entities with credit ratings similar to ours at the time of issuance. The difference between the debt recorded at inception and its principal amount is accreted to principal through interest expense through the estimated life of the note. | |||||||||||||||||||||||||||||||
The terms of our convertible notes give holders the right to require us to repurchase all or a portion of their notes at a date or dates earlier than the contractual maturity of the notes or upon the occurrence of certain events or circumstances. In these cases, we amortize any initial debt discount or imputed interest over the period from issuance of the notes through the earliest date that holders can require us to repurchase all or a portion of their notes. As a result, the period of amortization can be significantly shorter than the contractual maturity. (See "Holder Put Date" in the table below.) | |||||||||||||||||||||||||||||||
As of August 28, 2014, the trading price of our common stock was higher than the initial conversion prices of all of our outstanding convertible notes. As a result, the conversion values were in excess of principal amounts for such notes. The following table summarizes certain features of our convertible notes outstanding as of August 28, 2014: | |||||||||||||||||||||||||||||||
Holder Put Date | Outstanding Principal | Underlying Shares | Initial Conversion Price Per Share | Conversion Price Per Share Threshold(1) | Conversion Value in Excess of Principal(2) | ||||||||||||||||||||||||||
2032C Notes | May-19 | $ | 362 | 38 | $ | 9.63 | $ | 12.52 | $ | 873 | |||||||||||||||||||||
2032D Notes | May-21 | 344 | 34 | 9.98 | 12.97 | 785 | |||||||||||||||||||||||||
2033E Notes | Feb-18 | 300 | 27 | 10.93 | 14.21 | 600 | |||||||||||||||||||||||||
2033F Notes | Feb-20 | 300 | 27 | 10.93 | 14.21 | 600 | |||||||||||||||||||||||||
2043G Notes(3) | Nov-28 | 1,025 | 35 | 29.16 | 37.91 | 128 | |||||||||||||||||||||||||
$ | 2,331 | 161 | $ | 2,986 | |||||||||||||||||||||||||||
(1) | Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price. | ||||||||||||||||||||||||||||||
(2) | Based on our closing share price of $32.81 as of August 28, 2014. | ||||||||||||||||||||||||||||||
(3) | The original principal amount of $820 million accretes up to $917 million in November 2028 and $1.03 billion at maturity in 2043. | ||||||||||||||||||||||||||||||
The debt and equity components of all of our convertible notes outstanding as of August 28, 2014 were required to be accounted for separately. Principal and carrying amounts of the liability components for our convertible notes were as follows: | |||||||||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||||||||
Term | Outstanding Principal | Unamortized Discount | Net Carrying Amount | Outstanding Principal | Unamortized Discount | Net Carrying Amount | |||||||||||||||||||||||||
(Years)(1) | |||||||||||||||||||||||||||||||
2014 Notes | N/A | $ | — | $ | — | $ | — | $ | 485 | $ | (20 | ) | $ | 465 | |||||||||||||||||
2027 Notes | N/A | — | — | — | 175 | (28 | ) | 147 | |||||||||||||||||||||||
2031A Notes | N/A | — | — | — | 345 | (68 | ) | 277 | |||||||||||||||||||||||
2031B Notes(2) | N/A | 114 | (27 | ) | 362 | 345 | (92 | ) | 253 | ||||||||||||||||||||||
2032C Notes | 5 | 362 | (48 | ) | 314 | 550 | (87 | ) | 463 | ||||||||||||||||||||||
2032D Notes | 7 | 344 | (56 | ) | 288 | 450 | (81 | ) | 369 | ||||||||||||||||||||||
2033E Notes | 3 | 300 | (22 | ) | 278 | 300 | (28 | ) | 272 | ||||||||||||||||||||||
2033F Notes | 5 | 300 | (35 | ) | 265 | 300 | (40 | ) | 260 | ||||||||||||||||||||||
2043G Notes | 14 | 1,025 | (389 | ) | 636 | — | — | — | |||||||||||||||||||||||
$ | 2,445 | $ | (577 | ) | $ | 2,143 | $ | 2,950 | $ | (444 | ) | $ | 2,506 | ||||||||||||||||||
(1) | Expected term for amortization of the remaining debt discount as of August 28, 2014. The expected term of the 2031B Notes was not applicable because substantially all of the holders had exercised their option to convert their notes, which were settled in cash in the first quarter of 2015. | ||||||||||||||||||||||||||||||
(2) As holders had elected to convert these notes and we elected to settle the conversions in cash, net carrying amount for 2014 included the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | |||||||||||||||||||||||||||||||
Carrying amounts of the equity components, which are included in additional capital in the accompanying consolidated balance sheets, for our convertible notes, were as follows: | |||||||||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||||||||
2014 Notes | $ | — | $ | 353 | |||||||||||||||||||||||||||
2027 Notes | — | 40 | |||||||||||||||||||||||||||||
2031A Notes | — | 89 | |||||||||||||||||||||||||||||
2031B Notes | — | 109 | |||||||||||||||||||||||||||||
2032C Notes | 67 | 101 | |||||||||||||||||||||||||||||
2032D Notes | 69 | 90 | |||||||||||||||||||||||||||||
2033E Notes (excludes $22 million as of 2014 in mezzanine equity) | 8 | 30 | |||||||||||||||||||||||||||||
2033F Notes (excludes $35 million as of 2014 in mezzanine equity) | 7 | 42 | |||||||||||||||||||||||||||||
2043G Notes | 173 | — | |||||||||||||||||||||||||||||
$ | 324 | $ | 854 | ||||||||||||||||||||||||||||
Interest expense for our convertible notes consisting of contractual interest and amortization of discount and issuance costs aggregated $132 million, $156 million and $124 million for 2014, 2013 and 2012. Interest expense by note was as follows: | |||||||||||||||||||||||||||||||
Contractual Interest | Amortization of Discount and Issuance Costs | ||||||||||||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | 2014 | 2013 | 2012 | |||||||||||||||||||||||||
2014 Notes | $ | 2 | $ | 13 | $ | 18 | $ | 14 | $ | 37 | $ | 47 | |||||||||||||||||||
2027 Notes | 1 | 3 | 3 | 2 | 7 | 6 | |||||||||||||||||||||||||
2031A Notes | 1 | 5 | 5 | 3 | 12 | 11 | |||||||||||||||||||||||||
2031B Notes | 3 | 6 | 6 | 5 | 10 | 10 | |||||||||||||||||||||||||
2032C Notes | 11 | 13 | 5 | 12 | 14 | 5 | |||||||||||||||||||||||||
2032D Notes | 13 | 14 | 5 | 8 | 9 | 3 | |||||||||||||||||||||||||
2033E Notes | 5 | 3 | — | 7 | 4 | — | |||||||||||||||||||||||||
2033F Notes | 6 | 3 | — | 6 | 3 | — | |||||||||||||||||||||||||
2043G Notes | 24 | — | — | 9 | — | — | |||||||||||||||||||||||||
$ | 66 | $ | 60 | $ | 42 | $ | 66 | $ | 96 | $ | 82 | ||||||||||||||||||||
2019 Notes | |||||||||||||||||||||||||||||||
On December 20, 2013, we issued $462 million in principal amount of the 2019 Notes. The 2019 Notes mature on January 15, 2019 and are collateralized by certain equipment, which had a carrying value of $190 million as of August 28, 2014. The principal amount of the 2019 Notes is payable in 10 semi-annual installments in January and July of each year, commencing in July 2014. The Export-Import Bank of the United States (the "Ex-Im Bank") guaranteed payment of all regularly scheduled installment payments of principal of, and interest on, the 2019 Notes. We paid $23 million to Ex-Im Bank for its guarantee upon issuance of the 2019 Notes. | |||||||||||||||||||||||||||||||
The 2019 Notes contains covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the equipment securing the 2019 Notes. Events of default also include, among others, the occurrence of any event or circumstance that, in the reasonable judgment of Ex-Im Bank, is likely materially and adversely to affect our ability to perform any payment obligation, or any of our other material obligations under the indenture, the 2019 Notes or under any other related transaction documents to which Ex-Im Bank is a party. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: At any time prior to the maturity date of the 2019 Notes, we may redeem the 2019 Notes, in whole or in part, at a price equal to the principal amount of the 2019 Notes to be redeemed plus a make-whole premium as described in the indenture, together with accrued and unpaid interest. | |||||||||||||||||||||||||||||||
2031B Notes | |||||||||||||||||||||||||||||||
On July 26, 2011, we issued $345 million of 2031B Notes due August 2031. During 2014, we exchanged $205 million of aggregate principal amount in the Exchange Transaction, repurchased $26 million of aggregate principal amount for cash and called for the redemption of the remaining $114 million of aggregate principal amount effective on August 22, 2014. Prior to such effective date, substantially all of the holders of the 2031B Notes had converted their notes, which were settled in cash with payments of $389 million in the first quarter of 2015. | |||||||||||||||||||||||||||||||
2032C and 2032D Notes | |||||||||||||||||||||||||||||||
On April 18, 2012, we issued $550 million of the 2032C Notes and $450 million of the 2032D Notes, each due May 2032. The initial conversion rate for the 2032C Notes is 103.8907 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.63 per share of common stock. The initial conversion rate for the 2032D Notes is 100.1803 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $9.98 per share of common stock. Interest is payable in May and November of each year. During 2014, we repurchased in privately-negotiated transactions $188 million and $106 million of aggregate principal amounts of the 2032C and 2032D Notes, respectively, for cash. | |||||||||||||||||||||||||||||||
Conversion Rights: Holders may convert their 2032 Notes under the following circumstances: (1) if the 2032 Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2032 Notes (approximately $12.52 per share for the 2032C Notes and $12.97 per share for the 2032D Notes); (3) if the trading price of the 2032 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2032 Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2032 Notes; or (5) at any time after February 1, 2032. | |||||||||||||||||||||||||||||||
We have the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due upon conversion. It is our intent to settle the principal amount of the 2032 Notes in cash upon any conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of the 2032 Notes are considered in diluted earnings per share under the treasury stock method. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: We may redeem for cash the 2032C Notes on or after May 1, 2016 and the 2032D Notes on or after May 1, 2017 if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period. The redemption price will equal the principal amount plus accrued and unpaid interest. If we redeem the 2032C Notes prior to May 4, 2019, or the 2032D Notes prior to May 4, 2021, we will also pay a make-whole premium in cash equal to the present value of all remaining scheduled payments of interest from the redemption date to May 4, 2019 for the 2032C Notes, or to May 4, 2021 for the 2032D Notes, using a discount rate equal to 1.50%. | |||||||||||||||||||||||||||||||
Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2032 Notes to repurchase for cash all or a portion of the 2032C Notes on May 1, 2019 and all or a portion of the 2032D Notes on May 1, 2021 at a price equal to the principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2032 Notes may require us to repurchase for cash all or a portion of their 2032 Notes at a price equal to the principal amount plus accrued and unpaid interest. | |||||||||||||||||||||||||||||||
2033E and 2033F Notes | |||||||||||||||||||||||||||||||
On February 12, 2013, we issued $300 million of the 2033E Notes and $300 million of the 2033F Notes. The initial conversion rate for the 2033 Notes is 91.4808 shares of common stock per $1,000 principal amount, equivalent to an initial conversion price of approximately $10.93 per share of common stock. Interest is payable in February and August of each year. | |||||||||||||||||||||||||||||||
Conversion Rights: Holders may convert their 2033 Notes under the following circumstances: (1) if the 2033 Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2033 Notes (approximately $14.21 per share); (3) if the trading price of the 2033 Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2033 Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture for the 2033 Notes; or (5) at any time after November 15, 2032. | |||||||||||||||||||||||||||||||
Upon conversion, we will pay cash equal to the lesser of the aggregate principal amount and the conversion value of the notes being converted and cash, shares of common stock or a combination of cash and shares of common stock, at our option, for any remaining conversion obligation. As a result, only the amounts payable in excess of the principal amounts upon conversion of the 2033 Notes are considered in diluted earnings per share under the treasury stock method. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: We may redeem for cash the 2033E Notes on or after February 20, 2018 and the 2033F Notes on or after February 20, 2020 at a price equal the principal amount plus accrued and unpaid interest. | |||||||||||||||||||||||||||||||
Cash Repurchase at the Option of the Holder: We may be required by the holders of the 2033 Notes to repurchase for cash all or a portion of the 2033E Notes on February 15, 2018 and on February 15, 2023 and all or a portion of the 2033F Notes on February 15, 2020 and on February 15, 2023 at a price equal to the principal amount plus accrued and unpaid interest. Upon a change in control or a termination of trading, as defined in the indenture, holders of the 2033 Notes may require us to repurchase for cash all or a portion of their 2033 Notes at a price equal to the principal amount plus accrued and unpaid interest. | |||||||||||||||||||||||||||||||
2043G Notes | |||||||||||||||||||||||||||||||
In connection with the Exchange Transactions, on November 12, 2013, we issued $1.03 billion principal amount of the 2043G Notes. Each $1,000 of principal amount at maturity had an original issue price of $800. An amount equal to the difference between the original issue price and the principal amount at maturity will accrete in accordance with a schedule set forth in the indenture. The initial conversion rate for the 2043G Notes is 34.2936 shares of common stock per $1,000 principal amount at maturity, equivalent to an initial conversion price of approximately $29.16 per share of common stock. | |||||||||||||||||||||||||||||||
Upon issuance of the 2043G Notes, we recorded $627 million of debt, $173 million of additional capital and $5 million of deferred debt issuance costs (included in other noncurrent assets). The amount recorded as debt was based on the fair value of the debt component as a standalone instrument and was determined using an interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2 fair value measurements). We recorded a debt discount of $398 million for the difference between the debt recorded at inception and the principal amount at maturity. Holders of the 2043G Notes have the right to require us to repurchase all or a portion of their notes on November 15, 2028 at the accreted principal amount, which is scheduled to be $917 million at such date. We have the option to pay cash, issue shares of common stock or any combination thereof, for the aggregate amount due upon conversion. It is our current intent to settle in cash the principal amount of the 2043G Notes upon conversion. As a result, the dilutive effect of the 2043G Notes in earnings per share is computed under the treasury stock method. | |||||||||||||||||||||||||||||||
Conversion Rights: Holders may convert their 2043G Notes under the following circumstances: (1) if the 2043G Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price of the 2043G Notes (approximately $37.91 per share); (3) if the trading price of the 2043G Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2043G Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture; or (5) at any time after August 15, 2043. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: Prior to November 20, 2018, we may redeem for cash the 2043G Notes if the closing price of our common stock is more than 130% of the conversion price for at least 20 trading days in the 30 consecutive trading days ending within five trading days prior to the date on which we provide notice of redemption at a redemption would equal to the principal amount at maturity plus accrued and unpaid interest. On or after November 20, 2018, we may redeem for cash the 2043G Notes without regard to the closing price of our common stock at a price equal the accreted principal amount plus accrued and unpaid interest. If we redeem the 2043G Notes prior to November 20, 2018, we are required to pay in cash a make-whole premium as specified in the indenture. | |||||||||||||||||||||||||||||||
Cash Repurchase at the Option of the Holder: Holders of the 2043G Notes may require us to repurchase for cash all or a portion of the 2043G Notes on November 15, 2028 at a price equal to the accreted principal amount at such date plus accrued and unpaid interest. Holders of the 2043G Notes may also require us to repurchase for cash all or a portion of their 2043G Notes at a price equal to the accreted principal amount plus accrued and unpaid interest upon a change in control or a termination of trading, as defined in the indenture. | |||||||||||||||||||||||||||||||
Other Notes Payable | |||||||||||||||||||||||||||||||
On August 27, 2013, we borrowed $312 million under a four-year term loan, collateralized by a security interest in certain production equipment. Principal was payable in equal quarterly installments, commencing on November 27, 2013. Interest accrued at a variable rate equal to the three-month London Interbank Offered Rate ("LIBOR") rate plus a margin of 3.25% per annum. Also on August 27, 2013, we entered into a variable-for-fixed interest rate swap calculated on an aggregate notional amount equal to the scheduled outstanding balance of the loan. The interest rate swap effectively fixed the rate at 4.2% per annum. On August 27, 2014, we repaid the remaining carrying value of $252 million of this note prior to its scheduled maturity and terminated the interest rate swaps. | |||||||||||||||||||||||||||||||
On October 2, 2012, we entered into a facility agreement to obtain financing collateralized by certain production equipment. Amounts drawn were payable in 10 equal semi-annual installments beginning six months after the draw date. On October 18, 2012, we drew $173 million with interest at 2.4% per annum. On January 31, 2013, we drew the remaining available amount under the facility of $41 million with interest at 2.4% per annum. On July 31, 2014, we repaid $32 million of this facility prior to its scheduled maturity and as of August 28, 2014, the outstanding principal balance was $120 million. On October 17, 2014, subsequent to fiscal 2014, we repaid the remaining carrying value of $120 million on this facility prior to its scheduled maturity date. | |||||||||||||||||||||||||||||||
On July 31, 2013, in connection with the MMJ Acquisition, we recorded a note payable of $120 million, collateralized by certain property, plant and equipment. Principal on the note is payable in equal quarterly installments through May 2016. Interest accrues at a variable rate of 0.85% above the secondary market rate for 90-day New Taiwan dollar commercial paper, subject to a minimum interest rate of 2.50% per annum. As of August 28, 2014, the outstanding balance was $70 million. | |||||||||||||||||||||||||||||||
On February 27, 2014, in connection with our acquisition of an additional 9.9% interest in MMT, we recorded a $127 million note payable to the seller for the present value of the monthly installments, due from March 2014 through December 2014. (See "Equity – Noncontrolling Interests in Subsidiaries – MMT" note.) As of August 28, 2014, the outstanding balance was $52 million. | |||||||||||||||||||||||||||||||
In connection with the IM Flash joint venture agreements, on April 6, 2012, we borrowed $65 million under a two-year senior unsecured promissory note from Intel, payable in approximately equal quarterly installments with interest at a rate of three-month LIBOR minus 50 basis points. The note was fully repaid in 2014 according to the scheduled terms. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.) | |||||||||||||||||||||||||||||||
Revolving Credit Facilities | |||||||||||||||||||||||||||||||
On September 5, 2012, we entered into a three-year revolving credit facility. Under this credit facility, we can draw up to the lesser of $255 million or 80% of the net outstanding balance of certain trade receivables, with any amounts drawn collateralized by a security interest in such receivables. The availability of the facility is subject to certain customary conditions, including the absence of any event or circumstance that has a material adverse effect on our business or financial condition. The revolving credit facility contains customary covenants and a repayment provision in the event that the aging of the receivables exceeds a specified threshold. Interest is payable on any outstanding principal balance at a variable rate equal to the 30-day Singapore Interbank Offering Rate plus 2.8% per annum. As of August 28, 2014, we had not drawn any of the amounts available under this facility. | |||||||||||||||||||||||||||||||
On June 27, 2013, we entered into a senior secured three-year revolving credit facility, collateralized by a security interest in certain trade receivables. Under this facility, we can draw up to 85% of the net outstanding balance of certain trade receivables, subject to certain adjustments, including an availability block that has the effect of limiting the maximum committed draw amount to approximately $153 million. The revolving credit facility contains customary covenants and conditions, including as a funding condition the absence of any event or circumstance that has a material adverse effect on our business or financial condition. Generally, interest is payable on any outstanding principal balance at a variable rate equal to the LIBOR plus a spread from 1.5% to 2.0%, or at our option, at a rate equal to an alternate base rate (defined as the highest of (1) the prime rate, (2) one-month LIBOR plus 1.0% or (3) the Federal Funds Effective Rate) plus a spread from 0.5% to 1.0%. In either case, the spread added to the applicable interest rate basis varies depending upon the amount of the monthly average undrawn availability under the facility. As of August 28, 2014, we had not drawn any of the amounts available under this facility. | |||||||||||||||||||||||||||||||
Maturities of Notes Payable and Future Minimum Lease Payments | |||||||||||||||||||||||||||||||
As of August 28, 2014, maturities of notes payable (including the MMJ Creditor Installment Payments) and future minimum lease payments under capital lease obligations were as follows: | |||||||||||||||||||||||||||||||
Notes Payable | Capital Lease Obligations | ||||||||||||||||||||||||||||||
2015 | $ | 803 | $ | 356 | |||||||||||||||||||||||||||
2016 | 352 | 301 | |||||||||||||||||||||||||||||
2017 | 320 | 103 | |||||||||||||||||||||||||||||
2018 | 602 | 60 | |||||||||||||||||||||||||||||
2019 | 684 | 55 | |||||||||||||||||||||||||||||
2020 and thereafter | 3,628 | 123 | |||||||||||||||||||||||||||||
Unamortized discounts and interest, respectively | (707 | ) | (87 | ) | |||||||||||||||||||||||||||
$ | 5,682 | $ | 911 | ||||||||||||||||||||||||||||
Commitments
Commitments | 12 Months Ended | ||||
Aug. 28, 2014 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Commitments Disclosure [Text Block] | ' | ||||
Commitments | |||||
As of August 28, 2014, we had commitments of approximately $1.18 billion for the acquisition of property, plant and equipment. We lease certain facilities and equipment under operating leases. Total rental expense was $57 million, $41 million and $48 million for 2014, 2013 and 2012, respectively. Minimum future rental commitments as of August 28, 2014 were as follows: | |||||
Operating Lease Commitments | |||||
2015 | $ | 22 | |||
2016 | 18 | ||||
2017 | 14 | ||||
2018 | 13 | ||||
2019 | 12 | ||||
2020 and thereafter | 37 | ||||
$ | 116 | ||||
Contingencies
Contingencies | 12 Months Ended |
Aug. 28, 2014 | |
Loss Contingency [Abstract] | ' |
Contingencies | ' |
Contingencies | |
We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition. | |
Rambus | |
On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips. Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.90 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal. | |
We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy. | |
In December 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters. We also entered into a seven-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term. We agreed to pay Rambus up to $10 million per quarter over seven years, for a total of $280 million, beginning in the second quarter of 2014. The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions. As a result, other operating expense for the first quarter of 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement. | |
Patent Matters | |
As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights. | |
On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including MMJ and Elpida Memory (USA) Inc. On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain MMJ and Elpida Memory (USA) Inc. DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 22, 2016. On March 23, 2012, MMJ and Elpida Memory (USA) Inc. filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against MMJ and Elpida Memory (USA) Inc. Accordingly, the plaintiffs' case against MMJ and Elpida Memory (USA) was stayed. On June 25, 2013, the U.S. Bankruptcy Court for the District of Delaware entered its Order (1) Granting Recognition of the Japanese Reorganization Plan of MMJ and the Tokyo District Court's Confirmation Orders, (2) Entrusting MMJ's U.S. Assets to Foreign Representatives and Approving Certain Plan Transactions, (3) Granting Permanent Injunction, and (4) Granting Related Relief (the "Recognition Order"). Pursuant to the Recognition Order, the plaintiffs are permanently enjoined from continuing their case against MMJ and Elpida Memory (USA) Inc. in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order). | |
On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board ("PTAB") held a hearing in connection with the three petitions on December 9, 2013. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University has appealed the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit. | |
On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. Trial is currently scheduled for August 21, 2015. | |
On December 7, 2007, Tessera, Inc. filed a patent infringement action against MMJ, Elpida Memory (USA) Inc., and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain MMJ and Elpida Memory (USA) Inc. products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, MMJ and Elpida Memory (USA) Inc. and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against MMJ and Elpida Memory (USA) Inc. and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by MMJ and Elpida Memory (USA) Inc. Tessera, Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. Additionally, by operation of the Recognition Order, plaintiff in that action is permanently enjoined from continuing its case against MMJ and Elpida Memory (USA) in respect of any claim or claims arising prior to the commencement of the Japan Proceeding (as defined in the Recognition Order). On July 30, 2014, we entered into a five-year term patent cross-license agreement with Tessera, which also settled the pending litigation against MMJ and Elpida Memory (USA). The agreement, which requires us to make quarterly payments over its term, gives us “life-of-product” protection for specifically identified DRAM products and a term license for certain other products. We capitalized an intangible asset for the term of the agreement and also recorded a $66 million charge to cost of goods sold in the fourth quarter of 2014. | |
Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales. | |
Except for the Tessera matter discussed above, we are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition. | |
Antitrust Matters | |
At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement. | |
On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002. | |
We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition. | |
Securities Matters | |
On July 12, 2013, seven former shareholders of Elpida (now known as MMJ) filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of MMJ as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of MMJ and deceive shareholders prior to MMJ filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys' fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu. | |
We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss. The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition. | |
Qimonda | |
On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against MTI and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 55% of our total shares in Inotera, and seeks an order requiring us to retransfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. | |
Following a series of hearings with pleadings, arguments and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda’s claims against Micron Technology for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. A hearing on the matter is scheduled for February 2, 2015. | |
We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or equivalent monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation or financial condition. As of August 28, 2014, the Inotera Shares had a carrying value in equity method investments for purposes of our financial reporting of $505 million and a market value of $2.06 billion. | |
Other | |
In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition. |
Redeemable_Convertible_Notes_R
Redeemable Convertible Notes Redeemable Convertible Notes | 12 Months Ended |
Aug. 28, 2014 | |
Redeemable Convertible Notes [Abstract] | ' |
Redeemable Convertible Notes [Text Block] | ' |
Redeemable Convertible Notes | |
Under the terms of the indentures of the 2033E and 2033F Notes, upon conversion, we would be required to pay cash equal to the lesser amount of (1) the aggregate principal amount or (2) the conversion value of the notes being converted (we could pay cash, shares of common stock or a combination thereof, at our option, for the remainder, if any, of our conversion obligation). Additionally, the 2033E and 2033F Notes were convertible at the option of the holders as of August 28, 2014. Therefore, the 2033E and 2033F Notes were classified as current debt and the aggregate difference of $57 million between the principal amount and the carrying value was classified as redeemable convertible notes in the mezzanine section of the accompanying consolidated balance sheet as of August 28, 2014. (See "Debt" note.) |
Equity
Equity | 12 Months Ended | |||||||||||||||||||||||||||
Aug. 28, 2014 | ||||||||||||||||||||||||||||
Equity [Abstract] | ' | |||||||||||||||||||||||||||
Equity | ' | |||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||
Micron Shareholders' Equity | ||||||||||||||||||||||||||||
Capped Calls | ||||||||||||||||||||||||||||
Issued and Outstanding Capped Calls: We have entered into capped calls, which are intended to reduce the effect of potential dilution from our convertible notes. The capped calls provide for our receipt of cash or shares, at our election, from our counterparties if the trading price of our stock is above a specified initial strike price at the expiration date. The amount receivable varies based on the trading price of our stock, up to a specified cap price. The dollar value of the cash or shares that we would receive from the capped calls upon their expiration date ranges from $0 if the trading price of our stock is below the initial strike price for all of the capped calls to $864 million if the trading price of our stock is at or above the cap price for all of the capped calls. We paid $57 million in 2011 to purchase the 2031 Capped Calls, $103 million in 2012 to purchase the 2032 Capped Calls and $48 million in 2013 to purchase the 2033 Capped Calls. The amounts paid were recorded as charges to additional capital. | ||||||||||||||||||||||||||||
The following table presents information related to the issued and outstanding capped calls as of August 28, 2014: | ||||||||||||||||||||||||||||
Capped Calls | Strike Price | Cap Price Range | Underlying Common Shares | Value at Expiration(1) | ||||||||||||||||||||||||
Expiration Dates | Low | High | Minimum | Maximum | ||||||||||||||||||||||||
2031 | Jul-15 | – | Feb-16 | $ | 9.5 | $ | 12.67 | $ | 13.17 | 34 | $ | — | $ | 117 | ||||||||||||||
2032C | May-16 | – | Nov-17 | 9.8 | 14.26 | 15.69 | 56 | — | 307 | |||||||||||||||||||
2032D | Nov-16 | – | May-18 | 10.16 | 14.62 | 16.04 | 44 | — | 244 | |||||||||||||||||||
2033E | Jan-18 | – | Feb-18 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
2033F | Jan-20 | – | Feb-20 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
188 | $ | — | $ | 864 | ||||||||||||||||||||||||
(1) | Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the low strike price, to the maximum amount if the market price per share of our common stock is at or above the high cap price. If share settlement were elected, the number of shares received would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. | |||||||||||||||||||||||||||
Unwind of Capped Calls: In May 2014, we and the counterparties agreed to terminate and unwind a portion of our 2031 Capped Calls. We elected share settlement and received 3 million shares of our stock, equivalent to approximately $86 million based on the trading stock price at the time of the unwind. The shares were retired from treasury stock in 2014. | ||||||||||||||||||||||||||||
Restrictions on Net Assets | ||||||||||||||||||||||||||||
As a result of the Japan Proceedings, for so long as such proceedings are continuing, the MMJ Group is subject to certain restrictions on dividends, loans and advances. In addition, our ability to access IMFT's cash and other assets through dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. As a result, our total restricted net assets (net assets less intercompany balances and noncontrolling interests) as of August 28, 2014 were $3.10 billion for the MMJ Group, which included cash and equivalents of $1.60 billion, and $793 million for IMFT. | ||||||||||||||||||||||||||||
(See "Micron Memory Japan, Inc." note and "IMFT" below.) | ||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||
Changes in accumulated other comprehensive income (loss) by component for the year ended August 28, 2014, were as follows: | ||||||||||||||||||||||||||||
Cumulative Foreign Currency Translation Adjustments | Gains (Losses) on Derivative Instruments, Net | Gains (Losses) on Investments, Net | Pension Liability Adjustments | Total | ||||||||||||||||||||||||
Balance as of August 29, 2013 | $ | 44 | $ | 21 | $ | — | $ | (2 | ) | $ | 63 | |||||||||||||||||
Other comprehensive income before reclassifications | 1 | (4 | ) | 4 | 1 | 2 | ||||||||||||||||||||||
Amount reclassified out of accumulated other comprehensive income | (3 | ) | (4 | ) | (3 | ) | 1 | (9 | ) | |||||||||||||||||||
Tax effects | — | (1 | ) | — | 1 | — | ||||||||||||||||||||||
Other comprehensive income (loss) | (2 | ) | (9 | ) | 1 | 3 | (7 | ) | ||||||||||||||||||||
Balance as of August 28, 2014 | $ | 42 | $ | 12 | $ | 1 | $ | 1 | $ | 56 | ||||||||||||||||||
Noncontrolling Interests in Subsidiaries | ||||||||||||||||||||||||||||
As of | 2014 | 2013 | ||||||||||||||||||||||||||
Noncontrolling Interest Balance | Noncontrolling Interest Percentage | Noncontrolling Interest Balance | Noncontrolling Interest Percentage | |||||||||||||||||||||||||
IMFT(1) | $ | 693 | 49 | % | $ | 601 | 49 | % | ||||||||||||||||||||
MP Mask(1) | 93 | 50 | % | 92 | 50 | % | ||||||||||||||||||||||
MMT | 9 | <l% | 155 | 11 | % | |||||||||||||||||||||||
Other | 7 | Various | 16 | Various | ||||||||||||||||||||||||
$ | 802 | $ | 864 | |||||||||||||||||||||||||
(1) Entity is a variable interest entity. | ||||||||||||||||||||||||||||
IMFT | ||||||||||||||||||||||||||||
Since inception in 2006 through August 28, 2014, we have owned 51% of IMFT, a venture between us and Intel to manufacture NAND Flash memory products and certain emerging memory technologies for the exclusive use of the members. IMFT is governed by a Board of Managers and the number of managers appointed by each member to the board varies based on the members' respective ownership interests, which is based on cumulative contributions to IMFT. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights with an Intel put right, commencing in January 2015, and our call right commencing in January 2018, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel's interest in IMFT. If Intel elects to sell to us, we would set the closing date of the transaction within two years following such election and could elect to receive financing of the purchase price from Intel for one to two years from the closing date. | ||||||||||||||||||||||||||||
IMFT manufactures NAND Flash memory products using designs and technology we develop with Intel. We generally share with Intel the costs of product design, other NAND Flash R&D costs and R&D costs of certain emerging memory technologies. Our R&D expenses were reduced by reimbursements from Intel of $137 million, $127 million and $87 million for 2014, 2013 and 2012, respectively. | ||||||||||||||||||||||||||||
We sell a portion of our products to Intel through our IMFT venture at long-term negotiated prices approximating cost. Sales of NAND Flash products to Intel under this arrangement were $423 million, $387 million and $718 million for 2014, 2013 and 2012, respectively. Receivables from Intel for sales of NAND Flash products as of August 28, 2014 and August 29, 2013, were $66 million and $68 million, respectively. | ||||||||||||||||||||||||||||
The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances: | ||||||||||||||||||||||||||||
As of | 2014 | 2013 | ||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||
Cash and equivalents | $ | 84 | $ | 62 | ||||||||||||||||||||||||
Receivables | 73 | 76 | ||||||||||||||||||||||||||
Inventories | 48 | 49 | ||||||||||||||||||||||||||
Other current assets | 5 | 4 | ||||||||||||||||||||||||||
Total current assets | 210 | 191 | ||||||||||||||||||||||||||
Property, plant and equipment, net | 1,545 | 1,382 | ||||||||||||||||||||||||||
Other noncurrent assets | 47 | 46 | ||||||||||||||||||||||||||
Total assets | $ | 1,802 | $ | 1,619 | ||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||
Accounts payable and accrued expenses | $ | 92 | $ | 88 | ||||||||||||||||||||||||
Deferred income | 8 | 9 | ||||||||||||||||||||||||||
Equipment purchase contracts | 14 | 78 | ||||||||||||||||||||||||||
Current portion of long-term debt | 21 | 6 | ||||||||||||||||||||||||||
Total current liabilities | 135 | 181 | ||||||||||||||||||||||||||
Long-term debt | 71 | 13 | ||||||||||||||||||||||||||
Other noncurrent liabilities | 110 | 118 | ||||||||||||||||||||||||||
Total liabilities | $ | 316 | $ | 312 | ||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. | ||||||||||||||||||||||||||||
Our ability to access IMFT's cash and other assets through dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets. | ||||||||||||||||||||||||||||
The following table presents IMFT's distributions to and contributions from its shareholders: | ||||||||||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||||||||||||||||
IMFT distributions to Micron | $ | 10 | $ | 38 | $ | 439 | ||||||||||||||||||||||
IMFT distributions to Intel | 10 | 37 | 391 | |||||||||||||||||||||||||
Micron contributions to IMFT | 106 | 12 | 48 | |||||||||||||||||||||||||
Intel contributions to IMFT | 102 | 11 | 46 | |||||||||||||||||||||||||
IMFS | ||||||||||||||||||||||||||||
We partnered with Intel to form IMFS in 2007 to manufacture NAND Flash memory products for the exclusive use of the members. Our ownership percentage of IMFS had increased from 51% at inception to 82% in April 2012 due to a series of contributions by us that were not fully matched by Intel. In April 2012, we entered into a series of agreements with Intel and acquired Intel's remaining 18% interest in IMFS for $466 million. In addition, we acquired IMFT's assets located at our Virginia wafer fabrication facility, for which Intel received a distribution from IMFT of $139 million. For both transactions, the amounts Intel received approximated the book values of Intel's interests in the assets acquired. Additionally, we received a $300 million deposit from Intel, substantially all of which was applied to Intel's purchases of NAND Flash products from 2012 to 2014 under a supply agreement. In 2012, Micron and Intel paid capital contributions to IMFS of $103 million and $131 million, respectively. | ||||||||||||||||||||||||||||
IMFS sold products to the joint venture members generally in proportion to their ownership interests at long-term negotiated prices approximating cost. IMFS sales of NAND Flash product to Intel for 2012 were $158 million and as a result of the April 2012 agreements, Intel had no continuing rights to the output from the IMFS and Virginia facilities. | ||||||||||||||||||||||||||||
MP Mask | ||||||||||||||||||||||||||||
In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors. The MP Mask joint venture agreement allows either party to terminate the joint venture in either May 2016, provided notice is given prior to May 2015, or in each five-year successive period following May 2016, provided such notice is given at least twelve months prior to the end of the successive five-year period. At inception and through August 28, 2014, we owned approximately 50% and Photronics owned approximately 50% of MP Mask. We contributed $21 million to MP Mask and Photronics contributed $20 million to MP Mask in 2012. We purchase a substantial majority of the photomasks produced by MP Mask pursuant to a supply arrangement. | ||||||||||||||||||||||||||||
The following table presents the assets and liabilities of MP Mask included in our consolidated balance sheets: | ||||||||||||||||||||||||||||
As of | 2014 | 2013 | ||||||||||||||||||||||||||
Current assets | $ | 24 | $ | 26 | ||||||||||||||||||||||||
Noncurrent assets (primarily property, plant and equipment) | 203 | 182 | ||||||||||||||||||||||||||
Current liabilities | 28 | 25 | ||||||||||||||||||||||||||
Noncurrent liabilities | 14 | — | ||||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. | ||||||||||||||||||||||||||||
Creditors of MP Mask have recourse only to MP Mask's assets and do not have recourse to any other of our assets. | ||||||||||||||||||||||||||||
In February 2012, we sold to Photronics for $35 million a photomask production facility we had leased to them under an operating lease. The proceeds were equal to our net carrying value and no gain or loss was realized from the sale. | ||||||||||||||||||||||||||||
MMT | ||||||||||||||||||||||||||||
As of August 29, 2013, noncontrolling interests in MMT were 11%. In 2014, we purchased additional interests in MMT for an aggregate of $146 million, and as of August 28, 2014, noncontrolling interests in MMT were less than 1%. Substantially all of the MMT shares purchased in 2014 were financed with a short-term loan from a seller. As a result of the purchases of MMT shares in 2014, in aggregate, noncontrolling interests decreased by $180 million and additional capital increased by $34 million. (See "Debt – Other Notes Payable" note.) |
Derivative_Financial_Instrumen
Derivative Financial Instruments | 12 Months Ended | ||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||
Derivative Instrument Detail [Abstract] | ' | ||||||||||||||||||||
Derivative Financial Instruments | ' | ||||||||||||||||||||
Derivative Instruments | |||||||||||||||||||||
We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities and to reduce the volatility that changes in interest rates on variable-rate debt have on our earnings. We also have convertible note settlement obligations which became derivative instruments as a result of our elections to settle conversions in cash. We do not use derivative instruments for speculative purpose. | |||||||||||||||||||||
Derivative Instruments without Hedge Accounting Designation | |||||||||||||||||||||
Currency Derivatives: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities. Our primary objective in entering into currency derivatives is to reduce the volatility that changes in currency exchange rates have on our earnings. | |||||||||||||||||||||
To hedge our exposures to monetary assets and liabilities, we generally utilize a rolling hedge strategy with currency forward contracts that mature within 35 days. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured in U.S. dollars and the associated outstanding forward contracts are marked-to-market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2 fair value measurements). In connection with the currency exchange rate risk associated with the MMJ Acquisition in July 2013, we entered into currency exchange transactions (the "MMJ Acquisition Hedges"). The MMJ Acquisition Hedges were not designated for hedge accounting and were remeasured at fair value each period. We recorded losses from the MMJ Acquisition Hedges of $228 million in 2013 and gains of $8 million in 2012. To mitigate the risk of the yen strengthening against the U.S. dollar on the MMJ creditor installment payments due in December 2014 and December 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015. | |||||||||||||||||||||
Realized and unrealized gains and losses on currency derivatives without hedge accounting designation as well as the change in the underlying monetary assets and liabilities due to changes in currency exchange rates are included in other non-operating income (expense). | |||||||||||||||||||||
Interest Rate Swaps: As of August 29, 2013 we were party to interest rate swap contracts scheduled to mature in August 2017 to hedge against the variability of future interest payments due on variable-rate debt, which effectively converted the variable-rate debt to fixed-rate debt. We designated 80% of the swaps as cash flow hedges and the remaining 20% were not designated for hedge accounting treatment. On August 27, 2014, we repaid the remaining carrying value of $252 million of the note prior to its scheduled maturity and terminated the interest rate swaps. | |||||||||||||||||||||
Convertible Notes Settlement Obligations: In connection with our debt restructure activities in 2014, holders elected to convert substantially all of the outstanding 2014 Notes, 2027 Notes, 2031A Notes and 2031B Notes. As a result of our elections to settle the conversion amounts in cash, each of the settlement obligations became derivative debt liabilities subject to mark-to-market accounting treatment for a period of approximately 30 days, beginning on the date we notified the holder of our intention to settle the obligation in cash through the settlement date. The fair values of the underlying derivative settlement obligations were initially determined using the Black-Scholes option valuation model (Level 2 fair value measurements). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. The subsequent measurements and final settlement amounts of our convertible notes settlement obligations were based on the volume-weighted average stock price (Level 1 fair value measurements). Changes in fair values of the derivative settlement obligations were included in other non-operating income (expense), net. | |||||||||||||||||||||
Total gross notional amounts and fair values for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
Notional Amount(1) | Fair Value of | ||||||||||||||||||||
Current Assets(2) | Noncurrent Assets(3) | Current Liabilities(4) | Noncurrent Liabilities(5) | ||||||||||||||||||
As of August 28, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 554 | $ | — | $ | — | $ | (12 | ) | $ | (6 | ) | |||||||||
Singapore dollar | 330 | — | — | — | — | ||||||||||||||||
Euro | 245 | — | — | (1 | ) | — | |||||||||||||||
Shekel | 62 | — | — | (1 | ) | — | |||||||||||||||
$ | 1,191 | ||||||||||||||||||||
Convertible notes settlement obligations | 12 | — | — | (389 | ) | — | |||||||||||||||
$ | — | $ | — | $ | (403 | ) | $ | (6 | ) | ||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 336 | $ | 1 | $ | 3 | $ | — | $ | — | |||||||||||
Singapore dollar | 218 | — | — | — | — | ||||||||||||||||
Euro | 217 | 1 | — | (1 | ) | — | |||||||||||||||
Shekel | 78 | — | — | (1 | ) | — | |||||||||||||||
Interest rate swap contracts | 62 | — | — | — | — | ||||||||||||||||
Currency options - New Taiwan dollar | 351 | — | — | — | — | ||||||||||||||||
$ | 1,262 | $ | 2 | $ | 3 | $ | (2 | ) | $ | — | |||||||||||
-1 | Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares. | ||||||||||||||||||||
(2) | Included in receivables - other. | ||||||||||||||||||||
(3) | Included in other noncurrent assets. | ||||||||||||||||||||
(4) | Included in accounts payable and accrued expenses - other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations. | ||||||||||||||||||||
(5) | Included in other noncurrent liabilities. | ||||||||||||||||||||
Net gains (losses) for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | Location | |||||||||||||||||
Convertible notes settlement obligations | $ | (59 | ) | $ | — | $ | — | Other non-operating income (expense) | |||||||||||||
Foreign exchange contracts | (27 | ) | (222 | ) | (17 | ) | Other non-operating income (expense) | ||||||||||||||
Derivative Instruments with Cash Flow Hedge Accounting Designation | |||||||||||||||||||||
Currency Derivatives: We utilize currency forward contracts that generally mature within 12 months and currency options that generally mature within 12 to 18 months to hedge our exposure to changes in cash flows from changes in currency exchange rates for certain capital expenditures and forecasted operating cash flows. Currency forward contracts are measured at fair value based on market-based observable inputs including currency exchange spot and forward rates, interest rate and credit risk spread (Level 2 fair value measurements). Currency options are measured at their fair value using a modified Black-Scholes option valuation model using inputs of the current spot rate, strike price, risk-free interest rate, maturity, volatility and credit-risk spread (Level 2 fair value measurements). | |||||||||||||||||||||
Interest Rate Swaps: As noted above in "Derivative Instruments without Hedge Designation – Interest Rate Swaps," we were party to interest rate swap contracts scheduled to mature in August 2017 to hedge against the variability in future interest payments due on variable-rate debt and we designated 80% of the swaps as cash flow hedges. On August 27, 2014, we repaid the remaining carrying value of $252 million of the note prior to its scheduled maturity and terminated the interest rate swaps. Amounts reclassified from accumulated other comprehensive income (loss) were not significant. | |||||||||||||||||||||
For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gain or loss on the derivatives is included as a component of accumulated other comprehensive income (loss). Amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. The ineffective or excluded portion of the realized and unrealized gain or loss is included in other non-operating income (expense). Total gross notional amounts and fair values for derivative instruments with cash flow hedge accounting designation were as follows: | |||||||||||||||||||||
Notional Amount | Fair Value of Current Liabilities(1) | ||||||||||||||||||||
(in U.S. Dollars) | |||||||||||||||||||||
As of August 28, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 94 | $ | (2 | ) | ||||||||||||||||
Euro | 24 | — | |||||||||||||||||||
$ | 118 | $ | (2 | ) | |||||||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 6 | $ | (1 | ) | ||||||||||||||||
Euro | 6 | — | |||||||||||||||||||
Interest swap contracts | 250 | — | |||||||||||||||||||
Currency options - Yen | 21 | (2 | ) | ||||||||||||||||||
$ | 283 | $ | (3 | ) | |||||||||||||||||
(1) | Included in accounts payable and accrued expenses - other. | ||||||||||||||||||||
For 2014, 2013 and 2012, we recognized losses of $4 million, $8 million and $9 million, respectively, in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges. The ineffective and excluded portions of cash flow hedges recognized in other non-operating income (expense) were not significant in 2014, 2013 or 2012. For 2014, 2013 and 2012, we reclassified gains of $4 million, $1 million and $9 million, respectively, from accumulated other comprehensive income (loss) to earnings. As of August 28, 2014, $8 million of gains from cash flow hedges included in accumulated other accumulated comprehensive income (loss) is expected to be reclassified into earnings in the next 12 months. | |||||||||||||||||||||
Derivative Counterparty Credit Risk and Master Netting Arrangements | |||||||||||||||||||||
Our derivative instruments expose us to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument. As of August 28, 2014, our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts was generally equal to the fair value of our assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. In addition, we monitor the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis. | |||||||||||||||||||||
We also seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty under these arrangements have been presented in our consolidated balance sheet on a net basis. As of August 28, 2014 amounts netted were not significant. |
Fair_Value_Measurements
Fair Value Measurements | 12 Months Ended | ||||||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||||||||||
Fair Value Measurements | ' | ||||||||||||||||||||||||
Fair Value Measurements | |||||||||||||||||||||||||
Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3). | |||||||||||||||||||||||||
Fair Value Measurements on a Recurring Basis | |||||||||||||||||||||||||
All marketable debt and equity investments are classified as available-for-sale and are carried at fair value. Assets measured at fair value on a recurring basis were as follows: | |||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||
Level 1 | Level 2 | Total | Level 1 | Level 2 | Total | ||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||
Money market funds | $ | 1,281 | $ | — | $ | 1,281 | $ | 1,188 | $ | — | $ | 1,188 | |||||||||||||
Certificates of deposit | — | 402 | 402 | — | 38 | 38 | |||||||||||||||||||
Commercial paper | — | 22 | 22 | — | 35 | 35 | |||||||||||||||||||
1,281 | 424 | 1,705 | 1,188 | 73 | 1,261 | ||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||
Corporate bonds | — | 154 | 154 | — | 112 | 112 | |||||||||||||||||||
Government securities | — | 136 | 136 | — | 72 | 72 | |||||||||||||||||||
Commercial paper | — | 85 | 85 | — | 26 | 26 | |||||||||||||||||||
Certificates of deposit | — | 8 | 8 | — | 9 | 9 | |||||||||||||||||||
Asset-backed securities | — | 1 | 1 | — | 2 | 2 | |||||||||||||||||||
— | 384 | 384 | — | 221 | 221 | ||||||||||||||||||||
Long-term marketable investments: | |||||||||||||||||||||||||
Corporate bonds | — | 407 | 407 | — | 302 | 302 | |||||||||||||||||||
Government securities | — | 284 | 284 | — | 96 | 96 | |||||||||||||||||||
Asset-backed securities | — | 127 | 127 | — | 95 | 95 | |||||||||||||||||||
Marketable equity securities | 1 | — | 1 | 6 | — | 6 | |||||||||||||||||||
1 | 818 | 819 | 6 | 493 | 499 | ||||||||||||||||||||
Restricted cash: | |||||||||||||||||||||||||
Certificates of deposit | — | 27 | 27 | — | 302 | 302 | |||||||||||||||||||
— | 27 | 27 | — | 302 | 302 | ||||||||||||||||||||
$ | 1,282 | $ | 1,653 | $ | 2,935 | $ | 1,194 | $ | 1,089 | $ | 2,283 | ||||||||||||||
Government securities consist of securities issued directly by or deemed to be guaranteed by government entities such as U.S. and non U.S. agency securities, government bonds and treasury securities. Level 2 securities are valued using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from our pricing services. As of August 28, 2014, no adjustments were made to such pricing information. | |||||||||||||||||||||||||
Fair Value Measurements on a Nonrecurring Basis | |||||||||||||||||||||||||
In connection with the Exchange Transactions, we determined the fair value for the debt component of the Exchanged Notes as if it were a stand-alone instrument using an interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2). In connection with the debt conversions and settlements in 2014, we determined the initial fair value of the equity component of the converted notes that was reclassified to debt using the Black-Scholes option valuation model (Level 2). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. The subsequent measurements of our convertible notes settlement obligations were based on the value-weighted average stock price (Level 1). Changes in fair values of the derivatives settlement obligations were included in other non-operating income (expense). | |||||||||||||||||||||||||
Our non-marketable securities, equity method investments, and non-financial assets such as intellectual property and property, plant and equipment are carried at cost unless impairment is deemed to have occurred. | |||||||||||||||||||||||||
During 2012, the Board of Directors of Transform approved a liquidation plan. As a result, we impaired our investment in Transform to the estimated liquidation values for its assets and liabilities measured using unobservable inputs (Level 3). The fair values of Transform's primary assets, semiconductor equipment and a manufacturing facility, were based on quotations obtained from equipment dealers, which consider the remaining useful life and configuration of the equipment and sales of similar manufacturing facilities, and properties in comparable markets, respectively. Based on our valuation of Transform's net assets, we recognized an other-than-temporary impairment charge of $69 million in equity in net income (losses) of equity method investees. | |||||||||||||||||||||||||
In connection with our restructure and asset impairment charges, the fair value of our 200mm wafer fabrication equipment in Kiryat Gat, Israel was determined primarily based on the expected proceeds of the sale and the fair value of a supply agreement to manufacture NOR flash memory at the facility (Level 3 fair value measurement). The fair values of our MIT assets and our Light-emitting Diode ("LED") production assets were based on quotations obtained from equipment dealers, which consider the remaining useful life and configuration of the equipment (Level 3 fair value measurement). (See "Restructure and Asset Impairments" note.) | |||||||||||||||||||||||||
Fair Value of Financial Instruments | |||||||||||||||||||||||||
Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of debt instruments (carrying value excludes the equity and mezzanine components of our convertible notes, which are classified in equity) were as follows: | |||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||
Fair | Carrying | Fair | Carrying | ||||||||||||||||||||||
Value | Value | Value | Value | ||||||||||||||||||||||
Convertible notes | $ | 5,886 | $ | 2,143 | $ | 4,167 | $ | 2,506 | |||||||||||||||||
MMJ creditor installment payments and other notes | 3,634 | 3,539 | 2,269 | 2,279 | |||||||||||||||||||||
The fair values of our convertible notes were determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of our convertible notes, when available, our stock price and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2). The fair value of our other debt instruments was estimated based on discounted cash flows using inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2). |
Equity_Plans
Equity Plans | 12 Months Ended | |||||||||||||
Aug. 28, 2014 | ||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||
Equity Plans | ' | |||||||||||||
Equity Plans | ||||||||||||||
As of August 28, 2014, we had an aggregate of 161 million shares of common stock reserved for the issuance of stock options and restricted stock awards, of which 62 million shares were subject to outstanding awards and 99 million shares were available for future awards. Awards are subject to terms and conditions as determined by our Board of Directors. | ||||||||||||||
Stock Options | ||||||||||||||
Our stock options are generally exercisable in increments of either one-fourth or one-third per year beginning one year from the date of grant. Stock options issued after February 2014 generally expire eight years from the date of grant. Options issued from October 2004 to February 2014 generally expire six years from the date of grant. | ||||||||||||||
Option activity for 2014 is summarized as follows: | ||||||||||||||
Number of Shares | Weighted-Average Exercise Price Per Share | Weighted-Average Remaining Contractual Life | Aggregate Intrinsic Value | |||||||||||
(In Years) | ||||||||||||||
Outstanding at August 29, 2013 | 71 | $ | 7.41 | |||||||||||
Granted | 12 | 22.61 | ||||||||||||
Exercised | (32 | ) | 8.27 | |||||||||||
Cancelled or expired | (3 | ) | 9.27 | |||||||||||
Outstanding at August 28, 2014 | 48 | 10.57 | 3.8 | $ | 1,078 | |||||||||
Exercisable at August 28, 2014 | 14 | $ | 6.88 | 2.4 | $ | 362 | ||||||||
Expected to vest after August 28, 2014 | 33 | 11.92 | 4.3 | 692 | ||||||||||
The weighted-average grant-date fair value per share was $9.64, $3.34 and $3.18 for options granted during 2014, 2013 and 2012, respectively. The total intrinsic value was $421 million, $103 million, and $6 million for options exercised during 2014, 2013 and 2012, respectively. | ||||||||||||||
The fair values of option awards were estimated at each grant date using the Black-Scholes option valuation model. The Black-Scholes model requires the input of assumptions, including the expected stock-price volatility and estimated option life. The expected volatilities utilized were based on implied volatilities from traded options on our stock and on historical volatility. The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options. The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date. No dividends were assumed in estimated option values. Assumptions used in the Black-Scholes model are presented below: | ||||||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||
Average expected life in years | 4.9 | 5.1 | 5.1 | |||||||||||
Weighted-average expected volatility | 48 | % | 59 | % | 66 | % | ||||||||
Weighted-average risk-free interest rate | 1.6 | % | 0.7 | % | 0.9 | % | ||||||||
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards") | ||||||||||||||
As of August 28, 2014, there were 13 million shares of Restricted Stock Awards outstanding, of which 1 million were performance-based Restricted Stock Awards. For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth increments during each year of employment after the grant date. For performance-based Restricted Stock Awards, vesting is contingent upon meeting certain performance goals. Restricted Stock Awards activity for 2014 is summarized as follows: | ||||||||||||||
Number of Shares | Weighted-Average Grant Date Fair Value Per Share | |||||||||||||
Outstanding at August 29, 2013 | 13 | $ | 6.49 | |||||||||||
Granted | 7 | 21.88 | ||||||||||||
Restrictions lapsed | (6 | ) | 6.29 | |||||||||||
Cancelled | (1 | ) | 8.75 | |||||||||||
Outstanding at August 28, 2014 | 13 | 15.08 | ||||||||||||
Expected to vest after August 28, 2014 | 13 | $ | 14.91 | |||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||
Weighted-average grant-date fair values per share | $ | 21.88 | $ | 6.23 | $ | 5.43 | ||||||||
Aggregate fair values at vesting date | 115 | 17 | 32 | |||||||||||
Stock-based Compensation Expense | ||||||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||
Stock-based compensation expense by caption: | ||||||||||||||
Cost of goods sold | $ | 39 | $ | 27 | $ | 23 | ||||||||
Selling, general and administrative | 50 | 45 | 47 | |||||||||||
Research and development | 25 | 18 | 17 | |||||||||||
Other | 1 | 1 | — | |||||||||||
$ | 115 | $ | 91 | $ | 87 | |||||||||
Stock-based compensation expense by type of award: | ||||||||||||||
Stock options | $ | 61 | $ | 57 | $ | 57 | ||||||||
Restricted stock awards | 54 | 34 | 30 | |||||||||||
$ | 115 | $ | 91 | $ | 87 | |||||||||
Stock-based compensation expense of $9 million and $6 million was capitalized and remained in inventory as of August 28, 2014 and August 29, 2013, respectively. As of August 28, 2014, $275 million of total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards was expected to be recognized through the fourth quarter of 2018, resulting in a weighted-average period of 1.4 years. Stock-based compensation expense in the above presentation does not reflect any significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations. (See "Income Taxes" note.) |
Employee_Benefit_Plans
Employee Benefit Plans | 12 Months Ended |
Aug. 28, 2014 | |
Compensation and Retirement Disclosure [Abstract] | ' |
Pension and Other Postretirement Benefits Disclosure | ' |
Employee Benefit Plans | |
We have employee retirement plans at our U.S. and international sites. Details of the more significant plans are discussed as follows: | |
Employee Savings Plan for U.S. Employees | |
We have 401(k) retirement plans ("RAM Plans") under which U.S. employees may contribute up to 75% of their eligible pay (subject to IRS annual contribution limits) to various savings alternatives, none of which include direct investment in our stock. We match in cash eligible contributions from employees up to 5% of the employee's annual eligible earnings. Contribution expense for the RAM Plans was $44 million, $41 million and $41 million in 2014, 2013 and 2012, respectively. | |
Retirement Plans | |
We have pension plans in various countries. The pension plans are only available to local employees and are generally government mandated. As of August 28, 2014, the projected benefit obligations of our plans was $164 million and plan assets were $90 million. As of August 29, 2013, the projected benefit obligations of our plans was $196 million and plan assets were $116 million. Pension expense was not significant for 2014, 2013 or 2012. |
Restucture_and_Asset_Impairmen
Restucture and Asset Impairments | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Restructuring and Related Activities [Abstract] | ' | ||||||||||||
Restructuring and Asset Impairments | ' | ||||||||||||
Restructure and Asset Impairments | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Loss on impairment of LED assets | $ | (6 | ) | $ | 33 | $ | — | ||||||
Loss on impairment of MIT assets | (5 | ) | 62 | — | |||||||||
Gain on termination of lease to Transform | — | (25 | ) | — | |||||||||
Loss on restructure of ST Consortium agreement | — | 26 | — | ||||||||||
Other | 51 | 30 | 10 | ||||||||||
$ | 40 | $ | 126 | $ | 10 | ||||||||
In order to optimize operations, improve efficiency and increase our focus on our core memory operations, we have entered into various restructure activities. For 2014, our MBU and EBU operating segments recorded restructure and asset impairment charges of $21 million and $20 million, respectively. For 2013, restructure and asset impairment charges of $20 million, $14 million, $12 million and $12 million were recorded by our SBU, EBU, MBU and CNBU operating segments, respectively. Our other segments that do not meet the thresholds of a reportable segment recorded the remaining restructure and asset impairment charges. (See "Segments" note.) As of August 28, 2014, we had accrued $14 million for unpaid other restructure activities related to our workforce optimization activities. As of August 28, 2014, we do not anticipate incurring any significant additional costs for these restructure activities. | |||||||||||||
For 2014 and 2013, other restructure included charges associated with workforce optimization activities and with our efforts to wind down our 200mm operations primarily in Agrate, Italy and Kiryat Gat, Israel. | |||||||||||||
For 2013, we also recognized charges of $33 million primarily to impair certain production assets used in the development of LED technology, $62 million to impair the assets of MIT, a wholly-owned subsidiary, to their estimated fair values in connection with the sale of MIT to LFoundry, and $26 million in connection with the restructure of a consortium agreement with ST, whereby certain assets and approximately 500 employees from our Agrate, Italy fabrication facility were transferred to ST. For 2013, we also recognized a gain of $25 million related to the termination of a lease with Transform, an equity method investee, to a portion of our manufacturing facilities in Boise, Idaho. | |||||||||||||
(See "Fair Value Measurements" note.) |
Other_Operating_Income_Expense
Other Operating (Income) Expense, Net | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Other Income and Expenses [Abstract] | ' | ||||||||||||
Other Operating (Income) Expense, Net | ' | ||||||||||||
Other Operating (Income) Expense, Net | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Rambus settlement | $ | 233 | $ | — | $ | — | |||||||
(Gain) loss on disposition of property, plant and equipment | 10 | (3 | ) | 5 | |||||||||
Other | (11 | ) | (5 | ) | 27 | ||||||||
$ | 232 | $ | (8 | ) | $ | 32 | |||||||
In December 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters. As a result, other operating expense for 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement. (See "Contingencies" note.) | |||||||||||||
Other operating expense for 2012 included $17 million from the termination of a lease with IMFT and $10 million to write off a receivable in connection with resolution of certain prior year tax matters. |
Other_NonOperating_Income_Net_
Other Non-Operating Income , Net Other Non-Operating Income (Expense), Net | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Other Nonoperating Income (Expense) [Abstract] | ' | ||||||||||||
Other Non-Operating Income Expense, Net [Text Block] | ' | ||||||||||||
Other Non-Operating Income (Expense), Net | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Loss on restructure of debt | $ | (184 | ) | $ | (31 | ) | $ | — | |||||
Gain (loss) from changes in currency exchange rates | (28 | ) | (229 | ) | (6 | ) | |||||||
Gain from disposition of interest in Aptina | 119 | — | — | ||||||||||
Gain from issuance of Inotera shares | 93 | 48 | — | ||||||||||
Other | 8 | (6 | ) | 35 | |||||||||
$ | 8 | $ | (218 | ) | $ | 29 | |||||||
Income_Taxes
Income Taxes | 12 Months Ended | ||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||||||||||||||
Income Taxes | ' | ||||||||||||||||||||
Income Taxes | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||||||||
Income (loss) before income taxes, net income attributable to noncontrolling interests and equity in net income (loss) of equity method investees: | |||||||||||||||||||||
Foreign | $ | 2,619 | $ | 839 | $ | 274 | |||||||||||||||
U.S. | 114 | 446 | (1,028 | ) | |||||||||||||||||
$ | 2,733 | $ | 1,285 | $ | (754 | ) | |||||||||||||||
Income tax (provision) benefit: | |||||||||||||||||||||
Current: | |||||||||||||||||||||
Foreign | $ | (46 | ) | $ | (17 | ) | $ | (22 | ) | ||||||||||||
U.S. federal | (3 | ) | — | 14 | |||||||||||||||||
State | (2 | ) | — | — | |||||||||||||||||
(51 | ) | (17 | ) | (8 | ) | ||||||||||||||||
Deferred: | |||||||||||||||||||||
Foreign | (81 | ) | 9 | 25 | |||||||||||||||||
U.S. federal | 4 | — | — | ||||||||||||||||||
(77 | ) | 9 | 25 | ||||||||||||||||||
Income tax (provision) benefit | $ | (128 | ) | $ | (8 | ) | $ | 17 | |||||||||||||
Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit was as follows: | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||||||||
U.S. federal income tax (provision) benefit at statutory rate | $ | (956 | ) | $ | (450 | ) | $ | 264 | |||||||||||||
Change in unrecognized tax benefits | (152 | ) | 2 | 52 | |||||||||||||||||
State taxes, net of federal benefit | (39 | ) | 6 | 9 | |||||||||||||||||
Gain on MMJ Acquisition | (11 | ) | 520 | — | |||||||||||||||||
Change in valuation allowance | 544 | (418 | ) | (368 | ) | ||||||||||||||||
Foreign tax rate differential | 474 | 339 | 77 | ||||||||||||||||||
Tax credits | 11 | 36 | 2 | ||||||||||||||||||
Transaction costs related to the MMJ Acquisition | — | (38 | ) | — | |||||||||||||||||
Other | 1 | (5 | ) | (19 | ) | ||||||||||||||||
Income tax (provision) benefit | $ | (128 | ) | $ | (8 | ) | $ | 17 | |||||||||||||
Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following: | |||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||
Deferred tax assets: | |||||||||||||||||||||
Net operating loss and tax credit carryforwards | $ | 3,162 | $ | 4,048 | |||||||||||||||||
Property, plant and equipment | 284 | 313 | |||||||||||||||||||
Accrued salaries, wages and benefits | 152 | 107 | |||||||||||||||||||
Other accrued liabilities | 113 | 8 | |||||||||||||||||||
Other | 104 | 169 | |||||||||||||||||||
Gross deferred tax assets | 3,815 | 4,645 | |||||||||||||||||||
Less valuation allowance | (2,443 | ) | (3,155 | ) | |||||||||||||||||
Deferred tax assets, net of valuation allowance | 1,372 | 1,490 | |||||||||||||||||||
Deferred tax liabilities: | |||||||||||||||||||||
Debt discount | (291 | ) | (294 | ) | |||||||||||||||||
Unremitted earnings on certain subsidiaries | (115 | ) | (126 | ) | |||||||||||||||||
Product and process technology | (29 | ) | (74 | ) | |||||||||||||||||
Other | (67 | ) | (14 | ) | |||||||||||||||||
Deferred tax liabilities | (502 | ) | (508 | ) | |||||||||||||||||
Net deferred tax assets | $ | 870 | $ | 982 | |||||||||||||||||
Reported as: | |||||||||||||||||||||
Current deferred tax assets (included in other current assets) | $ | 228 | $ | 123 | |||||||||||||||||
Noncurrent deferred tax assets | 816 | 861 | |||||||||||||||||||
Current deferred tax liabilities (included in accounts payable and accrued expenses) | (4 | ) | (2 | ) | |||||||||||||||||
Noncurrent deferred tax liabilities (included in other noncurrent liabilities) | (170 | ) | — | ||||||||||||||||||
Net deferred tax assets | $ | 870 | $ | 982 | |||||||||||||||||
As of August 28, 2014, we had a valuation allowance of $1.29 billion against substantially all U.S. net deferred tax assets, primarily related to net operating loss carryforwards. The valuation allowance is based on our assessment of the deferred tax assets that are more likely than not to be realized. As of August 28, 2014, we had partial valuation allowances of $979 million for Japan and $179 million for our other foreign subsidiaries against net deferred tax assets, primarily related to net operating loss carryforwards. As of August 28, 2014, we had $3.95 billion of net operating loss carryforwards in Japan of which $2.76 billion is subject to a valuation allowance. Our valuation allowance decreased $712 million in 2014 primarily due to the utilization of U.S. and foreign net operating losses as well as adjustments based on management's reassessment of the amount of foreign net operating losses that are more likely than not to be realized. | |||||||||||||||||||||
As of August 28, 2014, our federal, state and foreign net operating loss carryforward amounts and expiration periods as reported to tax authorities, were as follows: | |||||||||||||||||||||
Year of Expiration | U.S. Federal | State | Japan | Other Foreign | Total | ||||||||||||||||
2015 - 2019 | $ | — | $ | 102 | $ | 83 | $ | 513 | $ | 698 | |||||||||||
2020 - 2024 | — | 179 | 3,862 | 872 | 4,913 | ||||||||||||||||
2025 - 2029 | 2,081 | 934 | — | — | 3,015 | ||||||||||||||||
2030 - 2033 | 1,812 | 493 | — | — | 2,305 | ||||||||||||||||
Indefinite | — | — | — | 39 | 39 | ||||||||||||||||
$ | 3,893 | $ | 1,708 | $ | 3,945 | $ | 1,424 | $ | 10,970 | ||||||||||||
As of August 28, 2014, our federal and state tax credit carryforward amounts and expiration periods were as follows: | |||||||||||||||||||||
Year of Tax Credit Expiration | Federal | State | Total | ||||||||||||||||||
2015 - 2019 | $ | 9 | $ | 69 | $ | 78 | |||||||||||||||
2020 - 2024 | 91 | 55 | 146 | ||||||||||||||||||
2025 - 2029 | 78 | 38 | 116 | ||||||||||||||||||
2030 - 2034 | 72 | — | 72 | ||||||||||||||||||
Indefinite | — | 31 | 31 | ||||||||||||||||||
$ | 250 | $ | 193 | $ | 443 | ||||||||||||||||
We have not recognized deferred tax assets of $207 million for excess tax benefits that arose directly from tax deductions related to equity compensation greater than amounts recognized for financial reporting. These excess stock compensation benefits will be credited to additional paid-in capital if realized. We use the "with and without" method, as described in ASC 740, for purposes of determining when excess tax benefits have been realized. | |||||||||||||||||||||
Provision has been made for deferred taxes on undistributed earnings of non-U.S. subsidiaries to the extent that dividend payments from such companies are expected to result in additional tax liabilities. Remaining undistributed earnings of $4.91 billion as of August 28, 2014 have been indefinitely reinvested; therefore, no provision has been made for taxes due on approximately $6.55 billion of the excess of the financial reporting amount over the tax basis of investments in foreign subsidiaries that are indefinitely reinvested. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable. | |||||||||||||||||||||
Below is a reconciliation of the beginning and ending amount of unrecognized tax benefits: | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||||||||
Beginning unrecognized tax benefits | $ | 78 | $ | 77 | $ | 121 | |||||||||||||||
Increases related to tax positions taken during current year | 152 | 4 | 6 | ||||||||||||||||||
Foreign currency translation increases (decreases) to tax positions | 1 | 4 | (9 | ) | |||||||||||||||||
Settlements with tax authorities | (1 | ) | (8 | ) | (29 | ) | |||||||||||||||
Decreases related to tax positions from prior years | (1 | ) | — | (14 | ) | ||||||||||||||||
Lapse of statute of limitations | (1 | ) | — | — | |||||||||||||||||
Increases related to tax positions from prior years | — | — | 2 | ||||||||||||||||||
Unrecognized tax benefits acquired in current year | — | 1 | — | ||||||||||||||||||
Ending unrecognized tax benefits | $ | 228 | $ | 78 | $ | 77 | |||||||||||||||
Included in the unrecognized tax benefits balance as of August 28, 2014, August 29, 2013 and August 30, 2012 were $66 million, $63 million and $66 million, respectively, of unrecognized income tax benefits, which if recognized, would affect our effective tax rate. The increase in unrecognized tax benefits in fiscal 2014 primarily related to transfer pricing and other matters which were substantially offset by changes in our deferred tax asset valuation allowance. We recognize interest and penalties related to income tax matters within income tax expense. As of August 28, 2014, August 29, 2013 and August 30, 2012, the amount accrued for interest and penalties related to uncertain tax positions was $19 million, $16 million and $12 million, respectively. The resolution of tax audits or lapses of statute of limitations could reduce our unrecognized tax benefits. Although each matter is individually insignificant and the timing of final resolution is uncertain, the estimated potential reduction in our unrecognized tax benefits in the next 12 months ranges from $0 to $77 million, including interest and penalties. | |||||||||||||||||||||
We currently operate in several tax jurisdictions where we have arrangements that allow us to compute our tax provision at rates below the local statutory rates that expire in whole or in part at various dates through 2026. These arrangements benefitted our tax provision in 2014, 2013 and 2012 by $286 million ($0.24 per diluted share), $141 million ($0.13 per diluted share) and $52 million ($0.05 per diluted share), respectively. | |||||||||||||||||||||
We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states and various foreign jurisdictions throughout the world. Our U.S. federal and state tax returns remain open to examination for 2010 through 2014. In addition, tax returns open to examination in multiple foreign taxing jurisdictions range from the years 2005 to 2014. We believe that adequate amounts of taxes and related interest and penalties have been provided for, and any adjustments as a result of examinations are not expected to materially adversely affect our business, results of operations or financial condition. |
Earnings_Per_Share
Earnings Per Share | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||
Earnings Per Share | ' | ||||||||||||
Earnings Per Share | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Net income (loss) available to Micron shareholders – Basic | $ | 3,045 | $ | 1,190 | $ | (1,032 | ) | ||||||
Dilutive effect related to equity method investment | (2 | ) | — | — | |||||||||
Net income (loss) available to Micron shareholders – Diluted | $ | 3,043 | $ | 1,190 | $ | (1,032 | ) | ||||||
Weighted-average common shares outstanding – Basic | 1,060 | 1,022 | 991 | ||||||||||
Dilutive effect of equity plans and convertible notes | 138 | 35 | — | ||||||||||
Weighted-average common shares outstanding – Diluted | 1,198 | 1,057 | 991 | ||||||||||
Earnings (loss) per share: | |||||||||||||
Basic | $ | 2.87 | $ | 1.16 | $ | (1.04 | ) | ||||||
Diluted | 2.54 | 1.13 | (1.04 | ) | |||||||||
Listed below are the potential common shares, as of the end of the periods shown, that could dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been antidilutive: | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Equity plans | 7 | 40 | 105 | ||||||||||
Convertible notes | 26 | 186 | 258 | ||||||||||
Our 2031B Notes, 2033 Notes and 2043 Notes, and, to the extent our 2027 Notes and 2031A Notes were outstanding during the periods presented, contain terms that upon conversion require us to settle the aggregate principal amount in cash and the remainder of our conversion obligation amount in either shares of our common stock or cash, at our election. Our 2032 Notes, and, to the extent our 2014 Notes were outstanding during the periods presented, contain terms that upon conversion provide us the option to pay cash, issue shares of common stock or any combination thereof for the aggregate amount due. It is our current intent to settle the principal amount of our 2032 Notes in cash upon conversion. As a result of these conversion terms, the shares underlying the 2014 Notes, 2027 Notes, 2031 Notes, 2032 Notes, 2033 Notes and 2043 Notes were considered in diluted earnings per share for the period they were outstanding during 2014 under the treasury stock method. (See "Debt" note.) |
Segment_Information
Segment Information | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||
Segment Information | ' | ||||||||||||
Segment Information | |||||||||||||
In the third quarter of 2014, we reorganized our business units. All prior period amounts reflect this reorganization. Factors used to identify our segments include, among others, markets, customers and products. Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision makers. We have the following four business units, which are our reportable segments: | |||||||||||||
Compute and Networking Business Unit ("CNBU"): Includes DRAM and NOR Flash products sold to the compute, networking, graphics and cloud server markets. | |||||||||||||
Mobile Business Unit ("MBU"): Includes DRAM, NAND Flash and NOR Flash products sold to the smartphone, feature phone and tablet mobile-device market. | |||||||||||||
Storage Business Unit ("SBU"): Includes NAND Flash components and SSDs sold into enterprise and client storage, cloud and removable storage markets. SBU also includes NAND Flash products sold to Intel through our IMFT joint venture. | |||||||||||||
Embedded Business Unit ("EBU"): Includes DRAM, NAND Flash and NOR Flash products sold into automotive and industrial applications, as well as the connected home and consumer electronics markets. | |||||||||||||
Our other operations do not meet the thresholds of a reportable segment and are reported under All Other. | |||||||||||||
Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. The unallocated amount in 2014 related to the Rambus settlement. | |||||||||||||
We do not identify or report internally our assets or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items or taxes to segments. There are no differences in the accounting policies for segment reporting and our consolidated results of operations. | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Net sales: | |||||||||||||
CNBU | $ | 7,333 | $ | 3,462 | $ | 2,667 | |||||||
MBU | 3,627 | 1,214 | 1,176 | ||||||||||
SBU | 3,480 | 2,824 | 2,842 | ||||||||||
EBU | 1,774 | 1,275 | 1,097 | ||||||||||
All Other | 144 | 298 | 452 | ||||||||||
$ | 16,358 | $ | 9,073 | $ | 8,234 | ||||||||
Operating income (loss): | |||||||||||||
CNBU | $ | 1,957 | $ | 160 | $ | (458 | ) | ||||||
MBU | 683 | (265 | ) | (371 | ) | ||||||||
SBU | 255 | 173 | 199 | ||||||||||
EBU | 331 | 227 | 129 | ||||||||||
All Other | 94 | (59 | ) | (111 | ) | ||||||||
Unallocated | (233 | ) | — | — | |||||||||
$ | 3,087 | $ | 236 | $ | (612 | ) | |||||||
Depreciation and amortization expense was as follows: | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
CNBU | $ | 878 | $ | 687 | $ | 755 | |||||||
MBU | 475 | 293 | 372 | ||||||||||
SBU | 512 | 551 | 649 | ||||||||||
EBU | 226 | 215 | 228 | ||||||||||
All Other | 11 | 67 | 140 | ||||||||||
Depreciation and amortization expense included in operating income (loss) | 2,102 | 1,813 | 2,144 | ||||||||||
Other amortization | 168 | 113 | 78 | ||||||||||
Total depreciation and amortization expense | $ | 2,270 | $ | 1,926 | $ | 2,222 | |||||||
Product_Sales
Product Sales | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Segment Reconciliation [Abstract] | ' | ||||||||||||
Product Sales [Text Block] | ' | ||||||||||||
Product Sales | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
DRAM | $ | 11,164 | $ | 4,361 | $ | 3,178 | |||||||
NAND Flash | 4,468 | 3,589 | 3,627 | ||||||||||
NOR Flash | 505 | 792 | 977 | ||||||||||
Other | 221 | 331 | 452 | ||||||||||
$ | 16,358 | $ | 9,073 | $ | 8,234 | ||||||||
Certain_Concentrations
Certain Concentrations | 12 Months Ended | |||||||||
Aug. 28, 2014 | ||||||||||
Risks and Uncertainties [Abstract] | ' | |||||||||
Certain Concentrations | ' | |||||||||
Certain Concentrations | ||||||||||
Markets with concentrations of net sales were approximately as follows: | ||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||
Compute and graphics | 30 | % | 20 | % | 15 | % | ||||
Mobile | 20 | % | 15 | % | 15 | % | ||||
Solid state drives and other storage | 20 | % | 25 | % | 25 | % | ||||
Automotive, industrial, medical and other embedded | 10 | % | 15 | % | 15 | % | ||||
Server | 10 | % | 10 | % | 10 | % | ||||
Customer concentrations included net sales to Kingston of 10% for 2014, net sales to Intel of 10% and 12% for 2013 and 2012, respectively, and net sales to HP of 10% for 2013. Substantially all of our sales to Kingston are included in our CNBU segment, substantially all of our sales to Intel are included in our SBU segment and substantially all of our sales to HP are included in our CNBU and SBU segments. | ||||||||||
Certain of the raw materials and production equipment we use in manufacturing semiconductor products are available from multiple sources and in sufficient supply; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards. In some cases, materials are provided by a single supplier. | ||||||||||
Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor. A concentration of credit risk may exist with respect to receivables as a substantial portion of our customers are affiliated with the computing industry. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced significant losses on receivables. A concentration of risk may also exist with respect to derivatives as the number of counterparties to our currency hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements. The capped calls expose us to credit risk to the extent the counterparties may be unable to meet the terms of the agreements. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis. |
Geographic_Information
Geographic Information | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||
Schedule of geographic net sales and property, plant and equipment by geographic area | ' | ||||||||||||
Geographic Information | |||||||||||||
Geographic net sales based on customer ship-to location were as follows: | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
China | $ | 6,715 | $ | 3,783 | $ | 2,936 | |||||||
United States | 2,551 | 1,512 | 1,262 | ||||||||||
Taiwan | 2,313 | 980 | 1,022 | ||||||||||
Asia Pacific (excluding China, Taiwan and Japan) | 1,791 | 946 | 1,327 | ||||||||||
Japan | 1,253 | 589 | 460 | ||||||||||
Europe | 1,252 | 820 | 827 | ||||||||||
Other | 483 | 443 | 400 | ||||||||||
$ | 16,358 | $ | 9,073 | $ | 8,234 | ||||||||
Net property, plant and equipment by geographic area was as follows: | |||||||||||||
As of | 2014 | 2013 | |||||||||||
United States | $ | 3,282 | $ | 3,041 | |||||||||
Singapore | 3,101 | 3,225 | |||||||||||
Japan | 1,221 | 615 | |||||||||||
Taiwan | 761 | 307 | |||||||||||
China | 242 | 350 | |||||||||||
Other | 75 | 88 | |||||||||||
$ | 8,682 | $ | 7,626 | ||||||||||
Quarterly_Financial_Informatio
Quarterly Financial Information | 12 Months Ended | ||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||
Quarterly Financial Information Disclosure [Abstract] | ' | ||||||||||||||||
Quarterly Financial Information | ' | ||||||||||||||||
Quarterly Financial Information (Unaudited) | |||||||||||||||||
(in millions except per share amounts) | |||||||||||||||||
2014 | Fourth Quarter | Third Quarter | Second Quarter | First Quarter | |||||||||||||
Net sales | $ | 4,227 | $ | 3,982 | $ | 4,107 | $ | 4,042 | |||||||||
Gross margin | 1,385 | 1,368 | 1,403 | 1,281 | |||||||||||||
Operating income | 828 | 839 | 869 | 551 | |||||||||||||
Net income | 1,151 | 806 | 741 | 381 | |||||||||||||
Net income attributable to Micron | 1,150 | 806 | 731 | 358 | |||||||||||||
Earnings per share: | |||||||||||||||||
Basic | $ | 1.08 | $ | 0.76 | $ | 0.69 | $ | 0.34 | |||||||||
Diluted | 0.96 | 0.68 | 0.61 | 0.3 | |||||||||||||
The results of operations for the first quarter of 2014 included a $233 million charge to accrue a liability for the settlement of all pending litigation between us and Rambus, including all antitrust and patent matters, which reflects the discounted value of amounts due under the arrangement. (See "Contingencies" note.) | |||||||||||||||||
The results of operations in the first, second, third and fourth quarters of 2014 included losses of $92 million, $80 million, $16 million and $17 million, respectively, for losses on restructure of debt. (See "Debt – 2014 Debt Restructure" note.) | |||||||||||||||||
The results of operations for the fourth quarter of 2014 included a gain of $93 million from the issuance of shares by Inotera, which reduced our ownership interest from 35% to 33%. (See "Equity Method Investments – Inotera" note.) | |||||||||||||||||
The results of operations for the fourth quarter of 2014 included a gain of $119 million from the sale of interest in Aptina to ON Semiconductor Corporation. (See "Equity Method Investments – Other" note.) | |||||||||||||||||
The results of operations for the fourth quarter of 2014 included a $66 million charge associated with a license agreement with Tessera executed in the fourth quarter of 2014. (See "Contingencies" note.) | |||||||||||||||||
The results of operations for the fourth quarter of 2014 included a $190 million income tax benefit from increases in the amounts of the MMJ Group's deferred tax assets expected to be realized based on our forecasted utilization of net operating losses. (See "Income Taxes" note.) | |||||||||||||||||
2013 | Fourth Quarter | Third Quarter | Second Quarter | First Quarter | |||||||||||||
Net sales | $ | 2,843 | $ | 2,318 | $ | 2,078 | $ | 1,834 | |||||||||
Gross margin | 708 | 556 | 366 | 217 | |||||||||||||
Operating income (loss) | 207 | 149 | (23 | ) | (97 | ) | |||||||||||
Net income (loss) | 1,710 | 43 | (284 | ) | (275 | ) | |||||||||||
Net income (loss) attributable to Micron | 1,708 | 43 | (286 | ) | (275 | ) | |||||||||||
Earnings (loss) per share: | |||||||||||||||||
Basic | $ | 1.65 | $ | 0.04 | $ | (0.28 | ) | $ | (0.27 | ) | |||||||
Diluted | 1.51 | 0.04 | (0.28 | ) | (0.27 | ) | |||||||||||
The results of operations for the fourth quarter of 2013 included a gain of $1.48 billion for the MMJ Acquisition. The fourth quarter of 2013 includes the MMJ Group's results of operation from the July 31, 2013 acquisition date. (See "Micron Memory Japan, Inc." note.) | |||||||||||||||||
The results of operations for the fourth quarter of 2013 included a gain of $48 million from the issuance of shares by Inotera, which reduced our ownership interest from 40% to 35%. (See "Equity Method Investments – Inotera" note.) | |||||||||||||||||
The results of operations for the fourth, third, second and first quarters of 2013 included losses of $3 million, $47 million, $120 million and $58 million, respectively, for the MMJ Acquisition Hedges. (See "Derivative Instruments – Derivative Instruments without Hedge Accounting Designation" note.) | |||||||||||||||||
In 2013 we took action to dispose of 200mm wafer manufacturing facilities and optimize operations including our workforce. The results of operations for the fourth, third and second quarters of 2013 include charges of $32 million, $55 million and $60 million, respectively, for the restructure and asset impairments. The results of operations for the first quarter of 2013 included a credit of $21 million for restructure activities. (See "Restructure and Asset Impairments" note.) | |||||||||||||||||
The results of operations in the second quarter of 2013 included a loss of $31 million on extinguishment of debt. (See "Debt – 2013 Debt Restructure" note.) |
Schedule_I_Condensed_Parent_Co
Schedule I Condensed Parent Company Financials (Micron Technology, Inc. [Member]) | 12 Months Ended | ||||||||||||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||||||||||||
Micron Technology, Inc. [Member] | ' | ||||||||||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ' | ||||||||||||||||||||||||||||||
Condensed Financial Information of Parent Company Only Disclosure [Text Block] | ' | ||||||||||||||||||||||||||||||
SCHEDULE I | |||||||||||||||||||||||||||||||
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT | |||||||||||||||||||||||||||||||
MICRON TECHNOLOGY, INC. | |||||||||||||||||||||||||||||||
(Parent Company Only) | |||||||||||||||||||||||||||||||
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME | |||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||
For the year ended | August 28, | August 29, | August 30, | ||||||||||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||||||||||||
Net sales | $ | 5,819 | $ | 4,404 | $ | 4,590 | |||||||||||||||||||||||||
Cost of goods sold | 3,514 | 3,721 | 4,194 | ||||||||||||||||||||||||||||
Gross margin | 2,305 | 683 | 396 | ||||||||||||||||||||||||||||
Selling, general and administrative | 264 | 238 | 281 | ||||||||||||||||||||||||||||
Research and development | 1,389 | 921 | 917 | ||||||||||||||||||||||||||||
Other operating (income) expense, net | 251 | 77 | 18 | ||||||||||||||||||||||||||||
Operating income (loss) | 401 | (553 | ) | (820 | ) | ||||||||||||||||||||||||||
Gain on MMJ Acquisition | (33 | ) | 1,484 | — | |||||||||||||||||||||||||||
Interest income (expense), net | (209 | ) | (189 | ) | (160 | ) | |||||||||||||||||||||||||
Other non-operating income (expense), net | (86 | ) | (248 | ) | 17 | ||||||||||||||||||||||||||
73 | 494 | (963 | ) | ||||||||||||||||||||||||||||
Income tax (provision) benefit | 18 | (1 | ) | 8 | |||||||||||||||||||||||||||
Equity in earnings (loss) of subsidiaries | 2,956 | 703 | 29 | ||||||||||||||||||||||||||||
Equity in net loss of equity method investees | (2 | ) | (6 | ) | (106 | ) | |||||||||||||||||||||||||
Net income (loss) attributable to Micron | 3,045 | 1,190 | (1,032 | ) | |||||||||||||||||||||||||||
Other comprehensive income (loss) | (7 | ) | (17 | ) | (52 | ) | |||||||||||||||||||||||||
Comprehensive income (loss) attributable to Micron | $ | 3,038 | $ | 1,173 | $ | (1,084 | ) | ||||||||||||||||||||||||
See accompanying notes to condensed financial statements. | |||||||||||||||||||||||||||||||
SCHEDULE I | |||||||||||||||||||||||||||||||
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT | |||||||||||||||||||||||||||||||
MICRON TECHNOLOGY, INC. | |||||||||||||||||||||||||||||||
(Parent Company Only) | |||||||||||||||||||||||||||||||
CONDENSED BALANCE SHEETS | |||||||||||||||||||||||||||||||
(in millions except par value amounts) | |||||||||||||||||||||||||||||||
As of | August 28, | August 29, | |||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||
Cash and equivalents | $ | 1,249 | $ | 1,202 | |||||||||||||||||||||||||||
Short-term investments | 384 | 221 | |||||||||||||||||||||||||||||
Receivables | 114 | 159 | |||||||||||||||||||||||||||||
Notes and accounts receivable from subsidiaries | 1,767 | 826 | |||||||||||||||||||||||||||||
Finished goods | 84 | 88 | |||||||||||||||||||||||||||||
Work in process | 228 | 332 | |||||||||||||||||||||||||||||
Raw materials and supplies | 68 | 43 | |||||||||||||||||||||||||||||
Other current assets | 215 | 30 | |||||||||||||||||||||||||||||
Total current assets | 4,109 | 2,901 | |||||||||||||||||||||||||||||
Investment in subsidiaries | 10,149 | 7,465 | |||||||||||||||||||||||||||||
Long-term marketable investments | 819 | 499 | |||||||||||||||||||||||||||||
Noncurrent notes receivable from and prepaid expenses to subsidiaries | 111 | 573 | |||||||||||||||||||||||||||||
Property, plant and equipment, net | 1,519 | 1,613 | |||||||||||||||||||||||||||||
Equity method investments | 9 | 12 | |||||||||||||||||||||||||||||
Other noncurrent assets | 595 | 472 | |||||||||||||||||||||||||||||
Total assets | $ | 17,311 | $ | 13,535 | |||||||||||||||||||||||||||
Liabilities and equity | |||||||||||||||||||||||||||||||
Accounts payable and accrued expenses | $ | 758 | $ | 650 | |||||||||||||||||||||||||||
Short-term debt and accounts payable to subsidiaries | 619 | 416 | |||||||||||||||||||||||||||||
Current debt | 1,077 | 646 | |||||||||||||||||||||||||||||
Other current liabilities | 38 | 44 | |||||||||||||||||||||||||||||
Total current liabilities | 2,492 | 1,756 | |||||||||||||||||||||||||||||
Long-term debt | 3,231 | 2,438 | |||||||||||||||||||||||||||||
Other noncurrent liabilities | 760 | 199 | |||||||||||||||||||||||||||||
Total liabilities | 6,483 | 4,393 | |||||||||||||||||||||||||||||
Commitments and contingencies | |||||||||||||||||||||||||||||||
Redeemable convertible notes | 57 | — | |||||||||||||||||||||||||||||
Micron shareholders' equity: | |||||||||||||||||||||||||||||||
Common stock, $0.10 par value, 3,000 shares authorized, 1,073 shares issued and outstanding (1,044 as of August 29, 2013) | 107 | 104 | |||||||||||||||||||||||||||||
Other equity | 10,664 | 9,038 | |||||||||||||||||||||||||||||
Total Micron shareholders' equity | 10,771 | 9,142 | |||||||||||||||||||||||||||||
Total liabilities and equity | $ | 17,311 | $ | 13,535 | |||||||||||||||||||||||||||
See accompanying notes to condensed financial statements. | |||||||||||||||||||||||||||||||
SCHEDULE I | |||||||||||||||||||||||||||||||
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT | |||||||||||||||||||||||||||||||
MICRON TECHNOLOGY, INC. | |||||||||||||||||||||||||||||||
(Parent Company Only) | |||||||||||||||||||||||||||||||
CONDENSED STATEMENTS OF CASH FLOWS | |||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||
For the year ended | August 28, | August 29, | August 30, | ||||||||||||||||||||||||||||
2014 | 2013 | 2012 | |||||||||||||||||||||||||||||
Net cash (used for) provided by operating activities | $ | 888 | $ | (347 | ) | $ | (48 | ) | |||||||||||||||||||||||
Cash flows from investing activities | |||||||||||||||||||||||||||||||
Purchases of available-for-sale securities | (1,047 | ) | (924 | ) | (559 | ) | |||||||||||||||||||||||||
Expenditures for property, plant, and equipment | (323 | ) | (281 | ) | (682 | ) | |||||||||||||||||||||||||
Cash contributions to subsidiaries | (121 | ) | (23 | ) | (84 | ) | |||||||||||||||||||||||||
Expenditures for intangible assets | (43 | ) | (34 | ) | (40 | ) | |||||||||||||||||||||||||
Payments to settle hedging activities | (27 | ) | (256 | ) | (51 | ) | |||||||||||||||||||||||||
Cash paid for MMJ Acquisition | — | (596 | ) | — | |||||||||||||||||||||||||||
Loan to equity method investee | — | (45 | ) | — | |||||||||||||||||||||||||||
Cash paid to terminate lease to IMFT | — | — | (107 | ) | |||||||||||||||||||||||||||
Additions to equity method investments | — | — | (17 | ) | |||||||||||||||||||||||||||
Proceeds from sales and maturities of available-for-sale securities | 557 | 678 | 151 | ||||||||||||||||||||||||||||
Proceeds from repayment of loans to subsidiaries, net | 379 | 851 | 556 | ||||||||||||||||||||||||||||
Cash distributions from subsidiaries | 227 | 38 | 499 | ||||||||||||||||||||||||||||
Cash received from disposition of interest in Aptina | 105 | — | — | ||||||||||||||||||||||||||||
Proceeds from receipt of loan payments | 56 | — | — | ||||||||||||||||||||||||||||
Proceeds from sales of property, plant and equipment | 45 | 38 | 63 | ||||||||||||||||||||||||||||
Proceeds from settlement of hedging activities | 23 | 38 | 26 | ||||||||||||||||||||||||||||
Other | 7 | 9 | (28 | ) | |||||||||||||||||||||||||||
Net cash used for investing activities | (162 | ) | (507 | ) | (273 | ) | |||||||||||||||||||||||||
Cash flows from financing activities | |||||||||||||||||||||||||||||||
Repayments of debt | (2,469 | ) | (777 | ) | (117 | ) | |||||||||||||||||||||||||
Cash paid to purchase stock under equity plans | (76 | ) | (5 | ) | (6 | ) | |||||||||||||||||||||||||
Payments on equipment purchase contracts | (69 | ) | (73 | ) | (41 | ) | |||||||||||||||||||||||||
Payments of licensing obligations | (47 | ) | (31 | ) | (18 | ) | |||||||||||||||||||||||||
Debt issuance costs | (33 | ) | (17 | ) | (21 | ) | |||||||||||||||||||||||||
Cash paid for capped call transactions | — | (48 | ) | (103 | ) | ||||||||||||||||||||||||||
Proceeds from issuance of debt | 1,750 | 693 | 1,113 | ||||||||||||||||||||||||||||
Proceeds from issuance of stock under equity plans | 265 | 150 | 5 | ||||||||||||||||||||||||||||
Proceeds from equipment sale-leaseback transactions | — | 126 | 439 | ||||||||||||||||||||||||||||
Cash received for capped call transactions | — | 24 | — | ||||||||||||||||||||||||||||
Other | 1 | 2 | — | ||||||||||||||||||||||||||||
Net cash provided by (used for) financing activities | (678 | ) | 44 | 1,251 | |||||||||||||||||||||||||||
Effect of changes in currency exchange rates on cash and cash equivalents | (1 | ) | — | — | |||||||||||||||||||||||||||
Net increase (decrease) in cash and equivalents | 47 | (810 | ) | 930 | |||||||||||||||||||||||||||
Cash and equivalents at beginning of period | 1,202 | 2,012 | 1,082 | ||||||||||||||||||||||||||||
Cash and equivalents at end of period | $ | 1,249 | $ | 1,202 | $ | 2,012 | |||||||||||||||||||||||||
See accompanying notes to condensed financial statements. | |||||||||||||||||||||||||||||||
MICRON TECHNOLOGY, INC. | |||||||||||||||||||||||||||||||
SCHEDULE I | |||||||||||||||||||||||||||||||
CONDENSED FINANCIAL INFORMATION OF THE REGISTRANT | |||||||||||||||||||||||||||||||
NOTES TO CONDENSED FINANCIAL STATEMENTS | |||||||||||||||||||||||||||||||
(All tabular amounts in millions) | |||||||||||||||||||||||||||||||
Basis of Presentation | |||||||||||||||||||||||||||||||
Micron, a Delaware corporation, was incorporated in 1978. Micron is the parent company of its consolidated subsidiaries and, together with its consolidated subsidiaries, is one of the world's leading providers of advanced semiconductor solutions. | |||||||||||||||||||||||||||||||
These condensed financial statements have been prepared on a parent-only basis. Under this parent-only presentation, Micron's investments in its consolidated subsidiaries are presented under the equity method of accounting. In accordance with Rule 12-04 of Regulation S-X, these parent-only financial statements do not include all of the information and footnotes required by Generally Accepted Accounting Principles (GAAP) in the United States for annual financial statements. Because these parent-only financial statements and notes do not include all of the information and footnotes required by GAAP in the U.S. for annual financial statements, these parent-only financial statements and other information included should be read in conjunction with Micron's audited Consolidated Financial Statements contained within Part II, Item 8 of this Form 10-K for the year ended August 28, 2014. | |||||||||||||||||||||||||||||||
Long-Term Debt | |||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
Capital lease obligations(2) | N/A | N/A | $ | 172 | $ | 233 | $ | 405 | $ | 156 | $ | 397 | $ | 553 | |||||||||||||||||
2014 convertible senior notes | 1.875 | % | 7.88 | % | — | — | — | 465 | — | 465 | |||||||||||||||||||||
2022 senior notes | 5.875 | % | 6.14 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
2025 senior notes | 5.5 | % | 5.56 | % | — | 1,150 | 1,150 | — | — | — | |||||||||||||||||||||
2027 convertible senior notes | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
2031A convertible senior notes | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
2031B convertible senior notes(3) | 1.875 | % | 6.98 | % | 362 | — | 362 | — | 253 | 253 | |||||||||||||||||||||
2032C convertible senior notes(4) | 2.375 | % | 5.95 | % | — | 314 | 314 | — | 463 | 463 | |||||||||||||||||||||
2032D convertible senior notes(4) | 3.125 | % | 6.33 | % | — | 288 | 288 | — | 369 | 369 | |||||||||||||||||||||
2033E convertible senior notes(4)(5) | 1.625 | % | 4.5 | % | 278 | — | 278 | — | 272 | 272 | |||||||||||||||||||||
2033F convertible senior notes(4)(5) | 2.125 | % | 4.93 | % | 265 | — | 265 | — | 260 | 260 | |||||||||||||||||||||
2043G convertible senior notes | 3 | % | 6.76 | % | — | 636 | 636 | — | — | — | |||||||||||||||||||||
Other | 1.65 | % | 1.65 | % | — | 10 | 10 | 25 | — | 25 | |||||||||||||||||||||
$ | 1,077 | $ | 3,231 | $ | 4,308 | $ | 646 | $ | 2,438 | $ | 3,084 | ||||||||||||||||||||
(1) | Micron has either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of its convertible notes. Since it is Micron's current intent to settle in cash the principal amount of all of its convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||
(2) Weighted-average imputed rate of 4.7% and 4.7% as of August 28, 2014 and August 29, 2013, respectively. | |||||||||||||||||||||||||||||||
(3) | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of Micron's obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||
(4) | Since the closing price of Micron's common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of Micron's common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||
(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require Micron to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Micron's senior notes are unsecured obligations ranking equally in right of payment with all of Micron's other existing and future unsecured indebtedness, and are effectively subordinated to all of Micron's other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness. The convertible notes, 2022 Notes and 2025 Notes of Micron are structurally subordinated to $1.57 billion of other notes payable of its subsidiaries and capital lease obligations. MTI guarantees certain debt obligations of its subsidiaries. MTI does not guarantee the MMJ creditor installment payments. As of August 28, 2014, Micron had guaranteed $610 million of debt obligations of its subsidiaries. Micron's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of its other existing and future unsecured indebtedness. | |||||||||||||||||||||||||||||||
Capital Lease Obligations | |||||||||||||||||||||||||||||||
Micron has various capital lease obligations due in periodic installments with a weighted-average remaining term of 2 years. In 2013, Micron received $126 million in proceeds from equipment sale-leaseback transactions and, as a result, recorded capital lease obligations aggregating $126 million with a weighted-average effective interest rate of 4.3%, payable in periodic installments through July 2017. | |||||||||||||||||||||||||||||||
As of August 28, 2014 and August 29, 2013, Micron had production equipment with carrying values of $305 million and $458 million, respectively, under capital leases. | |||||||||||||||||||||||||||||||
Convertible Senior Notes and Other Senior Notes | |||||||||||||||||||||||||||||||
For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Debt" to Micron's consolidated financial statements. | |||||||||||||||||||||||||||||||
Maturities of Notes Payable and Future Minimum Lease Payments | |||||||||||||||||||||||||||||||
As of August 28, 2014, maturities of notes payable and future minimum lease payments under capital lease obligations were as follows: | |||||||||||||||||||||||||||||||
Notes Payable | Capital Lease Obligations | ||||||||||||||||||||||||||||||
2015 | $ | 389 | $ | 188 | |||||||||||||||||||||||||||
2016 | — | 200 | |||||||||||||||||||||||||||||
2017 | — | 30 | |||||||||||||||||||||||||||||
2018 | 300 | 3 | |||||||||||||||||||||||||||||
2019 | 362 | 3 | |||||||||||||||||||||||||||||
2020 and thereafter | 3,320 | 6 | |||||||||||||||||||||||||||||
Discounts and interest, respectively | (468 | ) | (25 | ) | |||||||||||||||||||||||||||
$ | 3,903 | $ | 405 | ||||||||||||||||||||||||||||
Commitments | |||||||||||||||||||||||||||||||
Micron has provided various financial guarantees issued in the normal course of business on behalf of its subsidiaries. These contracts include debt guarantees and guarantees on certain banking facilities. Micron enters into these arrangements to facilitate commercial transactions with third parties by enhancing the value of the transaction to the third party. Micron has entered into agreements covering certain activities of its subsidiaries, and occasionally Micron may be required to perform under such agreements on behalf of its subsidiaries. | |||||||||||||||||||||||||||||||
As of August 28, 2014, the maximum potential amount of future payments Micron could have been required to make under its debt guarantees was approximately $610 million. Substantially all of this amount relates to guarantees for debt of wholly-owned entities whereby Micron would be obligated to perform under the guarantee if a subsidiary were to default on the terms of their debt arrangements. In the event of performance under the guarantee, Micron would be permitted to seek reimbursement from the subsidiary company(s) through liquidation of the assets collateralized by the various debt instruments. At the time these contracts were entered into, the collateralized assets approximated the value of the outstanding guarantees. The majority of these guarantees expire at various times between December 2014 and January 2019. Micron also guarantees credit facilities of certain of its subsidiaries that provide for up to $408 million of financing. As of August 28, 2014, no amounts had been drawn under these credit facilities. | |||||||||||||||||||||||||||||||
Micron guarantees certain banking facilities for its wholly-owned consolidated entities. Substantially all of these guarantees relate to bank overdraft protections. The maximum potential amount of future payments Micron could be required to make under these guarantees varies based on the extent of potential overdrafts. Micron's business processes substantially mitigate the risk of wholly-owned subsidiaries overdrafting their bank accounts. The majority of these guarantees have no contractual expiration. | |||||||||||||||||||||||||||||||
Contingencies | |||||||||||||||||||||||||||||||
As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that Micron and its subsidiaries' products or manufacturing processes infringe their intellectual property rights. Micron has accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date. Micron is currently a party to various litigation regarding patent, antitrust, commercial and other matters. Micron is a party to the matters listed in the "Contingencies" note in the consolidated financial statements, with the exception of the complaint filed on July 12, 2013 by seven former shareholders of Elpida (now known as MMJ) against the board of directors of MMJ as of February 2013 and the patent infringement case Tessera Inc., which was resolved on July 30, 2014. For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Contingencies" to Micron's consolidated financial statements. | |||||||||||||||||||||||||||||||
Redeemable Convertible Notes | |||||||||||||||||||||||||||||||
For further information, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Redeemable Convertible Notes" to Micron's consolidated financial statements. | |||||||||||||||||||||||||||||||
Related Party Transaction | |||||||||||||||||||||||||||||||
Substantially all of Micron's activities relate to manufacturing services performed for a subsidiary and to royalties received from its subsidiaries for use of product and process technology. Micron's net sales to consolidated subsidiaries were $5.64 billion, $4.19 billion and $4.15 billion for 2014, 2013 and 2012, respectively. Gross margins on manufacturing activities are commensurate with market rates for such services. Transactions between Micron and its consolidated subsidiaries are eliminated in consolidation. | |||||||||||||||||||||||||||||||
Micron engages in various transactions with its equity method investees and eliminates the profits or losses on those transactions to the extent of its ownership interest until such time as the profits or losses are realized. As of August 28, 2014, Micron held a 50% ownership interest in Transform and, until August 15, 2014, an equity interest in Aptina. Net sales for 2014, 2013 and 2012 also included $43 million, $182 million and $372 million, respectively, from products sold to and services performed for Aptina. | |||||||||||||||||||||||||||||||
On August 15, 2014, ON Semiconductor Corporation acquired Aptina for approximately $433 million and Micron recognized a non-operating gain of $119 million on the sale of its shares based on its diluted ownership interest of approximately 27%. The gain approximated Micron's share of the consideration because the carrying value of its investment had been reduced to zero since the second quarter of 2012, at which time Micron ceased recognizing its proportionate share of Aptina's losses. For further information regarding transactions between Micron and its equity method investees, see "Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Equity Method Investments – Other" to Micron's consolidated financial statements. |
Schedule_II_Valuation_and_Qual
Schedule II Valuation and Qualifying Accounts | 12 Months Ended | |||||||||||||||||||
Aug. 28, 2014 | ||||||||||||||||||||
Valuation and Qualifying Accounts [Abstract] | ' | |||||||||||||||||||
Schedule II Valuation and Qualifying Accounts | ' | |||||||||||||||||||
SCHEDULE II | ||||||||||||||||||||
VALUATION AND QUALIFYING ACCOUNTS | ||||||||||||||||||||
(in millions) | ||||||||||||||||||||
MICRON TECHNOLOGY, INC. | ||||||||||||||||||||
Balance at | Business Acquisitions | Charged | Deductions/ | Balance at | ||||||||||||||||
Beginning of | (Credited) to | Write-Offs | End of | |||||||||||||||||
Year | Costs and | Year | ||||||||||||||||||
Expenses | ||||||||||||||||||||
Allowance for Doubtful Accounts | ||||||||||||||||||||
Year ended August 28, 2014 | $ | 5 | $ | — | $ | — | $ | (2 | ) | $ | 3 | |||||||||
Year ended August 29, 2013 | 5 | — | 1 | (1 | ) | 5 | ||||||||||||||
Year ended August 30, 2012 | 3 | — | 5 | (3 | ) | 5 | ||||||||||||||
Deferred Tax Asset Valuation Allowance | ||||||||||||||||||||
Year ended August 28, 2014 | $ | 3,155 | $ | — | $ | (544 | ) | $ | (168 | ) | $ | 2,443 | ||||||||
Year ended August 29, 2013 | 1,470 | 1,292 | 418 | (25 | ) | 3,155 | ||||||||||||||
Year ended August 30, 2012 | 1,169 | — | 368 | (67 | ) | 1,470 | ||||||||||||||
Certain deferred tax assets in prior years were corrected with corresponding changes in the valuation allowance, resulting in no change to net deferred tax assets. Changes in these items were not material for any period presented. |
Significant_Accounting_Policie1
Significant Accounting Policies (Policies) | 12 Months Ended |
Aug. 28, 2014 | |
Accounting Policies [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation: We are one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and its consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. | |
Reclassifications | ' |
Certain reclassifications have been made to prior period amounts to conform to current period presentation. Certain deferred tax assets in prior years were corrected with corresponding changes in the valuation allowance, resulting in no change to net deferred tax assets. Changes in these items were not material for any period presented. | |
Fiscal Period | ' |
Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2014, 2013 and 2012 each contained 52 weeks. Fiscal year 2015 will contain 53 weeks, and the first quarter of fiscal 2015 will contain 14 weeks. All period references are to our fiscal periods unless otherwise indicated. | |
Use of Estimates | ' |
Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates. | |
Product Warranty | ' |
Product Warranty: We generally provide a limited warranty that our products are in compliance with our specifications existing at the time of delivery. Under our general terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our general terms and conditions. Our warranty obligations are not significant. | |
Revenue Recognition | ' |
Revenue Recognition: We recognize product or license revenue when persuasive evidence that a sales arrangement exists, delivery has occurred, the price is fixed or determinable and collectability is reasonably assured. If we are unable to reasonably estimate returns or the price is not fixed or determinable, sales made under agreements allowing rights of return or price protection are deferred until customers have resold the product. | |
Research and Development | ' |
Research and Development: Costs related to the conceptual formulation and design of products and processes are expensed as research and development as incurred. Determining when product development is complete requires judgment. Development of a product is deemed complete once the product has been thoroughly reviewed and has passed tests for performance and reliability. Subsequent to product qualification, product costs are valued in inventory. Product design and other research and development costs for certain technologies are shared with our joint venture partners. Amounts receivable from cost-sharing arrangements are reflected as a reduction of research and development expense. (See "Equity Method Investments" and "Equity – Noncontrolling Interests in Subsidiaries" notes.) | |
Stock-based Compensation | ' |
Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We issue new shares upon the exercise of stock options or conversion of share units. (See "Equity Plans" note.) | |
Stock Repurchases | ' |
Stock Repurchases: When we repurchase and retire our common stock, any excess of the repurchase price paid over par value is allocated between paid-in capital and retained earnings. | |
Functional Currency | ' |
Functional Currency: The U.S. dollar is the functional currency for all of our consolidated operations. | |
Cash and Cash Equivalents | ' |
Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. | |
Investments | ' |
Investments with maturities greater than three months and less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. | |
Derivative and Hedging Instruments | ' |
Derivative and Hedging Instruments: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities or future cash flows and to reduce the volatility that changes in interest rates on variable-rate debt have on our earnings. Our currency derivatives have consisted of forward and option contracts and interest rate swap contracts. We do not use derivative instruments for trading or speculative purposes. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated as hedges for accounting purpose, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash-flow hedges, the effective portion of the gain or loss is included as a component of other comprehensive income (loss), and the ineffective or excluded portion of the gain or loss is included in other non-operating income (expense). The amounts in accumulated other comprehensive income (loss) for these cash flow hedges are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. Effectiveness is measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the forecasted cash flows of the hedged item. For the effectiveness assessment of our cash-flow hedges, changes in the time value are excluded for forward contracts. | |
We seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty under these arrangements have been presented in our consolidated balance sheet on a net basis. | |
(See "Derivative Instruments" note.) | |
Inventories | ' |
Inventories: Inventories are stated at the lower of average cost or market value. Cost includes depreciation, labor, material and overhead costs, including product and process technology costs. Determining market values of inventories involves numerous judgments, including projecting future average selling prices, sales volumes and costs to complete products in work in process inventories. When market values are below costs, we record a charge to cost of goods sold to write down inventories to their estimated market value in advance of when the inventories are actually sold. Inventories are primarily categorized as memory (including DRAM, NAND Flash and NOR Flash) for purposes of determining lower of average cost or market. The major characteristics considered in determining inventory categories for purposes of determining the lower of cost or market value are product type and markets. We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis. | |
Product and Process Technology | ' |
Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology and (3) maintain patent technology are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical and projected patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. | |
Property, Plant and Equipment | ' |
Property, Plant and Equipment: Property, plant and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, generally 5 to 7 years for equipment and generally 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in our results of operations. | |
We capitalize interest on borrowings during the active construction period of capital projects. Capitalized interest is added to the cost of the underlying assets and amortized over the useful lives of the assets. |
Variable_Interest_Entities_Pol
Variable Interest Entities (Policies) | 12 Months Ended |
Aug. 28, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Variable Interest Entities | ' |
We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. |
Micron_Memory_Japan_Inc_Micron
Micron Memory Japan, Inc. Micron Memory Japan, Inc. (Tables) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Business Acquisition [Line Items] | ' | ||||||||
Business Acquisition, Pro Forma Information [Table Text Block] | ' | ||||||||
The following unaudited pro forma financial information presents the combined results of operations as if the MMJ Acquisition had occurred on September 2, 2011. The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities. The historical results of operations of the MMJ Group for the eleven months ended May 31, 2013 included a gain of $1.69 billion for the forgiveness of debt related to liabilities subject to compromise upon approval of the bankruptcy by the creditors and the Japan Court and, for the year ended June 30, 2012, included a $2.83 billion loss for impairment of long-lived assets. No adjustments were made to the unaudited pro forma financial information for these items, consistent with the requirements for preparation of the pro forma financial information. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the MMJ Acquisition occurred on September 2, 2011. | |||||||||
For the year ended | 2013 | 2012 | |||||||
Net sales | $ | 12,494 | $ | 11,492 | |||||
Net income (loss) | 3,825 | (4,439 | ) | ||||||
Net income (loss) attributable to Micron | 3,770 | (4,471 | ) | ||||||
Earnings (loss) per share: | |||||||||
Basic | $ | 3.69 | $ | (4.51 | ) | ||||
Diluted | 3.57 | (4.51 | ) | ||||||
The unaudited pro forma financial information for 2013 includes our results for the year ended August 29, 2013, which includes one month of results from the MMJ Group following the closing of the MMJ Acquisition, and the results of the MMJ Group, including the adjustments described above, for the eleven months ended May 31, 2013. The pro forma information for 2012 includes our results for the year ended August 30, 2012 and the results of the MMJ Group, including the adjustments described above, for the year ended June 30, 2012. | |||||||||
MMJ Acquisition [Member] | ' | ||||||||
Business Acquisition [Line Items] | ' | ||||||||
Schedule of Business Acquisitions, by Acquisition [Table Text Block] | ' | ||||||||
The valuation of assets acquired and liabilities assumed were as follows: | |||||||||
Assets acquired and liabilities assumed: | |||||||||
Cash and equivalents | $ | 999 | |||||||
Receivables | 697 | ||||||||
Inventories | 962 | ||||||||
Restricted cash | 557 | ||||||||
Other current assets | 142 | ||||||||
Property, plant and equipment | 935 | ||||||||
Equity method investment | 40 | ||||||||
Intangible assets | 10 | ||||||||
Deferred tax assets | 811 | ||||||||
Other noncurrent assets | 66 | ||||||||
Accounts payable and accrued expenses | (387 | ) | |||||||
Equipment purchase contracts | (22 | ) | |||||||
Current portion of long-term debt | (673 | ) | |||||||
Long-term debt | (1,461 | ) | |||||||
Other noncurrent liabilities | (75 | ) | |||||||
Total net assets acquired | 2,601 | ||||||||
Noncontrolling interests in MMJ | 168 | ||||||||
Consideration | 949 | ||||||||
Preliminary gain on acquisition recognized in 2013 | 1,484 | ||||||||
Adjustment for primarily pre-petition liabilities | (33 | ) | |||||||
Final gain on acquisition | $ | 1,451 | |||||||
Investments_Tables
Investments (Tables) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Investments [Abstract] | ' | ||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | ' | ||||||||
The fair values of available-for-sale investments, which approximated amortized costs, were as follows: | |||||||||
As of | 2014 | 2013 | |||||||
Money market funds | $ | 1,281 | $ | 1,188 | |||||
Corporate bonds | 561 | 414 | |||||||
Certificates of deposit | 437 | 349 | |||||||
Government securities | 420 | 168 | |||||||
Asset-backed securities | 128 | 97 | |||||||
Commercial paper | 107 | 61 | |||||||
Marketable equity securities | 1 | 6 | |||||||
$ | 2,935 | $ | 2,283 | ||||||
Investments Classified by Contractual Maturity Date [Table Text Block] | ' | ||||||||
The table below presents the fair value of available-for-sale debt securities by contractual maturity: | |||||||||
As of | 2014 | ||||||||
Money market funds | $ | 1,281 | |||||||
Due in 1 year or less | 835 | ||||||||
Due in 1 - 2 years | 438 | ||||||||
Due in 2 - 4 years | 351 | ||||||||
Due after 4 years | 29 | ||||||||
$ | 2,934 | ||||||||
Receivables_Tables
Receivables (Tables) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Receivables [Abstract] | ' | ||||||||
Schedule of Receivables | ' | ||||||||
As of | 2014 | 2013 | |||||||
Trade receivables (net of allowance for doubtful accounts of $3 and $5, respectively) | $ | 2,524 | $ | 2,069 | |||||
Income and other taxes | 104 | 74 | |||||||
Other | 278 | 186 | |||||||
$ | 2,906 | $ | 2,329 | ||||||
Inventories_Tables
Inventories (Tables) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Inventory Disclosure [Abstract] | ' | ||||||||
Schedule Of Inventory | ' | ||||||||
As of | 2014 | 2013 | |||||||
Finished goods | $ | 898 | $ | 796 | |||||
Work in process | 1,372 | 1,719 | |||||||
Raw materials and supplies | 185 | 134 | |||||||
$ | 2,455 | $ | 2,649 | ||||||
Property_Plant_and_Equipment_T
Property, Plant and Equipment (Tables) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Schedule of Property, Plant and Equipment | ' | ||||||||
As of | 2014 | 2013 | |||||||
Land | $ | 86 | $ | 86 | |||||
Buildings (includes $289 and $209, respectively, from capital leases) | 5,093 | 4,835 | |||||||
Equipment (includes $1,108 and $1,305, respectively, from capital leases) | 17,781 | 15,600 | |||||||
Construction in progress | 114 | 84 | |||||||
Software | 358 | 315 | |||||||
23,432 | 20,920 | ||||||||
Accumulated depreciation (includes $693 and $463, respectively, from capital leases) | (14,750 | ) | (13,294 | ) | |||||
$ | 8,682 | $ | 7,626 | ||||||
Equity_Method_Investments_Tabl
Equity Method Investments (Tables) | 12 Months Ended | ||||||||||||||
Aug. 28, 2014 | |||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | ' | ||||||||||||||
Equity Method Investments | ' | ||||||||||||||
As of | 2014 | 2013 | |||||||||||||
Investment Balance | Ownership Percentage | Investment Balance | Ownership Percentage | ||||||||||||
Inotera(1) | $ | 914 | 33 | % | $ | 344 | 35 | % | |||||||
Tera Probe | 48 | 40 | % | 40 | 40 | % | |||||||||
Other | 9 | Various | 12 | Various | |||||||||||
$ | 971 | $ | 396 | ||||||||||||
(1) Entity is a variable interest entity. | |||||||||||||||
As of August 28, 2014, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was the $914 million carrying value of our investment in Inotera. We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera. | |||||||||||||||
We recognize our share of earnings or losses from our equity method investees generally on a two-month lag. Equity in net income (loss) of equity method investees, net of tax, included the following: | |||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||
Inotera | $ | 465 | $ | (79 | ) | $ | (189 | ) | |||||||
Tera Probe | 11 | — | — | ||||||||||||
Other | (2 | ) | (4 | ) | (105 | ) | |||||||||
$ | 474 | $ | (83 | ) | $ | (294 | ) | ||||||||
The summarized financial information in the tables below reflects aggregate amounts for all of our equity method investees. Financial information is presented for equity method investments as of the respective dates and for the periods through which we recorded our proportionate share of each investee's results of operations. Summarized results of operations are presented only for the periods subsequent to the acquisition or through the disposition of our ownership interests. | |||||||||||||||
As of | 2014 | 2013 | |||||||||||||
Current assets | $ | 2,233 | $ | 1,018 | |||||||||||
Noncurrent assets | 2,502 | 2,634 | |||||||||||||
Current liabilities | 1,417 | 1,912 | |||||||||||||
Noncurrent liabilities | 254 | 435 | |||||||||||||
For the years ended | 2014 | 2013 | 2012 | ||||||||||||
Net sales | $ | 3,382 | $ | 1,788 | $ | 1,798 | |||||||||
Gross margin | 1,576 | 1 | (451 | ) | |||||||||||
Operating income (loss) | 1,371 | (203 | ) | (751 | ) | ||||||||||
Net income (loss) | 1,339 | (188 | ) | (793 | ) | ||||||||||
Intangible_Assets_Tables
Intangible Assets (Tables) | 12 Months Ended | ||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ||||||||||||||||
Schedule Of Finite Lived Intangible Assets By Major Class | ' | ||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||
Gross | Accumulated | Gross | Accumulated | ||||||||||||||
Amount | Amortization | Amount | Amortization | ||||||||||||||
Product and process technology | $ | 809 | $ | (341 | ) | $ | 642 | $ | (269 | ) | |||||||
Customer relationships | 1 | (1 | ) | 127 | (114 | ) | |||||||||||
$ | 810 | $ | (342 | ) | $ | 769 | $ | (383 | ) | ||||||||
Accounts_Payable_and_Accrued_E1
Accounts Payable and Accrued Expenses (Tables) | 12 Months Ended | ||||||||
Aug. 28, 2014 | |||||||||
Payables and Accruals [Abstract] | ' | ||||||||
Accounts Payable And Accrued Liabilities Schedule | ' | ||||||||
As of | 2014 | 2013 | |||||||
Accounts payable | $ | 1,119 | $ | 1,048 | |||||
Related party payables | 673 | 374 | |||||||
Salaries, wages and benefits | 456 | 267 | |||||||
Customer advances | 98 | 140 | |||||||
Income and other taxes | 71 | 47 | |||||||
Other | 281 | 239 | |||||||
$ | 2,698 | $ | 2,115 | ||||||
Debt_Tables
Debt (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The following table presents the net effect of each of the actions: | |||||||||||||||||||||||||||||||
Increase (Decrease) in Principal | Increase (Decrease) in Carrying Value | Increase (Decrease) in Cash | (Decrease) in Equity | Loss(1) | |||||||||||||||||||||||||||
Exchanges | $ | 585 | $ | 282 | $ | — | $ | (238 | ) | $ | 49 | ||||||||||||||||||||
Conversions and settlements | (770 | ) | (437 | ) | (1,446 | ) | (886 | ) | 130 | ||||||||||||||||||||||
Repurchases | (320 | ) | (269 | ) | (857 | ) | (567 | ) | 23 | ||||||||||||||||||||||
Issuances | 2,212 | 2,212 | 2,157 | — | — | ||||||||||||||||||||||||||
Early repayments | (336 | ) | (334 | ) | (339 | ) | — | 3 | |||||||||||||||||||||||
$ | 1,371 | $ | 1,454 | $ | (485 | ) | $ | (1,691 | ) | $ | 205 | ||||||||||||||||||||
(1) | The loss on 2014 debt restructure activities was recorded as $184 million in other non-operating expense and $21 million in interest expense in 2014. | ||||||||||||||||||||||||||||||
Schedule of Debt | ' | ||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
MMJ creditor installment payments | N/A | 6.25 | % | $ | 192 | $ | 939 | $ | 1,131 | $ | 527 | $ | 1,117 | $ | 1,644 | ||||||||||||||||
Capital lease obligations(2) | N/A | N/A | 323 | 588 | 911 | 407 | 845 | 1,252 | |||||||||||||||||||||||
2014 convertible senior notes | 1.875 | % | 7.88 | % | — | — | — | 465 | — | 465 | |||||||||||||||||||||
2019 senior notes | 1.258 | % | 1.97 | % | 92 | 324 | 416 | — | — | — | |||||||||||||||||||||
2022 senior notes | 5.875 | % | 6.14 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
2025 senior notes | 5.5 | % | 5.56 | % | — | 1,150 | 1,150 | — | — | — | |||||||||||||||||||||
2027 convertible senior notes | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
2031A convertible senior notes | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
2031B convertible senior notes(3) | 1.875 | % | 6.98 | % | 362 | — | 362 | — | 253 | 253 | |||||||||||||||||||||
2032C convertible senior notes(4) | 2.375 | % | 5.95 | % | — | 314 | 314 | — | 463 | 463 | |||||||||||||||||||||
2032D convertible senior notes(4) | 3.125 | % | 6.33 | % | — | 288 | 288 | — | 369 | 369 | |||||||||||||||||||||
2033E convertible senior notes(4)(5) | 1.625 | % | 4.5 | % | 278 | — | 278 | — | 272 | 272 | |||||||||||||||||||||
2033F convertible senior notes(4)(5) | 2.125 | % | 4.93 | % | 265 | — | 265 | — | 260 | 260 | |||||||||||||||||||||
2043G convertible senior notes | 3 | % | 6.76 | % | — | 636 | 636 | — | — | — | |||||||||||||||||||||
Other notes payable | 2.289 | % | 3.4 | % | 126 | 116 | 242 | 186 | 449 | 635 | |||||||||||||||||||||
$ | 1,638 | $ | 4,955 | $ | 6,593 | $ | 1,585 | $ | 4,452 | $ | 6,037 | ||||||||||||||||||||
(1) | We have either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||
(2) Weighted-average imputed rate of 4.3% and 4.1% as of August 28, 2014 and August 29, 2013, respectively. | |||||||||||||||||||||||||||||||
(3) | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||
(4) | Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||
(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Schedule of Debt Restructuring [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The following table presents the remaining amounts of MMJ Creditor Installment Payments (stated in Japanese yen and U.S. dollars) and the amount of unamortized discount as of August 28, 2014: | |||||||||||||||||||||||||||||||
MMJ Creditor Installment Payments | |||||||||||||||||||||||||||||||
2015 | ¥ | 20,330 | $ | 196 | |||||||||||||||||||||||||||
2016 | 20,197 | 194 | |||||||||||||||||||||||||||||
2017 | 20,063 | 193 | |||||||||||||||||||||||||||||
2018 | 19,928 | 192 | |||||||||||||||||||||||||||||
2019 | 28,674 | 276 | |||||||||||||||||||||||||||||
2020 | 33,024 | 318 | |||||||||||||||||||||||||||||
142,216 | 1,369 | ||||||||||||||||||||||||||||||
Less unamortized discount | (24,700 | ) | (238 | ) | |||||||||||||||||||||||||||
MMJ Creditor Installment Payments | ¥ | 117,516 | $ | 1,131 | |||||||||||||||||||||||||||
Schedule Of Convertible Debt Instruments With Debt And Equity Components [Text Block] | ' | ||||||||||||||||||||||||||||||
The following table summarizes certain features of our convertible notes outstanding as of August 28, 2014: | |||||||||||||||||||||||||||||||
Holder Put Date | Outstanding Principal | Underlying Shares | Initial Conversion Price Per Share | Conversion Price Per Share Threshold(1) | Conversion Value in Excess of Principal(2) | ||||||||||||||||||||||||||
2032C Notes | May-19 | $ | 362 | 38 | $ | 9.63 | $ | 12.52 | $ | 873 | |||||||||||||||||||||
2032D Notes | May-21 | 344 | 34 | 9.98 | 12.97 | 785 | |||||||||||||||||||||||||
2033E Notes | Feb-18 | 300 | 27 | 10.93 | 14.21 | 600 | |||||||||||||||||||||||||
2033F Notes | Feb-20 | 300 | 27 | 10.93 | 14.21 | 600 | |||||||||||||||||||||||||
2043G Notes(3) | Nov-28 | 1,025 | 35 | 29.16 | 37.91 | 128 | |||||||||||||||||||||||||
$ | 2,331 | 161 | $ | 2,986 | |||||||||||||||||||||||||||
(1) | Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price. | ||||||||||||||||||||||||||||||
(2) | Based on our closing share price of $32.81 as of August 28, 2014. | ||||||||||||||||||||||||||||||
(3) | The original principal amount of $820 million accretes up to $917 million in November 2028 and $1.03 billion at maturity in 2043. | ||||||||||||||||||||||||||||||
The debt and equity components of all of our convertible notes outstanding as of August 28, 2014 were required to be accounted for separately. Principal and carrying amounts of the liability components for our convertible notes were as follows: | |||||||||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||||||||
Term | Outstanding Principal | Unamortized Discount | Net Carrying Amount | Outstanding Principal | Unamortized Discount | Net Carrying Amount | |||||||||||||||||||||||||
(Years)(1) | |||||||||||||||||||||||||||||||
2014 Notes | N/A | $ | — | $ | — | $ | — | $ | 485 | $ | (20 | ) | $ | 465 | |||||||||||||||||
2027 Notes | N/A | — | — | — | 175 | (28 | ) | 147 | |||||||||||||||||||||||
2031A Notes | N/A | — | — | — | 345 | (68 | ) | 277 | |||||||||||||||||||||||
2031B Notes(2) | N/A | 114 | (27 | ) | 362 | 345 | (92 | ) | 253 | ||||||||||||||||||||||
2032C Notes | 5 | 362 | (48 | ) | 314 | 550 | (87 | ) | 463 | ||||||||||||||||||||||
2032D Notes | 7 | 344 | (56 | ) | 288 | 450 | (81 | ) | 369 | ||||||||||||||||||||||
2033E Notes | 3 | 300 | (22 | ) | 278 | 300 | (28 | ) | 272 | ||||||||||||||||||||||
2033F Notes | 5 | 300 | (35 | ) | 265 | 300 | (40 | ) | 260 | ||||||||||||||||||||||
2043G Notes | 14 | 1,025 | (389 | ) | 636 | — | — | — | |||||||||||||||||||||||
$ | 2,445 | $ | (577 | ) | $ | 2,143 | $ | 2,950 | $ | (444 | ) | $ | 2,506 | ||||||||||||||||||
(1) | Expected term for amortization of the remaining debt discount as of August 28, 2014. The expected term of the 2031B Notes was not applicable because substantially all of the holders had exercised their option to convert their notes, which were settled in cash in the first quarter of 2015. | ||||||||||||||||||||||||||||||
(2) As holders had elected to convert these notes and we elected to settle the conversions in cash, net carrying amount for 2014 included the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | |||||||||||||||||||||||||||||||
Carrying amounts of the equity components, which are included in additional capital in the accompanying consolidated balance sheets, for our convertible notes, were as follows: | |||||||||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||||||||
2014 Notes | $ | — | $ | 353 | |||||||||||||||||||||||||||
2027 Notes | — | 40 | |||||||||||||||||||||||||||||
2031A Notes | — | 89 | |||||||||||||||||||||||||||||
2031B Notes | — | 109 | |||||||||||||||||||||||||||||
2032C Notes | 67 | 101 | |||||||||||||||||||||||||||||
2032D Notes | 69 | 90 | |||||||||||||||||||||||||||||
2033E Notes (excludes $22 million as of 2014 in mezzanine equity) | 8 | 30 | |||||||||||||||||||||||||||||
2033F Notes (excludes $35 million as of 2014 in mezzanine equity) | 7 | 42 | |||||||||||||||||||||||||||||
2043G Notes | 173 | — | |||||||||||||||||||||||||||||
$ | 324 | $ | 854 | ||||||||||||||||||||||||||||
Schedule Of Convertible Debt Instruments Interest Expense [Text Block] | ' | ||||||||||||||||||||||||||||||
Interest expense for our convertible notes consisting of contractual interest and amortization of discount and issuance costs aggregated $132 million, $156 million and $124 million for 2014, 2013 and 2012. Interest expense by note was as follows: | |||||||||||||||||||||||||||||||
Contractual Interest | Amortization of Discount and Issuance Costs | ||||||||||||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | 2014 | 2013 | 2012 | |||||||||||||||||||||||||
2014 Notes | $ | 2 | $ | 13 | $ | 18 | $ | 14 | $ | 37 | $ | 47 | |||||||||||||||||||
2027 Notes | 1 | 3 | 3 | 2 | 7 | 6 | |||||||||||||||||||||||||
2031A Notes | 1 | 5 | 5 | 3 | 12 | 11 | |||||||||||||||||||||||||
2031B Notes | 3 | 6 | 6 | 5 | 10 | 10 | |||||||||||||||||||||||||
2032C Notes | 11 | 13 | 5 | 12 | 14 | 5 | |||||||||||||||||||||||||
2032D Notes | 13 | 14 | 5 | 8 | 9 | 3 | |||||||||||||||||||||||||
2033E Notes | 5 | 3 | — | 7 | 4 | — | |||||||||||||||||||||||||
2033F Notes | 6 | 3 | — | 6 | 3 | — | |||||||||||||||||||||||||
2043G Notes | 24 | — | — | 9 | — | — | |||||||||||||||||||||||||
$ | 66 | $ | 60 | $ | 42 | $ | 66 | $ | 96 | $ | 82 | ||||||||||||||||||||
Maturities of Notes Payable and Future Minimum Lease Payments [Table Text Block] | ' | ||||||||||||||||||||||||||||||
As of August 28, 2014, maturities of notes payable (including the MMJ Creditor Installment Payments) and future minimum lease payments under capital lease obligations were as follows: | |||||||||||||||||||||||||||||||
Notes Payable | Capital Lease Obligations | ||||||||||||||||||||||||||||||
2015 | $ | 803 | $ | 356 | |||||||||||||||||||||||||||
2016 | 352 | 301 | |||||||||||||||||||||||||||||
2017 | 320 | 103 | |||||||||||||||||||||||||||||
2018 | 602 | 60 | |||||||||||||||||||||||||||||
2019 | 684 | 55 | |||||||||||||||||||||||||||||
2020 and thereafter | 3,628 | 123 | |||||||||||||||||||||||||||||
Unamortized discounts and interest, respectively | (707 | ) | (87 | ) | |||||||||||||||||||||||||||
$ | 5,682 | $ | 911 | ||||||||||||||||||||||||||||
Exchanged [Member] | ' | ||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The table below summarizes the Exchange Transactions: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
Amounts reduced in connection with the Exchanged Notes: | |||||||||||||||||||||||||||||||
2027 Notes | $ | 80 | $ | 68 | $ | 51 | |||||||||||||||||||||||||
2031A Notes | 155 | 125 | 148 | ||||||||||||||||||||||||||||
2031B Notes | 205 | 152 | 212 | ||||||||||||||||||||||||||||
440 | 345 | 411 | |||||||||||||||||||||||||||||
Amounts added in connection with the issued notes: | |||||||||||||||||||||||||||||||
2043G Notes | 1,025 | 627 | 173 | ||||||||||||||||||||||||||||
Net increase (decrease) as a result of the Exchange Transactions | $ | 585 | $ | 282 | $ | (238 | ) | ||||||||||||||||||||||||
Conversion And Settlement [Member] | ' | ||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
A summary of the conversion activities for these notes is as follows: | |||||||||||||||||||||||||||||||
Debt Principal | (Increase) Decrease in Carrying Value of Debt | Equity Component Reclassified To Debt(1) | Loss(2) | ||||||||||||||||||||||||||||
2014 Notes | $ | 485 | $ | 478 | $ | 341 | $ | 9 | |||||||||||||||||||||||
2027 Notes | 95 | 80 | 58 | 42 | |||||||||||||||||||||||||||
2031A Notes | 190 | 154 | 217 | 70 | |||||||||||||||||||||||||||
2031B Notes(3) | — | (275 | ) | 270 | 9 | ||||||||||||||||||||||||||
$ | 770 | $ | 437 | $ | 886 | $ | 130 | ||||||||||||||||||||||||
(1) Based on Level 2 fair value measurements. | |||||||||||||||||||||||||||||||
(2) The loss on conversion and settlement activities was recorded as $120 million in other non-operating expense and $10 million in interest expense in 2014. | |||||||||||||||||||||||||||||||
(3) In the first quarter of 2015, we used an aggregate of $389 million in cash to settle the remaining 2031B Notes. In connection therewith, we incurred an additional charge of $24 million for the settlement of the 2031B Notes in the first quarter of 2015. | |||||||||||||||||||||||||||||||
Repurchase [Member] | ' | ||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The table below summarizes amounts reduced in 2014 in connection with the Repurchased Notes: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
2031B Notes | $ | 26 | $ | 19 | $ | 43 | |||||||||||||||||||||||||
2032C Notes | 188 | 161 | 316 | ||||||||||||||||||||||||||||
2032D Notes | 106 | 89 | 208 | ||||||||||||||||||||||||||||
$ | 320 | $ | 269 | $ | 567 | ||||||||||||||||||||||||||
Commitments_Tables
Commitments (Tables) | 12 Months Ended | ||||
Aug. 28, 2014 | |||||
Commitments and Contingencies Disclosure [Abstract] | ' | ||||
Minimum Future Operating Lease Commitments | ' | ||||
Minimum future rental commitments as of August 28, 2014 were as follows: | |||||
Operating Lease Commitments | |||||
2015 | $ | 22 | |||
2016 | 18 | ||||
2017 | 14 | ||||
2018 | 13 | ||||
2019 | 12 | ||||
2020 and thereafter | 37 | ||||
$ | 116 | ||||
Equity_Tables
Equity (Tables) | 12 Months Ended | |||||||||||||||||||||||||||
Aug. 28, 2014 | ||||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | |||||||||||||||||||||||||||
Schedule of Options Indexed to Issuer's Equity [Table Text Block] | ' | |||||||||||||||||||||||||||
The following table presents information related to the issued and outstanding capped calls as of August 28, 2014: | ||||||||||||||||||||||||||||
Capped Calls | Strike Price | Cap Price Range | Underlying Common Shares | Value at Expiration(1) | ||||||||||||||||||||||||
Expiration Dates | Low | High | Minimum | Maximum | ||||||||||||||||||||||||
2031 | Jul-15 | – | Feb-16 | $ | 9.5 | $ | 12.67 | $ | 13.17 | 34 | $ | — | $ | 117 | ||||||||||||||
2032C | May-16 | – | Nov-17 | 9.8 | 14.26 | 15.69 | 56 | — | 307 | |||||||||||||||||||
2032D | Nov-16 | – | May-18 | 10.16 | 14.62 | 16.04 | 44 | — | 244 | |||||||||||||||||||
2033E | Jan-18 | – | Feb-18 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
2033F | Jan-20 | – | Feb-20 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
188 | $ | — | $ | 864 | ||||||||||||||||||||||||
(1) | Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the low strike price, to the maximum amount if the market price per share of our common stock is at or above the high cap price. If share settlement were elected, the number of shares received would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. | |||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | ' | |||||||||||||||||||||||||||
Cumulative Foreign Currency Translation Adjustments | Gains (Losses) on Derivative Instruments, Net | Gains (Losses) on Investments, Net | Pension Liability Adjustments | Total | ||||||||||||||||||||||||
Balance as of August 29, 2013 | $ | 44 | $ | 21 | $ | — | $ | (2 | ) | $ | 63 | |||||||||||||||||
Other comprehensive income before reclassifications | 1 | (4 | ) | 4 | 1 | 2 | ||||||||||||||||||||||
Amount reclassified out of accumulated other comprehensive income | (3 | ) | (4 | ) | (3 | ) | 1 | (9 | ) | |||||||||||||||||||
Tax effects | — | (1 | ) | — | 1 | — | ||||||||||||||||||||||
Other comprehensive income (loss) | (2 | ) | (9 | ) | 1 | 3 | (7 | ) | ||||||||||||||||||||
Balance as of August 28, 2014 | $ | 42 | $ | 12 | $ | 1 | $ | 1 | $ | 56 | ||||||||||||||||||
Schedule Of Noncontrolling Interests In Subsidiaries [Table Text Block] | ' | |||||||||||||||||||||||||||
As of | 2014 | 2013 | ||||||||||||||||||||||||||
Noncontrolling Interest Balance | Noncontrolling Interest Percentage | Noncontrolling Interest Balance | Noncontrolling Interest Percentage | |||||||||||||||||||||||||
IMFT(1) | $ | 693 | 49 | % | $ | 601 | 49 | % | ||||||||||||||||||||
MP Mask(1) | 93 | 50 | % | 92 | 50 | % | ||||||||||||||||||||||
MMT | 9 | <l% | 155 | 11 | % | |||||||||||||||||||||||
Other | 7 | Various | 16 | Various | ||||||||||||||||||||||||
$ | 802 | $ | 864 | |||||||||||||||||||||||||
(1) Entity is a variable interest entity. | ||||||||||||||||||||||||||||
IM Flash Technologies, LLC [Member] | ' | |||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | |||||||||||||||||||||||||||
IM Flash's distributions to, and contributions from, shareholders | ' | |||||||||||||||||||||||||||
The following table presents IMFT's distributions to and contributions from its shareholders: | ||||||||||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||||||||||||||||
IMFT distributions to Micron | $ | 10 | $ | 38 | $ | 439 | ||||||||||||||||||||||
IMFT distributions to Intel | 10 | 37 | 391 | |||||||||||||||||||||||||
Micron contributions to IMFT | 106 | 12 | 48 | |||||||||||||||||||||||||
Intel contributions to IMFT | 102 | 11 | 46 | |||||||||||||||||||||||||
Total IM Flash and MP Mask assets and liabilities | ' | |||||||||||||||||||||||||||
The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances: | ||||||||||||||||||||||||||||
As of | 2014 | 2013 | ||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||
Cash and equivalents | $ | 84 | $ | 62 | ||||||||||||||||||||||||
Receivables | 73 | 76 | ||||||||||||||||||||||||||
Inventories | 48 | 49 | ||||||||||||||||||||||||||
Other current assets | 5 | 4 | ||||||||||||||||||||||||||
Total current assets | 210 | 191 | ||||||||||||||||||||||||||
Property, plant and equipment, net | 1,545 | 1,382 | ||||||||||||||||||||||||||
Other noncurrent assets | 47 | 46 | ||||||||||||||||||||||||||
Total assets | $ | 1,802 | $ | 1,619 | ||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||
Accounts payable and accrued expenses | $ | 92 | $ | 88 | ||||||||||||||||||||||||
Deferred income | 8 | 9 | ||||||||||||||||||||||||||
Equipment purchase contracts | 14 | 78 | ||||||||||||||||||||||||||
Current portion of long-term debt | 21 | 6 | ||||||||||||||||||||||||||
Total current liabilities | 135 | 181 | ||||||||||||||||||||||||||
Long-term debt | 71 | 13 | ||||||||||||||||||||||||||
Other noncurrent liabilities | 110 | 118 | ||||||||||||||||||||||||||
Total liabilities | $ | 316 | $ | 312 | ||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. | ||||||||||||||||||||||||||||
MP Mask Technology Center LLC [Member] | ' | |||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | |||||||||||||||||||||||||||
Total IM Flash and MP Mask assets and liabilities | ' | |||||||||||||||||||||||||||
The following table presents the assets and liabilities of MP Mask included in our consolidated balance sheets: | ||||||||||||||||||||||||||||
As of | 2014 | 2013 | ||||||||||||||||||||||||||
Current assets | $ | 24 | $ | 26 | ||||||||||||||||||||||||
Noncurrent assets (primarily property, plant and equipment) | 203 | 182 | ||||||||||||||||||||||||||
Current liabilities | 28 | 25 | ||||||||||||||||||||||||||
Noncurrent liabilities | 14 | — | ||||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. |
Derivative_Financial_Instrumen1
Derivative Financial Instruments (Tables) | 12 Months Ended | ||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||
Derivative Instrument Detail [Abstract] | ' | ||||||||||||||||||||
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] | ' | ||||||||||||||||||||
Notional Amount(1) | Fair Value of | ||||||||||||||||||||
Current Assets(2) | Noncurrent Assets(3) | Current Liabilities(4) | Noncurrent Liabilities(5) | ||||||||||||||||||
As of August 28, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 554 | $ | — | $ | — | $ | (12 | ) | $ | (6 | ) | |||||||||
Singapore dollar | 330 | — | — | — | — | ||||||||||||||||
Euro | 245 | — | — | (1 | ) | — | |||||||||||||||
Shekel | 62 | — | — | (1 | ) | — | |||||||||||||||
$ | 1,191 | ||||||||||||||||||||
Convertible notes settlement obligations | 12 | — | — | (389 | ) | — | |||||||||||||||
$ | — | $ | — | $ | (403 | ) | $ | (6 | ) | ||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 336 | $ | 1 | $ | 3 | $ | — | $ | — | |||||||||||
Singapore dollar | 218 | — | — | — | — | ||||||||||||||||
Euro | 217 | 1 | — | (1 | ) | — | |||||||||||||||
Shekel | 78 | — | — | (1 | ) | — | |||||||||||||||
Interest rate swap contracts | 62 | — | — | — | — | ||||||||||||||||
Currency options - New Taiwan dollar | 351 | — | — | — | — | ||||||||||||||||
$ | 1,262 | $ | 2 | $ | 3 | $ | (2 | ) | $ | — | |||||||||||
-1 | Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares. | ||||||||||||||||||||
(2) | Included in receivables - other. | ||||||||||||||||||||
(3) | Included in other noncurrent assets. | ||||||||||||||||||||
(4) | Included in accounts payable and accrued expenses - other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations. | ||||||||||||||||||||
(5) | Included in other noncurrent liabilities. | ||||||||||||||||||||
Net gains (losses) for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | Location | |||||||||||||||||
Convertible notes settlement obligations | $ | (59 | ) | $ | — | $ | — | Other non-operating income (expense) | |||||||||||||
Foreign exchange contracts | (27 | ) | (222 | ) | (17 | ) | Other non-operating income (expense) | ||||||||||||||
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] | ' | ||||||||||||||||||||
Notional Amount | Fair Value of Current Liabilities(1) | ||||||||||||||||||||
(in U.S. Dollars) | |||||||||||||||||||||
As of August 28, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 94 | $ | (2 | ) | ||||||||||||||||
Euro | 24 | — | |||||||||||||||||||
$ | 118 | $ | (2 | ) | |||||||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 6 | $ | (1 | ) | ||||||||||||||||
Euro | 6 | — | |||||||||||||||||||
Interest swap contracts | 250 | — | |||||||||||||||||||
Currency options - Yen | 21 | (2 | ) | ||||||||||||||||||
$ | 283 | $ | (3 | ) | |||||||||||||||||
(1) | Included in accounts payable and accrued expenses - other. |
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||||||||||
Assets measured at fair value on a recurring basis | ' | ||||||||||||||||||||||||
Assets measured at fair value on a recurring basis were as follows: | |||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||
Level 1 | Level 2 | Total | Level 1 | Level 2 | Total | ||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||
Money market funds | $ | 1,281 | $ | — | $ | 1,281 | $ | 1,188 | $ | — | $ | 1,188 | |||||||||||||
Certificates of deposit | — | 402 | 402 | — | 38 | 38 | |||||||||||||||||||
Commercial paper | — | 22 | 22 | — | 35 | 35 | |||||||||||||||||||
1,281 | 424 | 1,705 | 1,188 | 73 | 1,261 | ||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||
Corporate bonds | — | 154 | 154 | — | 112 | 112 | |||||||||||||||||||
Government securities | — | 136 | 136 | — | 72 | 72 | |||||||||||||||||||
Commercial paper | — | 85 | 85 | — | 26 | 26 | |||||||||||||||||||
Certificates of deposit | — | 8 | 8 | — | 9 | 9 | |||||||||||||||||||
Asset-backed securities | — | 1 | 1 | — | 2 | 2 | |||||||||||||||||||
— | 384 | 384 | — | 221 | 221 | ||||||||||||||||||||
Long-term marketable investments: | |||||||||||||||||||||||||
Corporate bonds | — | 407 | 407 | — | 302 | 302 | |||||||||||||||||||
Government securities | — | 284 | 284 | — | 96 | 96 | |||||||||||||||||||
Asset-backed securities | — | 127 | 127 | — | 95 | 95 | |||||||||||||||||||
Marketable equity securities | 1 | — | 1 | 6 | — | 6 | |||||||||||||||||||
1 | 818 | 819 | 6 | 493 | 499 | ||||||||||||||||||||
Restricted cash: | |||||||||||||||||||||||||
Certificates of deposit | — | 27 | 27 | — | 302 | 302 | |||||||||||||||||||
— | 27 | 27 | — | 302 | 302 | ||||||||||||||||||||
$ | 1,282 | $ | 1,653 | $ | 2,935 | $ | 1,194 | $ | 1,089 | $ | 2,283 | ||||||||||||||
Estimated fair value and carrying value of debt instruments | ' | ||||||||||||||||||||||||
The estimated fair value and carrying value of debt instruments (carrying value excludes the equity and mezzanine components of our convertible notes, which are classified in equity) were as follows: | |||||||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||||||
Fair | Carrying | Fair | Carrying | ||||||||||||||||||||||
Value | Value | Value | Value | ||||||||||||||||||||||
Convertible notes | $ | 5,886 | $ | 2,143 | $ | 4,167 | $ | 2,506 | |||||||||||||||||
MMJ creditor installment payments and other notes | 3,634 | 3,539 | 2,269 | 2,279 | |||||||||||||||||||||
Equity_Plans_Tables
Equity Plans (Tables) | 12 Months Ended | |||||||||||||
Aug. 28, 2014 | ||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||
Schedule option activity | ' | |||||||||||||
Option activity for 2014 is summarized as follows: | ||||||||||||||
Number of Shares | Weighted-Average Exercise Price Per Share | Weighted-Average Remaining Contractual Life | Aggregate Intrinsic Value | |||||||||||
(In Years) | ||||||||||||||
Outstanding at August 29, 2013 | 71 | $ | 7.41 | |||||||||||
Granted | 12 | 22.61 | ||||||||||||
Exercised | (32 | ) | 8.27 | |||||||||||
Cancelled or expired | (3 | ) | 9.27 | |||||||||||
Outstanding at August 28, 2014 | 48 | 10.57 | 3.8 | $ | 1,078 | |||||||||
Exercisable at August 28, 2014 | 14 | $ | 6.88 | 2.4 | $ | 362 | ||||||||
Expected to vest after August 28, 2014 | 33 | 11.92 | 4.3 | 692 | ||||||||||
Assumptions used in Black-Scholes option valuation model | ' | |||||||||||||
Assumptions used in the Black-Scholes model are presented below: | ||||||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||
Average expected life in years | 4.9 | 5.1 | 5.1 | |||||||||||
Weighted-average expected volatility | 48 | % | 59 | % | 66 | % | ||||||||
Weighted-average risk-free interest rate | 1.6 | % | 0.7 | % | 0.9 | % | ||||||||
Schedule of restricted stock awards activity | ' | |||||||||||||
Restricted Stock Awards activity for 2014 is summarized as follows: | ||||||||||||||
Number of Shares | Weighted-Average Grant Date Fair Value Per Share | |||||||||||||
Outstanding at August 29, 2013 | 13 | $ | 6.49 | |||||||||||
Granted | 7 | 21.88 | ||||||||||||
Restrictions lapsed | (6 | ) | 6.29 | |||||||||||
Cancelled | (1 | ) | 8.75 | |||||||||||
Outstanding at August 28, 2014 | 13 | 15.08 | ||||||||||||
Expected to vest after August 28, 2014 | 13 | $ | 14.91 | |||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||
Weighted-average grant-date fair values per share | $ | 21.88 | $ | 6.23 | $ | 5.43 | ||||||||
Aggregate fair values at vesting date | 115 | 17 | 32 | |||||||||||
Stock-based compensation expense | ' | |||||||||||||
Stock-based Compensation Expense | ||||||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||||||
Stock-based compensation expense by caption: | ||||||||||||||
Cost of goods sold | $ | 39 | $ | 27 | $ | 23 | ||||||||
Selling, general and administrative | 50 | 45 | 47 | |||||||||||
Research and development | 25 | 18 | 17 | |||||||||||
Other | 1 | 1 | — | |||||||||||
$ | 115 | $ | 91 | $ | 87 | |||||||||
Stock-based compensation expense by type of award: | ||||||||||||||
Stock options | $ | 61 | $ | 57 | $ | 57 | ||||||||
Restricted stock awards | 54 | 34 | 30 | |||||||||||
$ | 115 | $ | 91 | $ | 87 | |||||||||
Restucture_and_Asset_Impairmen1
Restucture and Asset Impairments Restructuring and Asset Impairments (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Restructuring and Related Activities [Abstract] | ' | ||||||||||||
Schedule of Restructuring and Related Costs [Table Text Block] | ' | ||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Loss on impairment of LED assets | $ | (6 | ) | $ | 33 | $ | — | ||||||
Loss on impairment of MIT assets | (5 | ) | 62 | — | |||||||||
Gain on termination of lease to Transform | — | (25 | ) | — | |||||||||
Loss on restructure of ST Consortium agreement | — | 26 | — | ||||||||||
Other | 51 | 30 | 10 | ||||||||||
$ | 40 | $ | 126 | $ | 10 | ||||||||
Other_Operating_Income_Expense1
Other Operating (Income) Expense, Net (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Other Income and Expenses [Abstract] | ' | ||||||||||||
Schedule of Other operating (income) expense, net | ' | ||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Rambus settlement | $ | 233 | $ | — | $ | — | |||||||
(Gain) loss on disposition of property, plant and equipment | 10 | (3 | ) | 5 | |||||||||
Other | (11 | ) | (5 | ) | 27 | ||||||||
$ | 232 | $ | (8 | ) | $ | 32 | |||||||
Other_NonOperating_Income_Expe
Other Non-Operating Income (Expense), Net (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Other Nonoperating Income (Expense) [Abstract] | ' | ||||||||||||
Schedule of Other Nonoperating Income (Expense) [Table Text Block] | ' | ||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Loss on restructure of debt | $ | (184 | ) | $ | (31 | ) | $ | — | |||||
Gain (loss) from changes in currency exchange rates | (28 | ) | (229 | ) | (6 | ) | |||||||
Gain from disposition of interest in Aptina | 119 | — | — | ||||||||||
Gain from issuance of Inotera shares | 93 | 48 | — | ||||||||||
Other | 8 | (6 | ) | 35 | |||||||||
$ | 8 | $ | (218 | ) | $ | 29 | |||||||
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||||||||||||||
Income tax (provision) benefit | ' | ||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||||||||
Income (loss) before income taxes, net income attributable to noncontrolling interests and equity in net income (loss) of equity method investees: | |||||||||||||||||||||
Foreign | $ | 2,619 | $ | 839 | $ | 274 | |||||||||||||||
U.S. | 114 | 446 | (1,028 | ) | |||||||||||||||||
$ | 2,733 | $ | 1,285 | $ | (754 | ) | |||||||||||||||
Income tax (provision) benefit: | |||||||||||||||||||||
Current: | |||||||||||||||||||||
Foreign | $ | (46 | ) | $ | (17 | ) | $ | (22 | ) | ||||||||||||
U.S. federal | (3 | ) | — | 14 | |||||||||||||||||
State | (2 | ) | — | — | |||||||||||||||||
(51 | ) | (17 | ) | (8 | ) | ||||||||||||||||
Deferred: | |||||||||||||||||||||
Foreign | (81 | ) | 9 | 25 | |||||||||||||||||
U.S. federal | 4 | — | — | ||||||||||||||||||
(77 | ) | 9 | 25 | ||||||||||||||||||
Income tax (provision) benefit | $ | (128 | ) | $ | (8 | ) | $ | 17 | |||||||||||||
Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit | ' | ||||||||||||||||||||
Income tax (provision) benefit computed using the U.S. federal statutory rate reconciled to income tax (provision) benefit was as follows: | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||||||||
U.S. federal income tax (provision) benefit at statutory rate | $ | (956 | ) | $ | (450 | ) | $ | 264 | |||||||||||||
Change in unrecognized tax benefits | (152 | ) | 2 | 52 | |||||||||||||||||
State taxes, net of federal benefit | (39 | ) | 6 | 9 | |||||||||||||||||
Gain on MMJ Acquisition | (11 | ) | 520 | — | |||||||||||||||||
Change in valuation allowance | 544 | (418 | ) | (368 | ) | ||||||||||||||||
Foreign tax rate differential | 474 | 339 | 77 | ||||||||||||||||||
Tax credits | 11 | 36 | 2 | ||||||||||||||||||
Transaction costs related to the MMJ Acquisition | — | (38 | ) | — | |||||||||||||||||
Other | 1 | (5 | ) | (19 | ) | ||||||||||||||||
Income tax (provision) benefit | $ | (128 | ) | $ | (8 | ) | $ | 17 | |||||||||||||
Deferred tax assets and liabilities | ' | ||||||||||||||||||||
Deferred tax assets and liabilities consist of the following: | |||||||||||||||||||||
As of | 2014 | 2013 | |||||||||||||||||||
Deferred tax assets: | |||||||||||||||||||||
Net operating loss and tax credit carryforwards | $ | 3,162 | $ | 4,048 | |||||||||||||||||
Property, plant and equipment | 284 | 313 | |||||||||||||||||||
Accrued salaries, wages and benefits | 152 | 107 | |||||||||||||||||||
Other accrued liabilities | 113 | 8 | |||||||||||||||||||
Other | 104 | 169 | |||||||||||||||||||
Gross deferred tax assets | 3,815 | 4,645 | |||||||||||||||||||
Less valuation allowance | (2,443 | ) | (3,155 | ) | |||||||||||||||||
Deferred tax assets, net of valuation allowance | 1,372 | 1,490 | |||||||||||||||||||
Deferred tax liabilities: | |||||||||||||||||||||
Debt discount | (291 | ) | (294 | ) | |||||||||||||||||
Unremitted earnings on certain subsidiaries | (115 | ) | (126 | ) | |||||||||||||||||
Product and process technology | (29 | ) | (74 | ) | |||||||||||||||||
Other | (67 | ) | (14 | ) | |||||||||||||||||
Deferred tax liabilities | (502 | ) | (508 | ) | |||||||||||||||||
Net deferred tax assets | $ | 870 | $ | 982 | |||||||||||||||||
Reported as: | |||||||||||||||||||||
Current deferred tax assets (included in other current assets) | $ | 228 | $ | 123 | |||||||||||||||||
Noncurrent deferred tax assets | 816 | 861 | |||||||||||||||||||
Current deferred tax liabilities (included in accounts payable and accrued expenses) | (4 | ) | (2 | ) | |||||||||||||||||
Noncurrent deferred tax liabilities (included in other noncurrent liabilities) | (170 | ) | — | ||||||||||||||||||
Net deferred tax assets | $ | 870 | $ | 982 | |||||||||||||||||
Net operating loss carryforwards | ' | ||||||||||||||||||||
As of August 28, 2014, our federal, state and foreign net operating loss carryforward amounts and expiration periods as reported to tax authorities, were as follows: | |||||||||||||||||||||
Year of Expiration | U.S. Federal | State | Japan | Other Foreign | Total | ||||||||||||||||
2015 - 2019 | $ | — | $ | 102 | $ | 83 | $ | 513 | $ | 698 | |||||||||||
2020 - 2024 | — | 179 | 3,862 | 872 | 4,913 | ||||||||||||||||
2025 - 2029 | 2,081 | 934 | — | — | 3,015 | ||||||||||||||||
2030 - 2033 | 1,812 | 493 | — | — | 2,305 | ||||||||||||||||
Indefinite | — | — | — | 39 | 39 | ||||||||||||||||
$ | 3,893 | $ | 1,708 | $ | 3,945 | $ | 1,424 | $ | 10,970 | ||||||||||||
Federal and state tax credit carryforwards | ' | ||||||||||||||||||||
As of August 28, 2014, our federal and state tax credit carryforward amounts and expiration periods were as follows: | |||||||||||||||||||||
Year of Tax Credit Expiration | Federal | State | Total | ||||||||||||||||||
2015 - 2019 | $ | 9 | $ | 69 | $ | 78 | |||||||||||||||
2020 - 2024 | 91 | 55 | 146 | ||||||||||||||||||
2025 - 2029 | 78 | 38 | 116 | ||||||||||||||||||
2030 - 2034 | 72 | — | 72 | ||||||||||||||||||
Indefinite | — | 31 | 31 | ||||||||||||||||||
$ | 250 | $ | 193 | $ | 443 | ||||||||||||||||
Reconciliation of beginning and ending amount of unrecognized tax benefits | ' | ||||||||||||||||||||
Below is a reconciliation of the beginning and ending amount of unrecognized tax benefits: | |||||||||||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||||||||||
Beginning unrecognized tax benefits | $ | 78 | $ | 77 | $ | 121 | |||||||||||||||
Increases related to tax positions taken during current year | 152 | 4 | 6 | ||||||||||||||||||
Foreign currency translation increases (decreases) to tax positions | 1 | 4 | (9 | ) | |||||||||||||||||
Settlements with tax authorities | (1 | ) | (8 | ) | (29 | ) | |||||||||||||||
Decreases related to tax positions from prior years | (1 | ) | — | (14 | ) | ||||||||||||||||
Lapse of statute of limitations | (1 | ) | — | — | |||||||||||||||||
Increases related to tax positions from prior years | — | — | 2 | ||||||||||||||||||
Unrecognized tax benefits acquired in current year | — | 1 | — | ||||||||||||||||||
Ending unrecognized tax benefits | $ | 228 | $ | 78 | $ | 77 | |||||||||||||||
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||
Basic and diluted earnings per share | ' | ||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Net income (loss) available to Micron shareholders – Basic | $ | 3,045 | $ | 1,190 | $ | (1,032 | ) | ||||||
Dilutive effect related to equity method investment | (2 | ) | — | — | |||||||||
Net income (loss) available to Micron shareholders – Diluted | $ | 3,043 | $ | 1,190 | $ | (1,032 | ) | ||||||
Weighted-average common shares outstanding – Basic | 1,060 | 1,022 | 991 | ||||||||||
Dilutive effect of equity plans and convertible notes | 138 | 35 | — | ||||||||||
Weighted-average common shares outstanding – Diluted | 1,198 | 1,057 | 991 | ||||||||||
Earnings (loss) per share: | |||||||||||||
Basic | $ | 2.87 | $ | 1.16 | $ | (1.04 | ) | ||||||
Diluted | 2.54 | 1.13 | (1.04 | ) | |||||||||
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | ' | ||||||||||||
Listed below are the potential common shares, as of the end of the periods shown, that could dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been antidilutive: | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Equity plans | 7 | 40 | 105 | ||||||||||
Convertible notes | 26 | 186 | 258 | ||||||||||
Segment_Information_Tables
Segment Information (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||
Segment Information | ' | ||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
Net sales: | |||||||||||||
CNBU | $ | 7,333 | $ | 3,462 | $ | 2,667 | |||||||
MBU | 3,627 | 1,214 | 1,176 | ||||||||||
SBU | 3,480 | 2,824 | 2,842 | ||||||||||
EBU | 1,774 | 1,275 | 1,097 | ||||||||||
All Other | 144 | 298 | 452 | ||||||||||
$ | 16,358 | $ | 9,073 | $ | 8,234 | ||||||||
Operating income (loss): | |||||||||||||
CNBU | $ | 1,957 | $ | 160 | $ | (458 | ) | ||||||
MBU | 683 | (265 | ) | (371 | ) | ||||||||
SBU | 255 | 173 | 199 | ||||||||||
EBU | 331 | 227 | 129 | ||||||||||
All Other | 94 | (59 | ) | (111 | ) | ||||||||
Unallocated | (233 | ) | — | — | |||||||||
$ | 3,087 | $ | 236 | $ | (612 | ) | |||||||
Depreciation and amortization expense was as follows: | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
CNBU | $ | 878 | $ | 687 | $ | 755 | |||||||
MBU | 475 | 293 | 372 | ||||||||||
SBU | 512 | 551 | 649 | ||||||||||
EBU | 226 | 215 | 228 | ||||||||||
All Other | 11 | 67 | 140 | ||||||||||
Depreciation and amortization expense included in operating income (loss) | 2,102 | 1,813 | 2,144 | ||||||||||
Other amortization | 168 | 113 | 78 | ||||||||||
Total depreciation and amortization expense | $ | 2,270 | $ | 1,926 | $ | 2,222 | |||||||
Product_Sales_Product_Sales_Ta
Product Sales Product Sales (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Segment Reconciliation [Abstract] | ' | ||||||||||||
Schedule of Product Sales [Text Block] | ' | ||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
DRAM | $ | 11,164 | $ | 4,361 | $ | 3,178 | |||||||
NAND Flash | 4,468 | 3,589 | 3,627 | ||||||||||
NOR Flash | 505 | 792 | 977 | ||||||||||
Other | 221 | 331 | 452 | ||||||||||
$ | 16,358 | $ | 9,073 | $ | 8,234 | ||||||||
Certain_Concentrations_Certain
Certain Concentrations Certain Concentrations (Tables) | 12 Months Ended | |||||||||
Aug. 28, 2014 | ||||||||||
Risks and Uncertainties [Abstract] | ' | |||||||||
Schedule of market concentration risk [Table Text Block] | ' | |||||||||
Markets with concentrations of net sales were approximately as follows: | ||||||||||
For the year ended | 2014 | 2013 | 2012 | |||||||
Compute and graphics | 30 | % | 20 | % | 15 | % | ||||
Mobile | 20 | % | 15 | % | 15 | % | ||||
Solid state drives and other storage | 20 | % | 25 | % | 25 | % | ||||
Automotive, industrial, medical and other embedded | 10 | % | 15 | % | 15 | % | ||||
Server | 10 | % | 10 | % | 10 | % |
Geographic_Information_Tables
Geographic Information (Tables) | 12 Months Ended | ||||||||||||
Aug. 28, 2014 | |||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||
Revenue from External Customers by Geographic Areas [Table Text Block] | ' | ||||||||||||
Geographic net sales based on customer ship-to location were as follows: | |||||||||||||
For the year ended | 2014 | 2013 | 2012 | ||||||||||
China | $ | 6,715 | $ | 3,783 | $ | 2,936 | |||||||
United States | 2,551 | 1,512 | 1,262 | ||||||||||
Taiwan | 2,313 | 980 | 1,022 | ||||||||||
Asia Pacific (excluding China, Taiwan and Japan) | 1,791 | 946 | 1,327 | ||||||||||
Japan | 1,253 | 589 | 460 | ||||||||||
Europe | 1,252 | 820 | 827 | ||||||||||
Other | 483 | 443 | 400 | ||||||||||
$ | 16,358 | $ | 9,073 | $ | 8,234 | ||||||||
Long-lived Assets by Geographic Areas [Table Text Block] | ' | ||||||||||||
Net property, plant and equipment by geographic area was as follows: | |||||||||||||
As of | 2014 | 2013 | |||||||||||
United States | $ | 3,282 | $ | 3,041 | |||||||||
Singapore | 3,101 | 3,225 | |||||||||||
Japan | 1,221 | 615 | |||||||||||
Taiwan | 761 | 307 | |||||||||||
China | 242 | 350 | |||||||||||
Other | 75 | 88 | |||||||||||
$ | 8,682 | $ | 7,626 | ||||||||||
Quarterly_Financial_Informatio1
Quarterly Financial Information Quarterly Financial Information (Tables) | 12 Months Ended | ||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||
Quarterly Financial Information Disclosure [Abstract] | ' | ||||||||||||||||
Schedule of Quarterly Financial Information [Text Block] | ' | ||||||||||||||||
2013 | Fourth Quarter | Third Quarter | Second Quarter | First Quarter | |||||||||||||
Net sales | $ | 2,843 | $ | 2,318 | $ | 2,078 | $ | 1,834 | |||||||||
Gross margin | 708 | 556 | 366 | 217 | |||||||||||||
Operating income (loss) | 207 | 149 | (23 | ) | (97 | ) | |||||||||||
Net income (loss) | 1,710 | 43 | (284 | ) | (275 | ) | |||||||||||
Net income (loss) attributable to Micron | 1,708 | 43 | (286 | ) | (275 | ) | |||||||||||
Earnings (loss) per share: | |||||||||||||||||
Basic | $ | 1.65 | $ | 0.04 | $ | (0.28 | ) | $ | (0.27 | ) | |||||||
Diluted | 1.51 | 0.04 | (0.28 | ) | (0.27 | ) | |||||||||||
2014 | Fourth Quarter | Third Quarter | Second Quarter | First Quarter | |||||||||||||
Net sales | $ | 4,227 | $ | 3,982 | $ | 4,107 | $ | 4,042 | |||||||||
Gross margin | 1,385 | 1,368 | 1,403 | 1,281 | |||||||||||||
Operating income | 828 | 839 | 869 | 551 | |||||||||||||
Net income | 1,151 | 806 | 741 | 381 | |||||||||||||
Net income attributable to Micron | 1,150 | 806 | 731 | 358 | |||||||||||||
Earnings per share: | |||||||||||||||||
Basic | $ | 1.08 | $ | 0.76 | $ | 0.69 | $ | 0.34 | |||||||||
Diluted | 0.96 | 0.68 | 0.61 | 0.3 | |||||||||||||
Schedule_I_Condensed_Parent_Co1
Schedule I Condensed Parent Company Financials (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||
Aug. 28, 2014 | |||||||||||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Debt | ' | ||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
MMJ creditor installment payments | N/A | 6.25 | % | $ | 192 | $ | 939 | $ | 1,131 | $ | 527 | $ | 1,117 | $ | 1,644 | ||||||||||||||||
Capital lease obligations(2) | N/A | N/A | 323 | 588 | 911 | 407 | 845 | 1,252 | |||||||||||||||||||||||
2014 convertible senior notes | 1.875 | % | 7.88 | % | — | — | — | 465 | — | 465 | |||||||||||||||||||||
2019 senior notes | 1.258 | % | 1.97 | % | 92 | 324 | 416 | — | — | — | |||||||||||||||||||||
2022 senior notes | 5.875 | % | 6.14 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
2025 senior notes | 5.5 | % | 5.56 | % | — | 1,150 | 1,150 | — | — | — | |||||||||||||||||||||
2027 convertible senior notes | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
2031A convertible senior notes | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
2031B convertible senior notes(3) | 1.875 | % | 6.98 | % | 362 | — | 362 | — | 253 | 253 | |||||||||||||||||||||
2032C convertible senior notes(4) | 2.375 | % | 5.95 | % | — | 314 | 314 | — | 463 | 463 | |||||||||||||||||||||
2032D convertible senior notes(4) | 3.125 | % | 6.33 | % | — | 288 | 288 | — | 369 | 369 | |||||||||||||||||||||
2033E convertible senior notes(4)(5) | 1.625 | % | 4.5 | % | 278 | — | 278 | — | 272 | 272 | |||||||||||||||||||||
2033F convertible senior notes(4)(5) | 2.125 | % | 4.93 | % | 265 | — | 265 | — | 260 | 260 | |||||||||||||||||||||
2043G convertible senior notes | 3 | % | 6.76 | % | — | 636 | 636 | — | — | — | |||||||||||||||||||||
Other notes payable | 2.289 | % | 3.4 | % | 126 | 116 | 242 | 186 | 449 | 635 | |||||||||||||||||||||
$ | 1,638 | $ | 4,955 | $ | 6,593 | $ | 1,585 | $ | 4,452 | $ | 6,037 | ||||||||||||||||||||
(1) | We have either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||
(2) Weighted-average imputed rate of 4.3% and 4.1% as of August 28, 2014 and August 29, 2013, respectively. | |||||||||||||||||||||||||||||||
(3) | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||
(4) | Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||
(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Maturities of Notes Payable and Future Minimum Lease Payments [Table Text Block] | ' | ||||||||||||||||||||||||||||||
As of August 28, 2014, maturities of notes payable (including the MMJ Creditor Installment Payments) and future minimum lease payments under capital lease obligations were as follows: | |||||||||||||||||||||||||||||||
Notes Payable | Capital Lease Obligations | ||||||||||||||||||||||||||||||
2015 | $ | 803 | $ | 356 | |||||||||||||||||||||||||||
2016 | 352 | 301 | |||||||||||||||||||||||||||||
2017 | 320 | 103 | |||||||||||||||||||||||||||||
2018 | 602 | 60 | |||||||||||||||||||||||||||||
2019 | 684 | 55 | |||||||||||||||||||||||||||||
2020 and thereafter | 3,628 | 123 | |||||||||||||||||||||||||||||
Unamortized discounts and interest, respectively | (707 | ) | (87 | ) | |||||||||||||||||||||||||||
$ | 5,682 | $ | 911 | ||||||||||||||||||||||||||||
Micron Technology, Inc. [Member] | ' | ||||||||||||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Debt | ' | ||||||||||||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
Capital lease obligations(2) | N/A | N/A | $ | 172 | $ | 233 | $ | 405 | $ | 156 | $ | 397 | $ | 553 | |||||||||||||||||
2014 convertible senior notes | 1.875 | % | 7.88 | % | — | — | — | 465 | — | 465 | |||||||||||||||||||||
2022 senior notes | 5.875 | % | 6.14 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
2025 senior notes | 5.5 | % | 5.56 | % | — | 1,150 | 1,150 | — | — | — | |||||||||||||||||||||
2027 convertible senior notes | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
2031A convertible senior notes | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
2031B convertible senior notes(3) | 1.875 | % | 6.98 | % | 362 | — | 362 | — | 253 | 253 | |||||||||||||||||||||
2032C convertible senior notes(4) | 2.375 | % | 5.95 | % | — | 314 | 314 | — | 463 | 463 | |||||||||||||||||||||
2032D convertible senior notes(4) | 3.125 | % | 6.33 | % | — | 288 | 288 | — | 369 | 369 | |||||||||||||||||||||
2033E convertible senior notes(4)(5) | 1.625 | % | 4.5 | % | 278 | — | 278 | — | 272 | 272 | |||||||||||||||||||||
2033F convertible senior notes(4)(5) | 2.125 | % | 4.93 | % | 265 | — | 265 | — | 260 | 260 | |||||||||||||||||||||
2043G convertible senior notes | 3 | % | 6.76 | % | — | 636 | 636 | — | — | — | |||||||||||||||||||||
Other | 1.65 | % | 1.65 | % | — | 10 | 10 | 25 | — | 25 | |||||||||||||||||||||
$ | 1,077 | $ | 3,231 | $ | 4,308 | $ | 646 | $ | 2,438 | $ | 3,084 | ||||||||||||||||||||
(1) | Micron has either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of its convertible notes. Since it is Micron's current intent to settle in cash the principal amount of all of its convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||
(2) Weighted-average imputed rate of 4.7% and 4.7% as of August 28, 2014 and August 29, 2013, respectively. | |||||||||||||||||||||||||||||||
(3) | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of Micron's obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||
(4) | Since the closing price of Micron's common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of Micron's common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||
(5) As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require Micron to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Maturities of Notes Payable and Future Minimum Lease Payments [Table Text Block] | ' | ||||||||||||||||||||||||||||||
As of August 28, 2014, maturities of notes payable and future minimum lease payments under capital lease obligations were as follows: | |||||||||||||||||||||||||||||||
Notes Payable | Capital Lease Obligations | ||||||||||||||||||||||||||||||
2015 | $ | 389 | $ | 188 | |||||||||||||||||||||||||||
2016 | — | 200 | |||||||||||||||||||||||||||||
2017 | — | 30 | |||||||||||||||||||||||||||||
2018 | 300 | 3 | |||||||||||||||||||||||||||||
2019 | 362 | 3 | |||||||||||||||||||||||||||||
2020 and thereafter | 3,320 | 6 | |||||||||||||||||||||||||||||
Discounts and interest, respectively | (468 | ) | (25 | ) | |||||||||||||||||||||||||||
$ | 3,903 | $ | 405 | ||||||||||||||||||||||||||||
Schedule_II_Valuation_and_Qual1
Schedule II Valuation and Qualifying Accounts [Schedule] Valuation and Qualifying Accounts (Tables) | 12 Months Ended | |||||||||||||||||||
Aug. 28, 2014 | ||||||||||||||||||||
Valuation and Qualifying Accounts [Abstract] | ' | |||||||||||||||||||
Valuation and Qualifying Accounts | ' | |||||||||||||||||||
Balance at | Business Acquisitions | Charged | Deductions/ | Balance at | ||||||||||||||||
Beginning of | (Credited) to | Write-Offs | End of | |||||||||||||||||
Year | Costs and | Year | ||||||||||||||||||
Expenses | ||||||||||||||||||||
Allowance for Doubtful Accounts | ||||||||||||||||||||
Year ended August 28, 2014 | $ | 5 | $ | — | $ | — | $ | (2 | ) | $ | 3 | |||||||||
Year ended August 29, 2013 | 5 | — | 1 | (1 | ) | 5 | ||||||||||||||
Year ended August 30, 2012 | 3 | — | 5 | (3 | ) | 5 | ||||||||||||||
Deferred Tax Asset Valuation Allowance | ||||||||||||||||||||
Year ended August 28, 2014 | $ | 3,155 | $ | — | $ | (544 | ) | $ | (168 | ) | $ | 2,443 | ||||||||
Year ended August 29, 2013 | 1,470 | 1,292 | 418 | (25 | ) | 3,155 | ||||||||||||||
Year ended August 30, 2012 | 1,169 | — | 368 | (67 | ) | 1,470 | ||||||||||||||
Significant_Accounting_Policie2
Significant Accounting Policies - Product and Process Technology (Details) (Maximum [Member]) | 12 Months Ended |
Aug. 28, 2014 | |
Maximum [Member] | ' |
Finite-Lived Intangible Assets [Line Items] | ' |
Maximum life of finite-lived intangible assets (in years) | '12 years 6 months |
Significant_Accounting_Policie3
Significant Accounting Policies - Property, Plant and Equipment (Details) | 12 Months Ended |
Aug. 28, 2014 | |
Building [Member] | Minimum [Member] | ' |
Property, Plant and Equipment [Line Items] | ' |
Property, plant and equipment useful life (in years) | '10 years |
Building [Member] | Maximum [Member] | ' |
Property, Plant and Equipment [Line Items] | ' |
Property, plant and equipment useful life (in years) | '30 years |
Equipment [Member] | Minimum [Member] | ' |
Property, Plant and Equipment [Line Items] | ' |
Property, plant and equipment useful life (in years) | '5 years |
Equipment [Member] | Maximum [Member] | ' |
Property, Plant and Equipment [Line Items] | ' |
Property, plant and equipment useful life (in years) | '7 years |
Software [Member] | Minimum [Member] | ' |
Property, Plant and Equipment [Line Items] | ' |
Property, plant and equipment useful life (in years) | '3 years |
Software [Member] | Maximum [Member] | ' |
Property, Plant and Equipment [Line Items] | ' |
Property, plant and equipment useful life (in years) | '5 years |
Micron_Memory_Japan_Inc_Detail
Micron Memory Japan, Inc. (Details) (USD $) | 1 Months Ended | 12 Months Ended | 0 Months Ended | 3 Months Ended | 12 Months Ended | 24 Months Ended | |||||||
Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Jul. 31, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Jul. 31, 2013 | Jul. 31, 2013 | Aug. 28, 2014 | Jul. 31, 2013 | |
mm | mm | MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | |||
Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | mm | mm | |||||||||||
Business Acquisition [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash paid for the MMJ Acquisition | ' | ' | ' | ' | $949,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Ownership percentage after stock transactions during period (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 99.50% | ' |
Diameter of Wafer Used in Production (in millimeters) | 200 | ' | 200 | ' | ' | ' | ' | ' | ' | ' | 300 | ' | 300 |
Business Acquisition, Equity Interest Held by Acquiree, Less than Wholly Owned Subsidiary, Ownership Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | 65.00% | ' | ' | ' |
Additional interest in MMT acquired | ' | ' | ' | ' | ' | ' | ' | ' | ' | 24.00% | ' | ' | ' |
Recognized amounts of identifiable assets acquired and liabilities assumed: [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and equivalents | ' | ' | ' | ' | 999,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Receivables | ' | ' | ' | ' | 697,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Inventories | ' | ' | ' | ' | 962,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Restricted cash | ' | ' | ' | ' | 557,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Other current assets | ' | ' | ' | ' | 142,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Property, plant and equipment | ' | ' | ' | ' | 935,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Equity method investment | ' | ' | ' | ' | 40,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Intangible assets | ' | ' | ' | ' | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred tax assets | ' | ' | ' | ' | 811,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Other noncurrent assets | ' | ' | ' | ' | 66,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Accounts payable and accrued expenses | ' | ' | ' | ' | -387,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Equipment purchase contracts | ' | ' | ' | ' | -22,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Current portion of long-term debt | ' | ' | ' | ' | -673,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Long-term debt | ' | ' | ' | ' | -1,461,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Other noncurrent liabilities | ' | ' | ' | ' | -75,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Total net assets acquired | ' | ' | ' | ' | 2,601,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Noncontrolling interests in MMJ | ' | ' | ' | ' | 168,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Consideration | ' | ' | ' | ' | 949,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Preliminary gain on acquisition recognized in 2013 | ' | ' | 1,484,000,000 | 0 | ' | 1,480,000,000 | ' | 1,484,000,000 | ' | ' | ' | ' | ' |
Adjustment for primarily pre-petition liabilities | ' | -33,000,000 | ' | ' | ' | ' | -33,000,000 | ' | ' | ' | ' | ' | ' |
Final gain on acquisition | ' | ' | ' | ' | ' | ' | ' | ' | 1,451,000,000 | ' | ' | ' | ' |
Business Acquisition, Pro Forma Information [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
MMJ Group net sales after acquisition date | 355,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
MMJ Group operating income after acquisition date | 46,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Transaction costs | ' | ' | ' | ' | ' | 50,000,000 | ' | 50,000,000 | ' | ' | ' | ' | ' |
Component of pro forma net income (loss) related to forgiveness of debt income for which no adjustment was made | ' | ' | 1,690,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Component of pro forma net income (loss) related to impairment of long-lived assets for which no adjustment was made | ' | ' | ' | 2,830,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | 12,494,000,000 | 11,492,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net income (loss) | ' | ' | 3,825,000,000 | -4,439,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net income (loss) attributable to Micron | ' | ' | $3,770,000,000 | ($4,471,000,000) | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Earnings (loss) per share: [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Basic (in dollars per share) | ' | ' | $3.69 | ($4.51) | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Diluted (in dollars per share) | ' | ' | $3.57 | ($4.51) | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Investments_Details
Investments (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | $2,935 | $2,283 | ' |
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract] | ' | ' | ' |
Money market funds | 1,281 | ' | ' |
Due in 1 year or less | 835 | ' | ' |
Due in 1-2 years | 438 | ' | ' |
Due in 2-4 years | 351 | ' | ' |
Due after 4 years | 29 | ' | ' |
Debt Securities, Fair Value | 2,934 | ' | ' |
Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract] | ' | ' | ' |
Net unrealized holding gains (losses) reclassified out of accumulated other comprehensive income | ' | ' | 31 |
Proceeds from the sale of available-for-sale securities | 355 | 526 | 149 |
Gross realized gains from sale of available-for-sale securities | ' | ' | 34 |
Money market funds [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | 1,281 | 1,188 | ' |
Corporate bonds [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | 561 | 414 | ' |
Certificates of deposit [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | 437 | 349 | ' |
Government securities [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | 420 | 168 | ' |
Asset-backed securities [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | 128 | 97 | ' |
Commercial paper [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | 107 | 61 | ' |
Marketable equity securities [Member] | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' |
Fair value of available-for-sale investments | $1 | $6 | ' |
Receivables_Details
Receivables (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Receivables [Abstract] | ' | ' |
Trade receivables (net of allowance for doubtful accounts of $3 and $5, respectively) | $2,524 | $2,069 |
Income and other taxes | 104 | 74 |
Other | 278 | 186 |
Receivables | 2,906 | 2,329 |
Allowance for doubtful accounts | 3 | 5 |
Intel [Member] | Collaborative Arrangement Process Design and Process Development [Member] | NAND Flash [Member] | ' | ' |
Receivables [Abstract] | ' | ' |
Other | $70 | $34 |
Inventories_Details
Inventories (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ' | ' |
Finished goods | $898 | $796 |
Work in process | 1,372 | 1,719 |
Raw materials and supplies | 185 | 134 |
Inventories | $2,455 | $2,649 |
Property_Plant_and_Equipment_D
Property, Plant and Equipment (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | $23,432 | $20,920 | ' |
Accumulated depreciation | -14,750 | -13,294 | ' |
Property, Plant and Equipment, Net | 8,682 | 7,626 | ' |
Depreciation [Abstract] | ' | ' | ' |
Depreciation expense | 1,993 | 1,721 | 2,053 |
Other noncurrent assets [Member] | ' | ' | ' |
Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract] | ' | ' | ' |
Land held for development | 57 | 54 | ' |
Assets Held under Capital Leases [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Accumulated depreciation | -693 | -463 | ' |
Land [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 86 | 86 | ' |
Land [Member] | Notes Payable, Other Payables [Member] | ' | ' | ' |
Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract] | ' | ' | ' |
Debt Instrument, Collateral Amount | 43 | ' | ' |
Buildings [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 5,093 | 4,835 | ' |
Buildings [Member] | Assets Held under Capital Leases [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 289 | 209 | ' |
Equipment [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 17,781 | 15,600 | ' |
Equipment [Member] | Assets Held under Capital Leases [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 1,108 | 1,305 | ' |
Construction in progress [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 114 | 84 | ' |
Software [Member] | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' |
Property, Plant and Equipment, Gross | 358 | 315 | ' |
Production Equipment And Buildings [Member] | Notes Payable, Other Payables [Member] | ' | ' | ' |
Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract] | ' | ' | ' |
Debt Instrument, Collateral Amount | $476 | ' | ' |
Equity_Method_Investments_Deta
Equity Method Investments (Details) | 12 Months Ended | 0 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | |||||||||||||||||||||||||
In Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 29, 2013 | Aug. 30, 2012 | 15-May-14 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Dec. 31, 2012 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Mar. 04, 2010 | Aug. 30, 2012 | Aug. 28, 2014 | ||||
USD ($) | USD ($) | USD ($) | Nanya [Member] | Nanya [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | |||||
Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | TWD | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | TWD | TWD | Inventories [Member] | Inventories [Member] | Inventories [Member] | Nanya [Member] | Variable interest entity, not primary beneficiary [Member] | USD ($) | USD ($) | USD ($) | JPY (¥) | MMJ Acquisition [Member] | USD ($) | USD ($) | USD ($) | Transform [Member] | Transform [Member] | Transform [Member] | |||||||||
USD ($) | USD ($) | DRAM [Member] | DRAM [Member] | DRAM [Member] | USD ($) | USD ($) | Origin Energy Limited [Member] | |||||||||||||||||||||||||||
USD ($) | USD ($) | USD ($) | ||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Investment Balance | $971 | $396 | ' | ' | ' | ' | $914 | [1] | $344 | [1] | $914 | [1] | $344 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | $48 | $40 | ' | ' | ' | $9 | $12 | ' | ' | ' | ' |
Ownership Percentage (in hundredths) | ' | ' | ' | ' | ' | ' | 33.00% | [1] | 35.00% | [1] | 33.00% | [1] | 35.00% | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40.00% | 40.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Variable Interest Entity Entity Maximum Loss Exposure Amount From Investment Balance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 914 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Equity in net income (loss) of equity method investees, net of tax | 474 | -83 | -294 | ' | ' | ' | ' | ' | 465 | -79 | ' | -189 | ' | ' | ' | ' | ' | ' | ' | 11 | 0 | 0 | ' | ' | -2 | -4 | -105 | ' | ' | ' | ||||
Equity Method Investment, Summarized Financial Information, Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Current assets | 2,233 | 1,018 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncurrent assets | 2,502 | 2,634 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Equity Method Investment, Summarized Financial Information, Liabilities [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Current liabilities | 1,417 | 1,912 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncurrent liabilities | 254 | 435 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Net sales | 3,382 | 1,788 | 1,798 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Gross margin | 1,576 | 1 | -451 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Operating income (loss) | 1,371 | -203 | -751 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Net income (loss) | 1,339 | -188 | -793 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Equity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Payments to acquire equity method investments | 0 | 0 | 187 | ' | ' | ' | ' | ' | ' | ' | ' | 170 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Ownership percentage after stock transactions during period (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40.00% | ' | ' | ' | 50.00% | ' | ' | ||||
Number of shares issued by Inotera | ' | ' | ' | ' | ' | 400 | ' | ' | ' | 634 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Stock price per share | ' | ' | ' | ' | ' | 31.5 | ' | ' | ' | ' | ' | ' | ' | 9.47 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Inotera ownership percentage before transaction | ' | ' | ' | ' | ' | 35.00% | 35.00% | 40.00% | ' | 40.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Ownership percentage in Inotera after its stock sale transaction | ' | ' | ' | ' | ' | 33.00% | 33.00% | 35.00% | ' | 35.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Gain from issuance of Inotera shares | 93 | 48 | 0 | ' | ' | ' | 93 | 48 | 93 | 48 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Percentage interest held by a third party (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 33.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ||||
Market value of equity interests | ' | ' | ' | ' | ' | ' | 3,720 | ' | 3,720 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 39 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Equity Method Investment, Quoted Market Price Per Share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 51.9 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ¥ 1,087 | ' | ' | ' | ' | ' | ' | ' | ||||
Equity Method Investment, Difference Between Carrying Value and Quoted Market Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Amount in accumulated other comprehensive income (loss) for cumulative translation adjustments on its investment | ' | ' | ' | ' | ' | ' | 44 | 44 | 44 | 44 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Amortization of difference between cost and underlying equity in net assets | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 48 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Percentage of Inotera's wafer production previously obligated to purchase (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Purchases of DRAM products from Inotera | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,680 | 1,260 | 646 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Research and development | 1,371 | 931 | 918 | -19 | -138 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Difference between cost of Tera Probe investment and underlying equity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 26 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Weighted-average period for remaining Inotera amortization (in years) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '6 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Other than temporary impairment in Transform | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 69 | ' | ||||
Gain from disposition of interest in Aptina | $119 | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
[1] | (1) Entity is a variable interest entity. |
Equity_Method_Investments_2_De
Equity Method Investments - 2 (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Related Party Transaction [Line Items] | ' | ' | ' |
Diameter of Wafer Used in Production (in millimeters) | ' | 200 | ' |
Micron Technology Italia, Srl. [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Diameter of Wafer Used in Production (in millimeters) | ' | 200 | ' |
Tera Probe [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Related party purchases from Tera Probe | $117 | $13 | ' |
Aptina [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Revenues from transactions with related party | 43 | 182 | 372 |
Cost of goods sold from transactions with related party | 37 | 219 | 395 |
Aptina [Member] | Short-term interest free loan to Aptina [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Proceeds from Collection of Notes Receivable | 45 | ' | ' |
Aptina [Member] | Short-term interest free loan to Aptina [Member] | Other current assets [Member] | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' |
Outstanding balance of loan to Aptina | ' | $45 | ' |
Intangible_Assets_Details
Intangible Assets (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Intangible Assets [Abstract] | ' | ' | ' |
Gross Amount | $810 | $769 | ' |
Accumulated Amortization | -342 | -383 | ' |
Amortization expense for intangible assets | 110 | 83 | 88 |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' |
Annual amortization for 2015 | 112 | ' | ' |
Annual amortization for 2016 | 98 | ' | ' |
Annual amortization for 2017 | 88 | ' | ' |
Annual amortization for 2018 | 77 | ' | ' |
Annual amortization for 2019 | 31 | ' | ' |
Product and process technology [Member] | ' | ' | ' |
Intangible Assets [Abstract] | ' | ' | ' |
Gross Amount | 809 | 642 | ' |
Accumulated Amortization | -341 | -269 | ' |
Product and process technology intangible asset capitalized during period | 177 | 100 | ' |
Product and process technology intangible asset capitalized during period, weighted-average useful lives (in years) | '6 years | '7 years | ' |
Customer relationships [Member] | ' | ' | ' |
Intangible Assets [Abstract] | ' | ' | ' |
Gross Amount | 1 | 127 | ' |
Accumulated Amortization | ($1) | ($114) | ' |
Accounts_Payable_and_Accrued_E2
Accounts Payable and Accrued Expenses (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Accounts payable | $1,119 | $1,048 |
Related party payables | 673 | 374 |
Salaries, wages and benefits | 456 | 267 |
Customer advances | 98 | 140 |
Income and other taxes | 71 | 47 |
Other | 281 | 239 |
Total accounts payable and accrued expenses | 2,698 | 2,115 |
Other Liabilities, Noncurrent [Abstract] | ' | ' |
Other noncurrent liabilities | 1,102 | 535 |
DRAM [Member] | ' | ' |
Customer advances | 90 | ' |
Intel [Member] | NAND Flash [Member] | ' | ' |
Customer advances | ' | 134 |
Customer advances [Member] | DRAM [Member] | ' | ' |
Other Liabilities, Noncurrent [Abstract] | ' | ' |
Other noncurrent liabilities | 90 | ' |
Inotera [Member] | DRAM [Member] | ' | ' |
Related party payables | 660 | 345 |
Tera Probe [Member] | ' | ' |
Related party payables | $13 | $29 |
Debt_Schedule_of_Longterm_Debt
Debt - Schedule of Long-term Debt (Details) | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share data in Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Jul. 26, 2011 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Apr. 18, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Apr. 18, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Feb. 12, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Feb. 12, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Nov. 12, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Nov. 12, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Dec. 20, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Feb. 10, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Jul. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Feb. 27, 2014 | Aug. 28, 2014 | Aug. 27, 2013 | Aug. 28, 2014 | Jan. 31, 2013 | Oct. 18, 2012 | Aug. 28, 2014 | Oct. 02, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Jul. 31, 2013 | Aug. 28, 2014 | Apr. 06, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | ||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | USD ($) | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | 2033E and 2033F convertible senior notes [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Secured Debt [Member] | Secured Debt [Member] | Secured Debt [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Line of Credit [Member] | Line of Credit [Member] | Line of Credit [Member] | Line of Credit [Member] | Line of Credit [Member] | Line of Credit [Member] | Line of Credit [Member] | Line of Credit [Member] | Loans Payable [Member] | Loans Payable [Member] | |||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | USD ($) | USD ($) | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Sales-leaseback transactions [Member] | Sales-leaseback transactions [Member] | Sales-leaseback transactions [Member] | Sales-leaseback transactions [Member] | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032C and 2032D convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033E and 2033F convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | Total outstanding convertible senior notes less 2031B notes [Member] | 2019 senior notes | 2019 senior notes | 2019 senior notes | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | USD ($) | USD ($) | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Secured Debt 2 [Member] | Secured Debt 2 [Member] | Secured Debt 2 [Member] | Secured Debt 1 [Member] | Secured Debt 1 [Member] | Secured Debt 1 [Member] | Secured Debt 1 [Member] | Secured Debt 3 [Member] | Secured Debt 3 [Member] | Secured Debt 3 [Member] | Intel Senior Note [Member] | Intel Senior Note [Member] | Intel Senior Note [Member] | Revolving Credit Facility 1 [Member] | Revolving Credit Facility 1 [Member] | Revolving Credit Facility 2 [Member] | Revolving Credit Facility 2 [Member] | Revolving Credit Facility 2 [Member] | Revolving Credit Facility 2 [Member] | Revolving Credit Facility 2 [Member] | Revolving Credit Facility 2 [Member] | USD ($) | Micron Technology, Inc. [Member] | ||||||||||||||||||||||||||||||||||||||||||||
USD ($) | JPY (¥) | USD ($) | USD ($) | USD ($) | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | integer | USD ($) | USD ($) | integer | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | integer | USD ($) | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Additional Capital [Member] | Additional Capital [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Other noncurrent assets [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Maximum [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | Maximum [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Libor [Member] | USD ($) | USD ($) | USD ($) | decimal | USD ($) | Taiwan Dollar Commercial Paper Rate [Member] | MMJ Acquisition [Member] | USD ($) | Libor [Member] | USD ($) | Sibor [Member] | USD ($) | Libor [Member] | Libor [Member] | Libor [Member] | Federal Funds Effective Rate [Member] | Federal Funds Effective Rate [Member] | USD ($) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | integer | integer | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | integer | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Variable Interest Rate One Month LIBOR Option [Member] | Minimum [Member] | Maximum [Member] | Minimum [Member] | Maximum [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Rate LIBOR Option [Member] | Variable Interest Rate LIBOR Option [Member] | Variable Interest Rate Federal Funds Effective Rate Option [Member] | Variable Interest Rate Federal Funds Effective Rate Option [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Current debt | $1,638,000,000 | $1,585,000,000 | ' | $1,077,000,000 | $646,000,000 | ' | ' | $192,000,000 | $527,000,000 | ' | ' | $323,000,000 | [1] | $407,000,000 | [1] | $172,000,000 | [2] | $156,000,000 | [2] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | [3] | $465,000,000 | [3] | ' | ' | ' | $0 | [4] | $465,000,000 | [4] | $0 | [3] | $0 | [3] | ' | ' | ' | $0 | [4] | $0 | [4] | $0 | [3] | $0 | [3] | ' | ' | ' | $0 | [4] | $0 | [4] | $362,000,000 | [3],[5] | $0 | [3] | ' | ' | ' | ' | $362,000,000 | [4],[6] | $0 | [4] | $0 | [3],[7] | $0 | [3] | ' | ' | ' | ' | $0 | [4],[8] | $0 | [4],[8] | $0 | [3],[7] | $0 | [3] | ' | ' | ' | ' | $0 | [4],[8] | $0 | [4],[8] | ' | $278,000,000 | [3],[7],[9] | $0 | [3] | ' | ' | ' | ' | $278,000,000 | [10],[4],[8] | $0 | [10],[4],[8] | $265,000,000 | [3],[7],[9] | $0 | [3] | ' | ' | ' | ' | $265,000,000 | [10],[4],[8] | $0 | [10],[4],[8] | ' | $0 | [3] | $0 | [3] | ' | ' | ' | ' | $0 | [4] | $0 | [4] | ' | ' | $92,000,000 | ' | $0 | $0 | ' | $0 | ' | $0 | $0 | $0 | ' | $0 | ' | $0 | $0 | $126,000,000 | $186,000,000 | $0 | $25,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Long-term debt | 4,955,000,000 | 4,452,000,000 | ' | 3,231,000,000 | 2,438,000,000 | ' | ' | 939,000,000 | 1,117,000,000 | ' | ' | 588,000,000 | [1] | 845,000,000 | [1] | 233,000,000 | [2] | 397,000,000 | [2] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | [3] | 0 | [3] | ' | ' | ' | 0 | [4] | 0 | [4] | 0 | [3] | 147,000,000 | [3] | ' | ' | ' | 0 | [4] | 147,000,000 | [4] | 0 | [3] | 277,000,000 | [3] | ' | ' | ' | 0 | [4] | 277,000,000 | [4] | 0 | [3],[5] | 253,000,000 | [3] | ' | ' | ' | ' | 0 | [4],[6] | 253,000,000 | [4] | 314,000,000 | [3],[7] | 463,000,000 | [3] | ' | ' | ' | ' | 314,000,000 | [4],[8] | 463,000,000 | [4],[8] | 288,000,000 | [3],[7] | 369,000,000 | [3] | ' | ' | ' | ' | 288,000,000 | [4],[8] | 369,000,000 | [4],[8] | ' | 0 | [3],[7],[9] | 272,000,000 | [3] | ' | ' | ' | ' | 0 | [10],[4],[8] | 272,000,000 | [10],[4],[8] | 0 | [3],[7],[9] | 260,000,000 | [3] | ' | ' | ' | ' | 0 | [10],[4],[8] | 260,000,000 | [10],[4],[8] | ' | 636,000,000 | [3] | 0 | [3] | ' | ' | ' | ' | 636,000,000 | [4] | 0 | [4] | ' | ' | 324,000,000 | ' | 0 | 600,000,000 | ' | 0 | ' | 600,000,000 | 0 | 1,150,000,000 | ' | 0 | ' | 1,150,000,000 | 0 | 116,000,000 | 449,000,000 | 10,000,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt | 6,593,000,000 | 6,037,000,000 | ' | 4,308,000,000 | 3,084,000,000 | ' | ' | 1,131,000,000 | 1,644,000,000 | 1,131,000,000 | 117,516,000,000 | 911,000,000 | [1] | 1,252,000,000 | [1] | 405,000,000 | [2] | 553,000,000 | [2] | ' | ' | ' | ' | 2,143,000,000 | 2,506,000,000 | ' | ' | ' | ' | 0 | [3] | 465,000,000 | [3] | ' | ' | ' | 0 | [4] | 465,000,000 | [4] | 0 | [3] | 147,000,000 | [3] | ' | ' | ' | 0 | [4] | 147,000,000 | [4] | 0 | [3] | 277,000,000 | [3] | ' | ' | ' | 0 | [4] | 277,000,000 | [4] | 362,000,000 | [11],[3],[5] | 253,000,000 | [3] | ' | ' | ' | ' | 362,000,000 | [4],[6] | 253,000,000 | [4] | 314,000,000 | [3],[7] | 463,000,000 | [3] | ' | ' | ' | ' | 314,000,000 | [4],[8] | 463,000,000 | [4],[8] | 288,000,000 | [3],[7] | 369,000,000 | [3] | ' | ' | ' | ' | 288,000,000 | [4],[8] | 369,000,000 | [4],[8] | ' | 278,000,000 | [3],[7],[9] | 272,000,000 | [3] | ' | ' | ' | ' | 278,000,000 | [10],[4],[8] | 272,000,000 | [10],[4],[8] | 265,000,000 | [3],[7],[9] | 260,000,000 | [3] | ' | ' | ' | ' | 265,000,000 | [10],[4],[8] | 260,000,000 | [10],[4],[8] | ' | 636,000,000 | [3] | 0 | [3] | ' | 627,000,000 | ' | ' | 636,000,000 | [4] | 0 | [4] | ' | ' | 416,000,000 | ' | 0 | 600,000,000 | ' | 0 | ' | 600,000,000 | 0 | 1,150,000,000 | ' | 0 | ' | 1,150,000,000 | 0 | 242,000,000 | 635,000,000 | 10,000,000 | 25,000,000 | ' | 52,000,000 | 127,000,000 | ' | 312,000,000 | ' | ' | ' | 120,000,000 | ' | 70,000,000 | ' | ' | ' | 65,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stated interest rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.88% | ' | ' | ' | ' | 1.88% | ' | 1.88% | ' | ' | ' | ' | 1.88% | ' | 1.50% | ' | ' | ' | ' | 1.50% | ' | 1.88% | ' | ' | ' | ' | ' | 1.88% | ' | 2.38% | ' | ' | ' | ' | ' | 2.38% | ' | 3.13% | ' | ' | ' | ' | ' | 3.13% | ' | ' | 1.63% | ' | ' | ' | ' | ' | 1.63% | ' | 2.13% | ' | ' | ' | ' | ' | 2.13% | ' | ' | 3.00% | ' | ' | ' | ' | ' | 3.00% | ' | ' | ' | 1.26% | ' | ' | 5.88% | ' | ' | ' | 5.88% | ' | 5.50% | ' | ' | ' | 5.50% | ' | 2.29% | ' | 1.65% | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2.40% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Effective interest rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | 6.25% | ' | ' | ' | 4.30% | 4.10% | 4.70% | 4.70% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7.88% | ' | ' | ' | ' | 7.88% | ' | 6.95% | ' | ' | ' | ' | 6.95% | ' | 6.55% | ' | ' | ' | ' | 6.55% | ' | 6.98% | ' | ' | ' | ' | ' | 6.98% | ' | 5.95% | ' | ' | ' | ' | ' | 5.95% | ' | 6.33% | ' | ' | ' | ' | ' | 6.33% | ' | ' | 4.50% | ' | ' | ' | ' | ' | 4.50% | ' | 4.93% | ' | ' | ' | ' | ' | 4.93% | ' | ' | 6.76% | ' | ' | ' | ' | ' | 6.76% | ' | ' | ' | 1.97% | ' | ' | 6.14% | ' | ' | ' | 6.14% | ' | 5.56% | ' | ' | ' | 5.56% | ' | 3.40% | ' | 1.65% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Weighted Average Remaining Term (in years) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '4 years 1 month | ' | '2 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Subordinated Debt | ' | ' | ' | 3,890,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Other notes payable of Micron's subsidiaries and capital lease obligations | 1,570,000,000 | ' | ' | 1,570,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Domestic Restricted Subsidiaries, Ownership Percentage by Parent | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 80.00% | ' | ' | ' | ' | ' | 80.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument Redemption Price Percentage of Principal Amount Redeemable Using Equity Offering Proceeds | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 35.00% | ' | ' | ' | ' | ' | 35.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Redemption Price, Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 105.88% | ' | ' | ' | ' | ' | 105.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Leases, Capital [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Proceeds from equipment sale-leaseback transactions | 14,000,000 | 126,000,000 | 609,000,000 | 0 | 126,000,000 | 439,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 126,000,000 | ' | 126,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Capital leases, Current period additions | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 126,000,000 | ' | 126,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Imputed interest rate of sale leaseback additions (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4.30% | ' | 4.30% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Due date | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31-Jul-17 | ' | 31-Jul-17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Convertible Debt Issuances [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Outstanding principal | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,445,000,000 | 2,950,000,000 | ' | ' | ' | ' | 0 | 485,000,000 | ' | ' | ' | ' | ' | 0 | 175,000,000 | ' | ' | ' | ' | ' | 0 | 345,000,000 | ' | ' | ' | ' | ' | 114,000,000 | 345,000,000 | ' | 345,000,000 | ' | ' | ' | ' | 362,000,000 | 550,000,000 | ' | 550,000,000 | ' | ' | ' | ' | 344,000,000 | 450,000,000 | ' | 450,000,000 | ' | ' | ' | ' | ' | 300,000,000 | 300,000,000 | ' | 300,000,000 | ' | ' | ' | ' | 300,000,000 | 300,000,000 | ' | 300,000,000 | ' | ' | ' | ' | ' | 1,025,000,000 | [12] | 0 | ' | ' | ' | ' | ' | ' | ' | 2,331,000,000 | ' | 462,000,000 | ' | ' | 600,000,000 | ' | ' | ' | ' | ' | 1,150,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||
Debt Instrument Put Date Earliest | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31-May-19 | ' | ' | ' | ' | ' | ' | ' | 31-May-21 | ' | ' | ' | ' | ' | ' | ' | ' | 28-Feb-18 | ' | ' | ' | ' | ' | ' | ' | 28-Feb-20 | ' | ' | ' | ' | ' | ' | ' | ' | 30-Nov-28 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Shares issuable upon conversion (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 38 | ' | ' | ' | ' | ' | ' | ' | 34 | ' | ' | ' | ' | ' | ' | ' | ' | 27 | ' | ' | ' | ' | ' | ' | ' | 27 | ' | ' | ' | ' | ' | ' | ' | ' | 35 | [12] | ' | ' | ' | ' | ' | ' | ' | ' | 161 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||
Initial conversion, price per share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $9.63 | ' | ' | ' | ' | ' | ' | ' | $9.98 | ' | ' | ' | ' | ' | ' | ' | ' | $10.93 | ' | ' | ' | ' | ' | ' | ' | $10.93 | ' | ' | ' | ' | ' | ' | ' | $10.93 | $29.16 | [12] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||
Conversion price per share threshold (dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $12.52 | [13] | ' | ' | ' | ' | ' | ' | ' | $12.97 | [13] | ' | ' | ' | ' | ' | ' | ' | ' | $14.21 | [13] | ' | ' | ' | ' | ' | ' | ' | $14.21 | [13] | ' | ' | ' | ' | ' | ' | ' | $14.21 | $37.91 | [12] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||
Conversion value in excess of principal | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 873,000,000 | [14] | ' | ' | ' | ' | ' | ' | ' | 785,000,000 | [14] | ' | ' | ' | ' | ' | ' | ' | ' | 600,000,000 | [14] | ' | ' | ' | ' | ' | ' | ' | 600,000,000 | [14] | ' | ' | ' | ' | ' | ' | ' | ' | 128,000,000 | [12] | ' | ' | ' | ' | ' | ' | ' | ' | 2,986,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||
Share Price (in dollars per share) | $32.81 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Scheduled Accreted Principal Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 917,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Expected term for amortization of the remaining debt discount (in years) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | [15] | ' | ' | ' | ' | ' | ' | ' | '7 years | [15] | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | [15] | ' | ' | ' | ' | ' | ' | ' | '5 years | [15] | ' | ' | ' | ' | ' | ' | ' | ' | '14 years | [15] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | ' | ' | ' | ' | ' | ' | ' | ' | ' | -238,000,000 | -24,700,000,000 | -87,000,000 | ' | -25,000,000 | ' | ' | ' | ' | ' | -577,000,000 | -444,000,000 | ' | ' | ' | ' | 0 | -20,000,000 | ' | ' | ' | ' | ' | 0 | -28,000,000 | ' | ' | ' | ' | ' | 0 | -68,000,000 | ' | ' | ' | ' | ' | -27,000,000 | -92,000,000 | ' | ' | ' | ' | ' | ' | -48,000,000 | -87,000,000 | ' | ' | ' | ' | ' | ' | -56,000,000 | -81,000,000 | ' | ' | ' | ' | ' | ' | ' | -22,000,000 | -28,000,000 | ' | ' | ' | ' | ' | ' | -35,000,000 | -40,000,000 | ' | ' | ' | ' | ' | ' | ' | -389,000,000 | 0 | ' | -398,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -707,000,000 | -468,000,000 | ||||||||||||||||||||||||||||||||||||||||
Equity component of convertible debt included in additional paid in capital | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 324,000,000 | 854,000,000 | ' | ' | ' | ' | 0 | 353,000,000 | ' | ' | ' | ' | ' | 0 | 40,000,000 | ' | ' | ' | ' | ' | 0 | 89,000,000 | ' | ' | ' | ' | ' | ' | 0 | 109,000,000 | ' | ' | ' | ' | ' | ' | 67,000,000 | 101,000,000 | ' | ' | ' | ' | ' | ' | 69,000,000 | 90,000,000 | ' | ' | ' | ' | ' | ' | ' | 8,000,000 | 30,000,000 | ' | ' | ' | ' | ' | ' | 7,000,000 | 42,000,000 | ' | ' | ' | ' | ' | ' | 173,000,000 | 173,000,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Redeemable convertible notes | 57,000,000 | 0 | ' | 57,000,000 | 0 | ' | 57,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 22,000,000 | ' | ' | ' | ' | ' | ' | ' | 35,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Interest Costs Incurred [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Contractual interest expense | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 66,000,000 | 60,000,000 | 42,000,000 | ' | ' | ' | 2,000,000 | 13,000,000 | 18,000,000 | ' | ' | ' | ' | 1,000,000 | 3,000,000 | 3,000,000 | ' | ' | ' | ' | 1,000,000 | 5,000,000 | 5,000,000 | ' | ' | ' | ' | 3,000,000 | 6,000,000 | 6,000,000 | ' | ' | ' | ' | ' | 11,000,000 | 13,000,000 | 5,000,000 | ' | ' | ' | ' | ' | 13,000,000 | 14,000,000 | 5,000,000 | ' | ' | ' | ' | ' | ' | 5,000,000 | 3,000,000 | 0 | ' | ' | ' | ' | ' | 6,000,000 | 3,000,000 | 0 | ' | ' | ' | ' | ' | ' | 24,000,000 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Amortization of debt discount and issuance costs | 167,000,000 | 122,000,000 | 81,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 66,000,000 | 96,000,000 | 82,000,000 | ' | ' | ' | 14,000,000 | 37,000,000 | 47,000,000 | ' | ' | ' | ' | 2,000,000 | 7,000,000 | 6,000,000 | ' | ' | ' | ' | 3,000,000 | 12,000,000 | 11,000,000 | ' | ' | ' | ' | 5,000,000 | 10,000,000 | 10,000,000 | ' | ' | ' | ' | ' | 12,000,000 | 14,000,000 | 5,000,000 | ' | ' | ' | ' | ' | 8,000,000 | 9,000,000 | 3,000,000 | ' | ' | ' | ' | ' | ' | 7,000,000 | 4,000,000 | 0 | ' | ' | ' | ' | ' | 6,000,000 | 3,000,000 | 0 | ' | ' | ' | ' | ' | ' | 9,000,000 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Convertible note interest expense | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 132,000,000 | 156,000,000 | 124,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rate (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 103.8907 | ' | ' | ' | ' | ' | ' | ' | 100.1803 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 91.4808 | 34.2936 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Principal amount per debenture used In coversion rate | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000 | ' | ' | ' | ' | ' | ' | ' | 1,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000 | 1,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rights, minimum number of trading days (in days) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rights, consecutive trading period (in days) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rights, threshold percentage of applicable conversion price (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 130.00% | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 98.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 98.00% | 98.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument Discounted Issue Price Per Debenture | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Make whole premium discount rate | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Payments of debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14,000,000 | ' | ' | ' | ' | ' | 13,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Unamortized deferred debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt instrument, original term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '4 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | '2 years | ' | ' | '3 years | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Margin on variable rate financing (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3.25% | ' | ' | ' | ' | ' | 0.85% | ' | ' | ' | -0.50% | ' | 2.80% | ' | 1.00% | 1.50% | 2.00% | 0.50% | 1.00% | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Derivative, Fixed Interest Rate | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4.20% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument Variable Reference Rate Period 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 months | ' | ' | ' | ' | ' | '90 days | ' | ' | ' | '3 months | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Minority Interest Decrease From Purchase Of Interest Ownership Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.90% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Collateral Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 190,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 255,000,000 | ' | 153,000,000 | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt instruments number of periodic payments | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument Payment Of Third Party Credit Enhancement Fee | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 23,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument Period After Draw Prior To Initial Payment 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '6 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Draw on facility agreement | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 41,000,000 | 173,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Long Term Debt Gross Assumed | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 120,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Percentage of collateral to face value of issued and ouststanding credit facility | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 80.00% | ' | 85.00% | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Long-term Debt, by Maturity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2015 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 803,000,000 | 389,000,000 | ||||||||||||||||||||||||||||||||||||||||
2016 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 352,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||
2017 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 320,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||||
2018 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 602,000,000 | 300,000,000 | ||||||||||||||||||||||||||||||||||||||||
2019 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 684,000,000 | 362,000,000 | ||||||||||||||||||||||||||||||||||||||||
2020 and thereafter | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,628,000,000 | 3,320,000,000 | ||||||||||||||||||||||||||||||||||||||||
Notes Payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,682,000,000 | 3,903,000,000 | ||||||||||||||||||||||||||||||||||||||||
Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2015 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 356,000,000 | ' | 188,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2016 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 301,000,000 | ' | 200,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2017 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 103,000,000 | ' | 30,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2018 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 60,000,000 | ' | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2019 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 55,000,000 | ' | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2020 and thereafter | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 123,000,000 | ' | 6,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Capital Lease Obligations | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $911,000,000 | ' | $405,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
[1] | Weighted-average imputed rate of 4.3% and 4.1% as of AugustB 28, 2014 and AugustB 29, 2013, respectively. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | Weighted-average imputed rate of 4.7% and 4.7% as of AugustB 28, 2014 and AugustB 29, 2013, respectively. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | We have either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | Micron has either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of its convertible notes. Since it is Micron's current intent to settle in cash the principal amount of all of its convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[5] | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[6] | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of Micron's obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[7] | Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[8] | Since the closing price of Micron's common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of Micron's common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[9] | As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[10] | As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require Micron to pay cash for the principal amount of any converted notes, amounts are classified as current. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[11] | As holders had elected to convert these notes and we elected to settle the conversions in cash, net carrying amount for 2014 included the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[12] | The original principal amount of $820 million accretes up to $917 million in November 2028 and $1.03 billion at maturity in 2043. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[13] | Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[14] | Based on our closing share price of $32.81 as of AugustB 28, 2014. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[15] | Expected term for amortization of the remaining debt discount as of AugustB 28, 2014. The expected term of the 2031B Notes was not applicable because substantially all of the holders had exercised their option to convert their notes, which were settled in cash in the first quarter of 2015. |
Debt_Extinguishment_of_Debt_De
Debt - Extinguishment of Debt (Details) (USD $) | 3 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 0 Months Ended | 3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 28, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Nov. 12, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Jul. 31, 2014 | Aug. 28, 2014 | Aug. 27, 2014 | Aug. 27, 2013 | Dec. 04, 2014 | Dec. 04, 2014 | ||||||||||||
Exchanged [Member] | Conversion And Settlement [Member] | Repurchase [Member] | Debt Issuance [Member] | Prepayment [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | Loans Payable And Capital Lease Obligation [Member] | 2043G convertible senior notes [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Interest Expense [Member] | Interest Expense [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Scenario, Forecast [Member] | Scenario, Forecast [Member] | ||||||||||||||||||||
Conversion And Settlement [Member] | Repurchase [Member] | Exchanged [Member] | Conversion And Settlement [Member] | Exchanged [Member] | Conversion And Settlement [Member] | Exchanged [Member] | Conversion And Settlement [Member] | Repurchase [Member] | Repurchase [Member] | Repurchase [Member] | Prepayment [Member] | Exchanged [Member] | Conversion And Settlement [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | Conversion And Settlement [Member] | Level 2 [Member] | Level 2 [Member] | Conversion And Settlement [Member] | Embedded Derivative Financial Instruments [Member] | Embedded Derivative Financial Instruments [Member] | Embedded Derivative Financial Instruments [Member] | Embedded Derivative Financial Instruments [Member] | Embedded Derivative Financial Instruments [Member] | Secured Debt 1 [Member] | Secured Debt 1 [Member] | Secured Debt 2 [Member] | Secured Debt 2 [Member] | 2031B convertible senior notes [Member] | Notes Payable, Other Payables [Member] | |||||||||||||||||||||||||||||
Conversion And Settlement [Member] | Repurchase [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Exchanged [Member] | Repurchase [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Conversion And Settlement [Member] | Secured Debt 1 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||
Conversion And Settlement [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt Instrument, Increase (Decrease), Net Principal | ' | ' | ' | ' | ' | $1,371 | ' | $585 | ($770) | ($320) | $2,212 | ($336) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt Instrument, Increase (Decrease), Net | ' | ' | ' | ' | ' | -1,454 | ' | -282 | 437 | ' | -2,212 | ' | 478 | ' | ' | 80 | ' | 154 | ' | -275 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||
Cash, increase (decrease), net change as a result of debt restructure activities | ' | ' | ' | ' | ' | -485 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Repayments to Settle Long-term Debt Obligations, Gross | ' | ' | ' | ' | ' | ' | ' | 0 | -1,446 | -857 | ' | -339 | ' | -477 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -389 | ' | ||||||||||||
Proceeds from Debt, Net of Issuance Costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,157 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Exchange, issuance and repurchase of convertible notes impact on to additional paid in capital | ' | ' | ' | ' | ' | -1,691 | 57 | -238 | -886 | -567 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Interest and debt expense incurred through restructure of debt | 17 | 16 | 80 | 92 | 31 | 205 | [2] | ' | 49 | 130 | 23 | 0 | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31 | ' | ' | ' | 184 | 120 | 38 | 23 | 21 | 10 | 130 | [3] | 9 | [3] | 42 | [3] | 70 | [3] | 9 | [1],[3] | ' | ' | ' | ' | ' | ' | 24 | ' | ||||||
Face value of debt extinguished | ' | ' | ' | ' | ' | ' | ' | 440 | 770 | 320 | ' | ' | 485 | 464 | 80 | 95 | 155 | 190 | 205 | 0 | [1] | 26 | 188 | 106 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 114 | ' | |||||||||||
ExtinguishmentOfDebtCarryingAmount | ' | ' | ' | ' | ' | ' | ' | 345 | ' | 269 | ' | 334 | ' | 431 | 68 | ' | 125 | ' | 152 | ' | 19 | 161 | 89 | 334 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 32 | ' | 252 | ' | ' | 120 | ||||||||||||
Debt Instrument, Scheduled Accreted Principal Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 820 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Outstanding principal | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,025 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Volume-weighted-average price of our common stock period of consecutive trading days (in days) | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt | 6,593 | ' | ' | ' | ' | 6,593 | 6,037 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 627 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 242 | 635 | ' | 120 | ' | 312 | ' | ' | ||||||||||||
Equity component of convertible debt included in additional paid in capital | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 173 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt Instrument, Unamortized Discount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 33 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component Derecognized | ' | ' | ' | ' | ' | ' | ' | 411 | ' | 567 | ' | ' | ' | 15 | 51 | ' | 148 | ' | 212 | ' | 43 | 316 | 208 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Debt Instrument, Convertible, Derivative Reclassification | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $886 | [4] | $341 | [4] | ' | $58 | [4] | $217 | [4] | $270 | [1],[4] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||
[1] | In the first quarter of 2015, we used an aggregate of $389 million in cash to settle the remaining 2031B Notes. In connection therewith, we incurred an additional charge of $24 million for the settlement of the 2031B Notes in the first quarter of 2015. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | The loss on 2014 debt restructure activities was recorded as $184 million in other non-operating expense and $21B million in interest expense in 2014. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | The loss on conversion and settlement activities was recorded as $120 million in other non-operating expense and $10B million in interest expense in 2014. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | Based on Level 2 fair value measurements. |
Debt_MMJ_Debt_Restructure_Deta
Debt MMJ Debt Restructure (Details) | 12 Months Ended | 1 Months Ended | |||||||||||||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Oct. 31, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | |
USD ($) | USD ($) | USD ($) | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Akita, now known as Micron Akita, Inc. [Member] | Scenario, Plan [Member] | Scenario, Plan [Member] | Secured Creditors [Member] | Unsecured Creditor [Member] | Unsecured Creditor [Member] | |
USD ($) | JPY (¥) | USD ($) | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Akita, now known as Micron Akita, Inc. [Member] | ||||
JPY (¥) | USD ($) | JPY (¥) | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | ||||||||
USD ($) | JPY (¥) | decimal | decimal | decimal | |||||||||||
Assumed Debt Subject to Bankruptcy [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Reorganization Plan Payments, Total Cash Payments | ' | ' | ' | ' | ¥ 200,000,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Recovery Rate Of Secured Creditors | ' | ' | ' | ' | ' | ' | ' | 100.00% | 100.00% | ' | ' | ' | ' | ' | ' |
Recovery Rate of Unsecured Creditors | ' | ' | ' | ' | ' | ' | ' | 17.40% | 17.40% | 19.00% | ' | ' | ' | ' | ' |
Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities | 3,843,000,000 | 743,000,000 | 203,000,000 | ' | ' | ' | 51,000,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Reorganization Plan Number of Annual Installment Payments | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6 | 7 | 7 |
Effective interest rate (in hundredths) | ' | ' | ' | 6.25% | 6.25% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Elpida Sponsor Agreement [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
2015 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 196,000,000 | 20,330,000,000 | ' | ' | ' |
2016 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 194,000,000 | 20,197,000,000 | ' | ' | ' |
2017 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 193,000,000 | 20,063,000,000 | ' | ' | ' |
2018 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 192,000,000 | 19,928,000,000 | ' | ' | ' |
2019 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 276,000,000 | 28,674,000,000 | ' | ' | ' |
2020 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 318,000,000 | 33,024,000,000 | ' | ' | ' |
Estimated Reorganization Payment to Third Party Creditors, Total Cash Payments | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,369,000,000 | 142,216,000,000 | ' | ' | ' |
Debt Instrument, Unamortized Discount | ' | ' | ' | ' | ' | ' | ' | -238,000,000 | -24,700,000,000 | ' | ' | ' | ' | ' | ' |
Debt | $6,593,000,000 | $6,037,000,000 | ' | $1,131,000,000 | ' | $1,644,000,000 | ' | $1,131,000,000 | ¥ 117,516,000,000 | ' | ' | ' | ' | ' | ' |
Commitments_Details
Commitments (Details) (USD $) | 12 Months Ended | ||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | |
Operating Leases, Rent Expense, Net [Abstract] | ' | ' | ' |
Rent expense | $57,000,000 | $41,000,000 | $48,000,000 |
Operating Leases, Future Minimum Payments Due [Abstract] | ' | ' | ' |
2015 | 22,000,000 | ' | ' |
2016 | 18,000,000 | ' | ' |
2017 | 14,000,000 | ' | ' |
2018 | 13,000,000 | ' | ' |
2019 | 12,000,000 | ' | ' |
2020 and thereafter | 37,000,000 | ' | ' |
Total operating lease commitments | 116,000,000 | ' | ' |
Capital Addition Purchase Commitments [Member] | ' | ' | ' |
Unrecorded Unconditional Purchase Obligation [Line Items] | ' | ' | ' |
Commitments for acquisition of property, plant and equipment | $1,180,000,000 | ' | ' |
Contingencies_Details
Contingencies (Details) (USD $) | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 0 Months Ended | 1 Months Ended | 12 Months Ended | 29 Months Ended | 12 Months Ended | ||||||||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Dec. 31, 2013 | Nov. 28, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Mar. 13, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Mar. 10, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Jun. 23, 2010 | Jul. 31, 2006 | Aug. 28, 2014 | Nov. 29, 2012 | Aug. 28, 2014 | |
Rambus Settlement [Member] | Rambus Settlement [Member] | Rambus Settlement [Member] | Tessera, Inc. [Member] | Qimonda AG Inotera Share Purchase Proceedings [Member] | Qimonda AG Inotera Share Purchase Proceedings [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Securities Matter [Member] | ||||
Inotera [Member] | Inotera [Member] | HSM Portfolio LLC and Technology Properties LLC [Member] | HSM Portfolio LLC and Technology Properties LLC [Member] | Board Of Trustees For The University Of Illinois [Member] | Board Of Trustees For The University Of Illinois [Member] | Semcon Tech, LLC [Member] | Tessera, Inc. [Member] | Tessera, Inc. [Member] | Tessera, Inc. [Member] | Rambus DRAM Complaint [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | Former Shareholders of Elpida Memory, Inc [Member] | ||||||||
integer | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | integer | integer | integer | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | integer | integer | integer | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | ||||||||||||||
integer | integer | integer | |||||||||||||||||||||
Loss Contingencies [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Approximation of damages claimed | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3,900,000,000 | ' | ' | ' | ' | ' |
Settlement agreement execution date | ' | ' | ' | ' | ' | 'December 31, 2013 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 'June 23, 2010 | ' | ' |
Patent license agreement, term of agreement (in years) | ' | ' | ' | ' | ' | '7 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' |
Settlement agreement, maximum quarterly installment payment | ' | ' | ' | ' | ' | 10,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Settlement agreement, number of years for installment payments (in years) | ' | ' | ' | ' | ' | '7 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '2 years | ' | ' |
Settlement agreement amount | ' | ' | ' | 280,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 67,000,000 | ' | ' | ' | ' |
Rambus settlement | 233,000,000 | 0 | 0 | ' | 233,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of other defendants | ' | ' | ' | ' | ' | ' | ' | ' | ' | 17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of patents allegedly infringed | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4 | 2 | 3 | ' | 1 | ' | ' | 4 | ' | ' | ' | ' | ' | ' |
Number of petitions submitted for inter-partes review | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of patent claims found to be invalid by the Patent and Trademark Office | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Tessera license charge | ' | ' | ' | ' | ' | ' | 66,000,000 | ' | ' | ' | ' | ' | ' | ' | 66,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Number of lawsuits filed | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 68 | ' | ' |
Approximate number of U.S. states and territories filing suit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40 | ' | ' | ' |
Settlement agreement number of installment payments | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' |
Amount paid into an escrow account in connection with settlement | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 67,000,000 | ' |
Number of plaintiffs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7 |
Loss contingency, damages awarded, value | ' | ' | ' | ' | ' | ' | ' | 1,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity method investment carrying value of shares acquired from Qimonda | ' | ' | ' | ' | ' | ' | ' | ' | 505,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity method investment quoted market value of shares acquired from Qimonda | ' | ' | ' | ' | ' | ' | ' | ' | $2,060,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Redeemable_Convertible_Notes_D
Redeemable Convertible Notes (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Debt Instrument [Line Items] | ' | ' |
Redeemable convertible notes | $57 | $0 |
2033E and 2033F convertible senior notes [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Redeemable convertible notes | $57 | ' |
Equity_Equity_Capped_Calls_Det
Equity Equity - Capped Calls (Details) (Call Option [Member], Convertible Debt [Member], USD $) | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||||||||||
Share data in Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Sep. 01, 2011 | 29-May-14 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 30, 2012 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | ||||||||||||
2031A and 2031B convertible senior notes [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | Purchased options [Member] | |||||||||||||
Minimum [Member] | Maximum [Member] | 2031A and 2031B convertible senior notes [Member] | 2031A and 2031B convertible senior notes [Member] | 2031A and 2031B convertible senior notes [Member] | 2031A and 2031B convertible senior notes [Member] | 2031A and 2031B convertible senior notes [Member] | 2032C and 2032D convertible senior notes [Member] | 2033E and 2033F convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | |||||||||||||||
Minimum [Member] | Maximum [Member] | Minimum [Member] | Maximum [Member] | Minimum [Member] | Maximum [Member] | Minimum [Member] | Maximum [Member] | Minimum [Member] | Maximum [Member] | ||||||||||||||||||||||||||
Option Indexed to Issuer's Equity [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Cash paid for capped call transactions | ' | ' | ' | ' | ' | $57,000,000 | ' | ' | ' | $103,000,000 | $48,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Option indexed to issuer's equity, strike price (in dollars per share) | ' | ' | ' | ' | $9.50 | ' | ' | ' | ' | ' | ' | $9.80 | ' | ' | $10.16 | ' | ' | $10.93 | ' | ' | $10.93 | ' | ' | ||||||||||||
Option Indexed to Issuer's Equity, capped ceiling | ' | ' | ' | ' | ' | ' | ' | $12.67 | $13.17 | ' | ' | ' | $14.26 | $15.69 | ' | $14.62 | $16.04 | ' | $14.51 | $14.51 | ' | $14.51 | $14.51 | ||||||||||||
Option indexed to issuer's equity, shares (in shares) | ' | 188 | ' | ' | 34 | ' | ' | ' | ' | ' | ' | 56 | ' | ' | 44 | ' | ' | 27 | ' | ' | 27 | ' | ' | ||||||||||||
Option indexed to issuer's equity settlement proceeds | ' | ' | 0 | [1] | 864,000,000 | [1] | ' | ' | ' | 0 | [1] | 117,000,000 | [1] | ' | ' | ' | 0 | [1] | 307,000,000 | [1] | ' | 0 | [1] | 244,000,000 | [1] | ' | 0 | [1] | 98,000,000 | [1] | ' | 0 | [1] | 98,000,000 | [1] |
Option indexed to issuer's equity settlement shares received | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Capped call fair value settlement, dollar value of shares received | ' | ' | ' | ' | ' | ' | $86,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Capped call settlement (treasury) shares retired (in shares) | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
[1] | Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the low strike price, to the maximum amount if the market price per share of our common stock is at or above the high cap price. If share settlement were elected, the number of shares received would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. |
Equity_Equity_Restrictions_on_
Equity Equity - Restrictions on Net Assets (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Sep. 01, 2011 |
In Millions, unless otherwise specified | ||||
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract] | ' | ' | ' | ' |
Cash and equivalents | $4,150 | $2,880 | $2,459 | $2,160 |
MMJ Group [Member] | ' | ' | ' | ' |
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract] | ' | ' | ' | ' |
Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries | 3,100 | ' | ' | ' |
Cash and equivalents | 1,600 | ' | ' | ' |
IM Flash Technologies, LLC [Member] | ' | ' | ' | ' |
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract] | ' | ' | ' | ' |
Amount of Restricted Net Assets for Consolidated and Unconsolidated Subsidiaries | $793 | ' | ' | ' |
Equity_Accumulated_Other_Compr
Equity - Accumulated Other Comprehensive Income (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' |
Accumulated other comprehensive income | $63 | ' | ' |
Other comprehensive income before reclassifications | 2 | ' | ' |
Amount reclassified out of accumulated other comprehensive income | -9 | ' | ' |
Tax effects | 0 | ' | ' |
Other comprehensive income (loss) | -7 | -16 | -58 |
Accumulated other comprehensive income | 56 | 63 | ' |
Cumulative Foreign Currency Translation Adjustment [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' |
Accumulated other comprehensive income | 44 | ' | ' |
Other comprehensive income before reclassifications | 1 | ' | ' |
Amount reclassified out of accumulated other comprehensive income | -3 | ' | ' |
Tax effects | 0 | ' | ' |
Other comprehensive income (loss) | -2 | ' | ' |
Accumulated other comprehensive income | 42 | ' | ' |
Gains (Losses) on Derivative Instruments, Net [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' |
Accumulated other comprehensive income | 21 | ' | ' |
Other comprehensive income before reclassifications | -4 | ' | ' |
Amount reclassified out of accumulated other comprehensive income | -4 | ' | ' |
Tax effects | -1 | ' | ' |
Other comprehensive income (loss) | -9 | ' | ' |
Accumulated other comprehensive income | 12 | ' | ' |
Gains (Losses) on Investments, Net [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' |
Accumulated other comprehensive income | 0 | ' | ' |
Other comprehensive income before reclassifications | 4 | ' | ' |
Amount reclassified out of accumulated other comprehensive income | -3 | ' | ' |
Tax effects | 0 | ' | ' |
Other comprehensive income (loss) | 1 | ' | ' |
Accumulated other comprehensive income | 1 | ' | ' |
Pension Liability Adjustments [Member] | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' |
Accumulated other comprehensive income | -2 | ' | ' |
Other comprehensive income before reclassifications | 1 | ' | ' |
Amount reclassified out of accumulated other comprehensive income | 1 | ' | ' |
Tax effects | 1 | ' | ' |
Other comprehensive income (loss) | 3 | ' | ' |
Accumulated other comprehensive income | $1 | ' | ' |
Equity_Equity_NCI_and_Consolid
Equity Equity - NCI and Consolidated VIE Disclosures (Details) (USD $) | 3 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Feb. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Apr. 06, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Apr. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Apr. 30, 2012 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 30, 2012 | Apr. 06, 2012 | Aug. 30, 2007 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | ||||
NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | Intel [Member] | Intel [Member] | Intel [Member] | Intel [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Singapore LLP [Member] | IM Flash Singapore LLP [Member] | MP Mask Technology Center, LLC [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Other Consolidated Entities [Member] | Other Consolidated Entities [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Variable Interest Entities Which We Have Determined That We Are the Primary Beneficiary [Member] | Noncontrolling Interest [Member] | Noncontrolling Interest [Member] | Noncontrolling Interest [Member] | Noncontrolling Interest [Member] | Additional Capital [Member] | Additional Capital [Member] | |||||||||||||||||
NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | Intel [Member] | Intel [Member] | Intel [Member] | Intel [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Singapore LLP [Member] | IM Flash Singapore LLP [Member] | IM Flash Singapore LLP [Member] | MP Mask Technology Center, LLC [Member] | MP Mask Technology Center, LLC [Member] | MP Mask Technology Center, LLC [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | ||||||||||||||||||||||||||||||||
Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | |||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncontrolling interests in subsidiaries | $802 | ' | ' | ' | $864 | ' | ' | ' | $802 | $864 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $9 | $155 | $7 | $16 | $693 | [1] | $601 | [1] | ' | ' | ' | ' | ' | $93 | [1] | $92 | [1] | ' | ' | ' | ' | ' | ' |
Variable interest entity, ownership percentage by noncontrolling owners (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 11.00% | ' | ' | 49.00% | [1] | 49.00% | [1] | ' | ' | ' | ' | ' | 50.00% | [1] | 50.00% | [1] | ' | ' | ' | ' | ' | ' |
Ownership percentage after stock transactions during period (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 51.00% | ' | ' | ' | 82.00% | 51.00% | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ||||
R and D expenses reduced by reimbursements from Intel | ' | ' | ' | ' | ' | ' | ' | ' | -1,371 | -931 | -918 | ' | ' | ' | ' | ' | 137 | 127 | 87 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Net sales | 4,227 | 3,982 | 4,107 | 4,042 | 2,843 | 2,318 | 2,078 | 1,834 | 16,358 | 9,073 | 8,234 | ' | 4,468 | 3,589 | 3,627 | ' | ' | ' | ' | ' | 423 | 387 | 718 | ' | 158 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Trade receivables | 2,524 | ' | ' | ' | 2,069 | ' | ' | ' | 2,524 | 2,069 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 66 | 68 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Noncontrolling Interest Items [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Distributions to Micron from Consolidated VIE's | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | 38 | 439 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Distributions to noncontrolling interests from consolidated VIE's | ' | ' | ' | ' | ' | ' | ' | ' | 18 | 37 | 391 | ' | ' | ' | ' | ' | ' | ' | ' | 139 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | 37 | 391 | ' | ' | ' | ' | ' | ' | 18 | 37 | 391 | ' | ' | ' | ||||
Micron contributions to consolidated VIE's | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 106 | 12 | 48 | 103 | ' | ' | 21 | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Cash received from noncontrolling interests | ' | ' | ' | ' | ' | ' | ' | ' | 102 | 11 | 197 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 102 | 11 | 46 | 131 | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Minority Interest Decrease From Purchase Of Interest Ownership Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 18.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Acquisition of noncontrolling interests | ' | ' | ' | ' | ' | ' | ' | ' | 146 | ' | 466 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 466 | ' | ' | 146 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 180 | ' | 466 | 180 | -34 | -34 | ||||
Intel's deposit to be applied to future purchases of NAND Flash | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 300 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Extension periods of a Joint Venture | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Notice Period Required to Terminate a Joint Venture | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '12 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Sale proceeds for facility sold to Photronics | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $35 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
[1] | (1) Entity is a variable interest entity. |
Equity_Equity_Consolidated_VIE
Equity Equity - Consolidated VIE assets and liabilities (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Sep. 01, 2011 | ||
In Millions, unless otherwise specified | ||||||
Assets | ' | ' | ' | ' | ||
Cash and equivalents | $4,150 | $2,880 | $2,459 | $2,160 | ||
Receivables | 2,906 | 2,329 | ' | ' | ||
Inventories | 2,455 | 2,649 | ' | ' | ||
Other current assets | 350 | 276 | ' | ' | ||
Total current assets | 10,245 | 8,911 | ' | ' | ||
Property, plant and equipment, net | 8,682 | 7,626 | ' | ' | ||
Other noncurrent assets | 497 | 439 | ' | ' | ||
Total assets | 22,498 | 19,118 | ' | ' | ||
Liabilities | ' | ' | ' | ' | ||
Accounts payable and accrued expenses | 2,698 | 2,115 | ' | ' | ||
Deferred income | 309 | 243 | ' | ' | ||
Equipment purchase contracts | 166 | 182 | ' | ' | ||
Current debt | 1,638 | 1,585 | ' | ' | ||
Total current liabilities | 4,811 | 4,125 | ' | ' | ||
Long-term debt | 4,955 | 4,452 | ' | ' | ||
Other noncurrent liabilities | 1,102 | 535 | ' | ' | ||
Total liabilities | 10,868 | 9,112 | ' | ' | ||
Variable Interest Entity, Primary Beneficiary [Member] | IM Flash Technologies, LLC [Member] | ' | ' | ' | ' | ||
Assets | ' | ' | ' | ' | ||
Cash and equivalents | 84 | [1] | 62 | [1] | ' | ' |
Receivables | 73 | [1] | 76 | [1] | ' | ' |
Inventories | 48 | [1] | 49 | [1] | ' | ' |
Other current assets | 5 | [1] | 4 | [1] | ' | ' |
Total current assets | 210 | [1] | 191 | [1] | ' | ' |
Property, plant and equipment, net | 1,545 | [1] | 1,382 | [1] | ' | ' |
Other noncurrent assets | 47 | [1] | 46 | [1] | ' | ' |
Total assets | 1,802 | [1] | 1,619 | [1] | ' | ' |
Liabilities | ' | ' | ' | ' | ||
Accounts payable and accrued expenses | 92 | [1] | 88 | [1] | ' | ' |
Deferred income | 8 | [1] | 9 | [1] | ' | ' |
Equipment purchase contracts | 14 | [1] | 78 | [1] | ' | ' |
Current debt | 21 | [1] | 6 | [1] | ' | ' |
Total current liabilities | 135 | [1] | 181 | [1] | ' | ' |
Long-term debt | 71 | [1] | 13 | [1] | ' | ' |
Other noncurrent liabilities | 110 | [1] | 118 | [1] | ' | ' |
Total liabilities | 316 | [1] | 312 | [1] | ' | ' |
Variable Interest Entity, Primary Beneficiary [Member] | MP Mask Technology Center, LLC [Member] | ' | ' | ' | ' | ||
Assets | ' | ' | ' | ' | ||
Total current assets | 24 | [1] | 26 | [1] | ' | ' |
Noncurrent assets (primarily property, plant and equipment) | 203 | [1] | 182 | [1] | ' | ' |
Liabilities | ' | ' | ' | ' | ||
Total current liabilities | 28 | [1] | 25 | [1] | ' | ' |
Noncurrent Liabilities | $14 | [1] | $0 | [1] | ' | ' |
[1] | Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. |
Derivative_Financial_Instrumen2
Derivative Financial Instruments - Fair Values (Details) | 0 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Millions, unless otherwise specified | Aug. 27, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 29, 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secured Debt 2 [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable, Other Payables [Member] | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Convertible notes settlement obligations [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Currency options [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Current Debt [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | Yen | Yen | Yen | Yen | Singapore dollar | Singapore dollar | Euro | Euro | Shekel | Shekel | USD ($) | New Taiwan dollar | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Convertible notes settlement obligations [Member] | Interest Rate Swap [Member] | Currency options [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Convertible notes settlement obligations [Member] | Interest Rate Swap [Member] | Currency options [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Currency options [Member] | Convertible notes settlement obligations [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Convertible notes settlement obligations [Member] | Interest Rate Swap [Member] | Currency options [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Currency options [Member] | Currency options [Member] | Currency options [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | Accounts Payable and Accrued Expenses [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | Reorganization obligation [Member] | Reorganization obligation [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Yen | Yen | Singapore dollar | Singapore dollar | Euro | Euro | Shekel | Shekel | USD ($) | USD ($) | New Taiwan dollar | Yen | Yen | Singapore dollar | Singapore dollar | Euro | Euro | Shekel | Shekel | USD ($) | USD ($) | New Taiwan dollar | Yen | Yen | Singapore dollar | Singapore dollar | Euro | Euro | Shekel | Shekel | USD ($) | New Taiwan dollar | USD ($) | Yen | Yen | Singapore dollar | Singapore dollar | Euro | Euro | Shekel | Shekel | USD ($) | USD ($) | New Taiwan dollar | Yen | Yen | Euro | Euro | USD ($) | Minimum [Member] | Maximum [Member] | Yen | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Currency options [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Less Than One Year From Balance Sheet Date [Member] | More Than One Year And Within Two Years From Balance Sheet Date [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Yen | Yen | Euro | Euro | USD ($) | Yen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JPY (¥) | JPY (¥) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notional Amount Outstanding | ' | $1,262 | [1] | $1,191 | [1] | $554 | [1] | $336 | [1] | ¥ 20,000 | ¥ 10,000 | $330 | [1] | $218 | [1] | $245 | [1] | $217 | [1] | $62 | [1] | $78 | [1] | ' | ' | $62 | [1] | $351 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $118 | $283 | ' | $94 | $6 | $24 | $6 | ' | $250 | ' | ' | $21 | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative, Nonmonetary Notional Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest Rate Derivatives [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hedging designation allocation | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 80.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative, Fair Value, Net [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Asset | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | [2] | 2 | [2] | 0 | [2] | 1 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 1 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [3] | 3 | [3] | 0 | [3] | 3 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Liability | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -403 | [4] | -2 | [4] | -12 | [4] | 0 | [4] | 0 | [4] | 0 | [4] | -1 | [4] | -1 | [4] | -1 | [4] | -1 | [4] | 0 | [4] | 0 | [4] | -389 | [4] | -6 | 0 | -6 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -2 | [6] | -3 | [6] | -2 | [6] | -1 | [6] | 0 | [6] | 0 | [6] | 0 | [6] | -2 | [6] | |||||||||||||||||||||||||||||||||||||||
Foreign Currency Cash Flow Hedges [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General maturity of non-designated currency forward contracts (in days) | ' | ' | '35 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General maturity of hedge contracts (in days or months) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '12 months | ' | ' | ' | ' | ' | ' | '12 months | '18 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Decrease of debt carrying amount due to extinguishment | ($252) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible notes settlement obligations derivative term (in days) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[1] | Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in shares. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | Included in receivables - other. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | Included in other noncurrent assets. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | Included in accounts payable and accrued expenses - other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[5] | Included in other noncurrent liabilities. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[6] | Included in accounts payable and accrued expenses - other |
Derivative_Financial_Instrumen3
Derivative Financial Instruments - Hedging Relationship (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | ||||
MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | ||||
Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Foreign Exchange Contract [Member] | Foreign Exchange Contract [Member] | Foreign Exchange Contract [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | Other Comprehensive Income [Member] | Other Comprehensive Income [Member] | Other Comprehensive Income [Member] | |||||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Derivative, Gain (Loss) on Derivative, Net | ($27) | ($222) | ($19) | ($3) | ($47) | ($120) | ($58) | ($59) | $0 | $0 | ($27) | ($222) | ($17) | ($228) | $8 | ' | ' | ' | ' | ' | ' |
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -4 | -8 | -9 |
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4 | 1 | 9 | ' | ' | ' |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | $8 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair_Value_Measurements_Assets
Fair Value Measurements - Assets measured (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | mm | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Nonrecurring [Member] | Fair Value, Measurements, Nonrecurring [Member] | Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Government securities [Member] | Government securities [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | |
Micron Semiconductor Israel Ltd. [Member] | Transform [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Government securities [Member] | Government securities [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Government securities [Member] | Government securities [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | |||||
mm | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | ||||||||||||||||||||||||||
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash equivalents | ' | ' | $1,705 | $1,261 | ' | ' | $1,281 | $1,188 | $402 | $38 | $22 | $35 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,281 | $1,188 | $1,281 | $1,188 | $0 | $0 | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $424 | $73 | $0 | $0 | $402 | $38 | $22 | $35 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Short-term investments | 384 | 221 | 384 | 221 | ' | ' | ' | ' | 8 | 9 | ' | ' | 154 | 112 | 136 | 72 | 85 | 26 | 1 | 2 | ' | ' | 0 | 0 | ' | ' | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ' | ' | 384 | 221 | ' | ' | 8 | 9 | ' | ' | 154 | 112 | 136 | 72 | 85 | 26 | 1 | 2 | ' | ' |
Long-term marketable investments | 819 | 499 | 819 | 499 | ' | ' | ' | ' | ' | ' | ' | ' | 407 | 302 | 284 | 96 | ' | ' | 127 | 95 | 1 | 6 | 1 | 6 | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | 0 | ' | ' | 0 | 0 | 1 | 6 | 818 | 493 | ' | ' | ' | ' | ' | ' | 407 | 302 | 284 | 96 | ' | ' | 127 | 95 | 0 | 0 |
Restricted cash | ' | ' | 27 | 302 | ' | ' | ' | ' | 27 | 302 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 27 | 302 | ' | ' | 27 | 302 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total assets measured at fair value on a recurring basis | ' | ' | 2,935 | 2,283 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,282 | 1,194 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,653 | 1,089 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other than temporary impairment in Transform | ' | ' | ' | ' | ' | $69 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Diameter of Wafer Used in Production (in millimeters) | ' | 200 | ' | ' | 200 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair_Value_Measurements_Fair_a
Fair Value Measurements - Fair and Carrying Value (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Fair value disclosure [Line Items] | ' | ' |
Debt | $6,593 | $6,037 |
Convertible Notes [Member] | ' | ' |
Fair value disclosure [Line Items] | ' | ' |
Debt | 2,143 | 2,506 |
Carrying Value [Member] | Convertible Notes [Member] | ' | ' |
Fair value disclosure [Line Items] | ' | ' |
Debt | 2,143 | 2,506 |
Carrying Value [Member] | MMJ creditor installment payments and other notes [Member] | ' | ' |
Fair value disclosure [Line Items] | ' | ' |
Debt | 3,539 | 2,279 |
Fair Value [Member] | Level 2 [Member] | Convertible Notes [Member] | ' | ' |
Fair value disclosure [Line Items] | ' | ' |
Convertible notes | 5,886 | 4,167 |
Fair Value [Member] | Level 2 [Member] | MMJ creditor installment payments and other notes [Member] | ' | ' |
Fair value disclosure [Line Items] | ' | ' |
MMJ creditor installment payments and other debt instruments | $3,634 | $2,269 |
Equity_Plans_Share_Based_Compe
Equity Plans - Share Based Compensation (Details) (USD $) | 12 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Number of shares of common stock reserved for issuance for stock options and restricted stock awards (in shares) | 161 | ' | ' |
Number of shares subject to outstanding awards (in shares) | 62 | ' | ' |
Number of shares available for future awards (in shares) | 99 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' |
Number of shares outstanding (in shares) | 71 | ' | ' |
Number of shares granted (in shares) | 12 | ' | ' |
Number of shares excercised (in shares) | -32 | ' | ' |
Number of shares cancelled or expired (in shares) | -3 | ' | ' |
Number of shares outstanding (in shares) | 48 | 71 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] | ' | ' | ' |
Weighted average exercise price per share for options outstanding (in dollars per share) | $7.41 | ' | ' |
Weighted average exercise price per share for options granted (in dollars per share) | $22.61 | ' | ' |
Weighted average exercise price per share for options exercised (in dollars per share) | $8.27 | ' | ' |
Weighted average exercise price per share for options cancelled or expired (in dollars per share) | $9.27 | ' | ' |
Weighted average exercise price per share for options outstanding (in dollars per share) | $10.57 | $7.41 | ' |
Share-based Compensation Arrangement by Share-based Payment Award Options, Outstanding, Additiona Disclosures [Abstract] | ' | ' | ' |
Weighted average remaining contractual term for options outstanding at August 28, 2014 (in years) | '3 years 9 months | ' | ' |
Aggregated intrinsic value for options outstanding at August 28, 2014 | $1,078 | ' | ' |
Options exercisable at August 28, 2014 (in shares) | 14 | ' | ' |
Weighted average exercise price per share for options exerciasble at August 28, 2014 (in dollars per share) | $6.88 | ' | ' |
Weighted average remaining contractual term for options exercisable at August 28, 2014 (in years) | '2 years 5 months | ' | ' |
Aggregated intrinsic value for options exercisable at August 28, 2014 | 362 | ' | ' |
Options expected to vest after August 28, 2014 (in shares) | 33 | ' | ' |
Weighted average exercise price per share for options expected to vest after August 28, 2014 (in dollars per share) | $11.92 | ' | ' |
Weighted average remaining contractual term for options expected to vest after August 28, 2014 (in years) | '4 years 3 months | ' | ' |
Aggregated intrinsic value for options expected to vest after August 28, 2014 | 692 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] | ' | ' | ' |
Weighted-average grant-date fair values per share of options granted during period (in dollars per share) | $9.64 | $3.34 | $3.18 |
Total intrinsic value for option exercised | 421 | 103 | 6 |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' |
Fair Value Assumptions, Method Used | 'Black-Scholes | ' | ' |
Average expected life (in years) | '4 years 11 months | '5 years 1 month | '5 years 1 month |
Weighted-average expected volatility (in hundredths) | 48.00% | 59.00% | 66.00% |
Weighted-average risk-free interest rate (in hundredths) | 1.60% | 0.70% | 0.90% |
Restricted Stock Awards activity | ' | ' | ' |
Number of Shares - Outstanding (in shares) | 13 | ' | ' |
Number of Shares - Granted (in shares) | 7 | ' | ' |
Number of Shares - Restrictions lapsed (in shares) | -6 | ' | ' |
Number of Shares - Cancelled (in shares) | -1 | ' | ' |
Number of Shares - Outstanding (in shares) | 13 | 13 | ' |
Restricted awards expected to vest after August 28, 2014 (in shares) | 13 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ' | ' | ' |
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share) | $6.49 | ' | ' |
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share) | $21.88 | $6.23 | $5.43 |
Weighted Average Grant Date Fair Value Per Share - Restrictions lapsed (in dollars per share) | $6.29 | ' | ' |
Weighted Average Grant Date Fair Value Per Share - Cancelled (in dollars per share) | $8.75 | ' | ' |
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share) | $15.08 | $6.49 | ' |
Weighted Average Grant Date Fair Value for restricted awards expected to vest after August 28, 2014 (in dollars per share) | $14.91 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' |
Aggregate fair values at vesting date | $115 | $17 | $32 |
Performance-based shares [Member] | ' | ' | ' |
Restricted Stock Awards activity | ' | ' | ' |
Number of Shares - Outstanding (in shares) | 1 | ' | ' |
Employee Stock Option [Member] | Minimum [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Stock option annual incremental vesting (percentage) | 25.00% | ' | ' |
General number of years from grant date until stock options expire (in years) | '6 years | ' | ' |
Employee Stock Option [Member] | Maximum [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Stock option annual incremental vesting (percentage) | 33.00% | ' | ' |
General number of years from grant date until stock options expire (in years) | '8 years | ' | ' |
Equity_Plans_Stockbased_compen
Equity Plans - Stock-based compensation expense (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | $115 | $91 | $87 |
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] | ' | ' | ' |
Total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards expected to be recognized | 275 | ' | ' |
Weighted average period that unrecognized compensation costs is expected to be recognized (in years) | '1 year 5 months | ' | ' |
Stock Options [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | 61 | 57 | 57 |
Restricted Stock Awards [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | 54 | 34 | 30 |
Employee plans [Member] | ' | ' | ' |
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] | ' | ' | ' |
Stock compensation expense capitalized and remained in inventory | 9 | 6 | ' |
Cost of Goods Sold [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | 39 | 27 | 23 |
Selling, General and Administrative Expenses [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | 50 | 45 | 47 |
Research and Development [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | 25 | 18 | 17 |
Other [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ' | ' | ' |
Stock-based compensation | $1 | $1 | $0 |
Employee_Benefit_Plans_Employe
Employee Benefit Plans - Employee Savings Plan for U.S. Employees (Details) (Employee Retirement Savings Plan [Member], USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Employee Retirement Savings Plan [Member] | ' | ' | ' |
Defined Contribution Plan Disclosure [Line Items] | ' | ' | ' |
Maximum annual contributions per employee (in hundredths) | 75.00% | ' | ' |
Maximum employer matching contribution, percent of employees' eligible earnings (in hundredths) | 5.00% | ' | ' |
Defined contribution plan contribution expense | $44 | $41 | $41 |
Employee_Benefit_Plans_Retirem
Employee Benefit Plans - Retirement Plans (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Defined Benefit Plan Disclosure [Line Items] | ' | ' |
Defined Benefit Plan, Benefit Obligation | $164 | $196 |
Defined Benefit Plan, Fair Value of Plan Assets | $90 | $116 |
Restucture_and_Asset_Impairmen2
Restucture and Asset Impairments Restructure and Asset Impairments (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||
In Millions, unless otherwise specified | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
mm | mm | ||||||
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | $32 | $55 | $60 | ($21) | $40 | $126 | $10 |
Diameter of Wafer Used in Production (in millimeters) | 200 | ' | ' | ' | ' | 200 | ' |
MBU [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | ' | ' | ' | ' | 21 | 12 | ' |
EBU [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | ' | ' | ' | ' | 20 | 14 | ' |
CNBU [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | ' | ' | ' | ' | ' | 12 | ' |
SBU [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | ' | ' | ' | ' | ' | 20 | ' |
Light-emitting Diode (LED) [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Loss on impairment of assets | ' | ' | ' | ' | -6 | 33 | 0 |
Micron Technology Italia, Srl. [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Loss on impairment of assets | ' | ' | ' | ' | -5 | 62 | 0 |
Transform [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Gain on termination of lease to Transform | ' | ' | ' | ' | 0 | -25 | 0 |
Consortium Agreement [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | ' | ' | ' | ' | 0 | 26 | 0 |
Number of positions transferred to ST | ' | ' | ' | ' | ' | 500 | ' |
Other Restucturing Activities [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructure | ' | ' | ' | ' | 51 | 30 | 10 |
Other Restucturing Activities [Member] | Workforce Optimization [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Reserve | ' | ' | ' | ' | $14 | ' | ' |
Other Restucturing Activities [Member] | Workforce Optimization [Member] | Agrate, Italy and Kiryat Gat, Israel wind-down activities [Member] | ' | ' | ' | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Diameter of Wafer Used in Production (in millimeters) | ' | ' | ' | ' | 200 | ' | ' |
Other_Operating_Income_Expense2
Other Operating (Income) Expense, Net (Details) (USD $) | 12 Months Ended | 3 Months Ended | 12 Months Ended | ||||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 30, 2012 | Aug. 30, 2012 | Nov. 28, 2013 | Aug. 28, 2014 |
Contract Termination [Member] | Receivable In Connection With Certain Tax Matters [Member] | Rambus Settlement [Member] | Rambus Settlement [Member] | ||||
Component Of Operating Other Income And Expense Net [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Rambus settlement | $233 | $0 | $0 | ' | ' | $233 | ' |
(Gain) loss on disposition of property, plant and equipment | 10 | -3 | 5 | ' | ' | ' | ' |
Other | -11 | -5 | 27 | 17 | 10 | ' | ' |
Other operating (income) expense, net | $232 | ($8) | $32 | ' | ' | ' | $233 |
Other_NonOperating_Income_Expe1
Other Non-Operating Income (Expense), Net (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Component of Other Non-Operating Income (Expense), Net [Line Items] | ' | ' | ' |
Loss on restructure of debt | ($184) | ($31) | $0 |
Gain (loss) from changes in currency exchange rates | -28 | -229 | -6 |
Gain from disposition of interest in Aptina | 119 | 0 | 0 |
Gain from issuance of Inotera shares | 93 | 48 | 0 |
Other | 8 | -6 | 35 |
Other non-operating income (expense), net | $8 | ($218) | $29 |
Income_Taxes_Details_1
Income Taxes (Details 1) (USD $) | 12 Months Ended | ||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | |
Income (loss) before taxes, net (income) loss attributable to noncontrolling interests and equity in net income (loss) of equity method investees [Abstract] | ' | ' | ' |
Foreign | $2,619,000,000 | $839,000,000 | $274,000,000 |
U.S. | 114,000,000 | 446,000,000 | -1,028,000,000 |
Income (loss) before income taxes, net income attributable to noncontrolling interests and equity in net income (loss) of equity method investees: | 2,733,000,000 | 1,285,000,000 | -754,000,000 |
Current [Abstract] | ' | ' | ' |
Foreign | -46,000,000 | -17,000,000 | -22,000,000 |
U.S. federal | -3,000,000 | 0 | 14,000,000 |
State | -2,000,000 | 0 | 0 |
Total income tax (provision) benefit - current | -51,000,000 | -17,000,000 | -8,000,000 |
Deferred [Abstract] | ' | ' | ' |
Foreign | -81,000,000 | 9,000,000 | 25,000,000 |
U.S. federal | 4,000,000 | 0 | 0 |
Total income tax (provision) benefit - deferred | -77,000,000 | 9,000,000 | 25,000,000 |
Income tax (provision) benefit | -128,000,000 | -8,000,000 | 17,000,000 |
Income tax (provision) benefit, income tax reconciliation [Abstract] | ' | ' | ' |
U.S. federal income tax (provision) benefit at statutory rate | -956,000,000 | -450,000,000 | 264,000,000 |
Change in unrecognized tax benefits | -152,000,000 | 2,000,000 | 52,000,000 |
State taxes, net of federal benefit | -39,000,000 | 6,000,000 | 9,000,000 |
Gain on MMJ Acquisition | -11,000,000 | 520,000,000 | 0 |
Change in valuation allowance | 544,000,000 | -418,000,000 | -368,000,000 |
Foreign tax rate differential | 474,000,000 | 339,000,000 | 77,000,000 |
Tax credits | 11,000,000 | 36,000,000 | 2,000,000 |
Transaction costs related to the MMJ Acquisition | 0 | -38,000,000 | 0 |
Other | 1,000,000 | -5,000,000 | -19,000,000 |
Income tax (provision) benefit | -128,000,000 | -8,000,000 | 17,000,000 |
Deferred tax assets: | ' | ' | ' |
Net operating loss and tax credit carryforwards | 3,162,000,000 | 4,048,000,000 | ' |
Property, plant and equipment | 284,000,000 | 313,000,000 | ' |
Accrued salaries, wages and benefits | 152,000,000 | 107,000,000 | ' |
Other accrued liabilities | 113,000,000 | 8,000,000 | ' |
Other | 104,000,000 | 169,000,000 | ' |
Gross deferred tax assets | 3,815,000,000 | 4,645,000,000 | ' |
Less valuation allowance | -2,443,000,000 | -3,155,000,000 | ' |
Deferred tax assets, net of valuation allowance | 1,372,000,000 | 1,490,000,000 | ' |
Deferred tax liabilities: | ' | ' | ' |
Debt discount | -291,000,000 | -294,000,000 | ' |
Unremitted earnings on certain subsidiaries | -115,000,000 | -126,000,000 | ' |
Product and process technology | -29,000,000 | -74,000,000 | ' |
Other | -67,000,000 | -14,000,000 | ' |
Deferred tax liabilities | -502,000,000 | -508,000,000 | ' |
Net deferred tax assets | 870,000,000 | 982,000,000 | ' |
Reported as: | ' | ' | ' |
Noncurrent deferred tax assets | 816,000,000 | 861,000,000 | ' |
Net deferred tax assets | 870,000,000 | 982,000,000 | ' |
Net tax benefits, Not Recorded as Deferred Tax Assets, Compensation and Benefits, Share-based Compensation Cost | 207,000,000 | ' | ' |
Remaining undistributed earnings of non-U.S. subsidiaries which have been indefinitely reinvested | 4,910,000,000 | ' | ' |
Total basis differences for investments in indefinitely reinvested foreign subsidiaries | 6,550,000,000 | ' | ' |
Other current assets [Member] | ' | ' | ' |
Reported as: | ' | ' | ' |
Current deferred tax assets (included in other current assets) | 228,000,000 | 123,000,000 | ' |
Accounts payable and accrued expenses [Member] | ' | ' | ' |
Reported as: | ' | ' | ' |
Current deferred tax liabilities (included in accounts payable and accrued expenses) | -4,000,000 | -2,000,000 | ' |
Other noncurrent liabilities [Member] | ' | ' | ' |
Reported as: | ' | ' | ' |
Noncurrent deferred tax liabilities (included in other noncurrent liabilities) | ($170,000,000) | $0 | ' |
Income_Taxes_Income_Taxes_Valu
Income Taxes Income Taxes - Valuation Allowances (Details) (USD $) | 12 Months Ended | |
Aug. 28, 2014 | Aug. 29, 2013 | |
Valuation Allowance [Line Items] | ' | ' |
Valuation allowance | $2,443,000,000 | $3,155,000,000 |
Changes in valuation allowance | -712,000,000 | ' |
Valuation Allowance, Operating Loss Carryforwards [Member] | U.S. [Member] | ' | ' |
Valuation Allowance [Line Items] | ' | ' |
Valuation allowance | 1,290,000,000 | ' |
Valuation Allowance, Operating Loss Carryforwards [Member] | Japan [Member] | ' | ' |
Valuation Allowance [Line Items] | ' | ' |
Valuation allowance | 979,000,000 | ' |
Net operating loss carryforwards, valuation allowance | 2,760,000,000 | ' |
Valuation Allowance, Operating Loss Carryforwards [Member] | Other foreign subsidiaries member [Member] | ' | ' |
Valuation Allowance [Line Items] | ' | ' |
Valuation allowance | $179,000,000 | ' |
Income_Taxes_Operating_Loss_Ca
Income Taxes - Operating Loss Carryforwards (Details 2) (USD $) | Aug. 28, 2014 |
In Millions, unless otherwise specified | |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | $10,970 |
2015 - 2019 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 698 |
2020 - 2024 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 4,913 |
2025 - 2029 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 3,015 |
2030 - 2033 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 2,305 |
Indefinite | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 39 |
Federal [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 3,893 |
Federal [Member] | 2015 - 2019 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Federal [Member] | 2020 - 2024 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Federal [Member] | 2025 - 2029 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 2,081 |
Federal [Member] | 2030 - 2033 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 1,812 |
Federal [Member] | Indefinite | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
State [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 1,708 |
State [Member] | 2015 - 2019 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 102 |
State [Member] | 2020 - 2024 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 179 |
State [Member] | 2025 - 2029 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 934 |
State [Member] | 2030 - 2033 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 493 |
State [Member] | Indefinite | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Japan [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 3,945 |
Japan [Member] | 2015 - 2019 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 83 |
Japan [Member] | 2020 - 2024 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 3,862 |
Japan [Member] | 2025 - 2029 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Japan [Member] | 2030 - 2033 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Japan [Member] | Indefinite | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Other foreign subsidiaries member [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 1,424 |
Other foreign subsidiaries member [Member] | 2015 - 2019 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 513 |
Other foreign subsidiaries member [Member] | 2020 - 2024 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 872 |
Other foreign subsidiaries member [Member] | 2025 - 2029 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Other foreign subsidiaries member [Member] | 2030 - 2033 | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | 0 |
Other foreign subsidiaries member [Member] | Indefinite | ' |
Operating Loss Carryforwards [Line Items] | ' |
Net operating loss carryforwards | $39 |
Income_Taxes_Tax_Credit_Carryf
Income Taxes - Tax Credit Carryforwards (Details 3) (USD $) | Aug. 28, 2014 |
In Millions, unless otherwise specified | |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | $443 |
2015 - 2019 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 78 |
2020 - 2024 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 146 |
2025 - 2029 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 116 |
2030 - 2034 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 72 |
Indefinite | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 31 |
Federal [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 250 |
Federal [Member] | 2015 - 2019 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 9 |
Federal [Member] | 2020 - 2024 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 91 |
Federal [Member] | 2025 - 2029 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 78 |
Federal [Member] | 2030 - 2034 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 72 |
Federal [Member] | Indefinite | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 0 |
State [Member] | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 193 |
State [Member] | 2015 - 2019 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 69 |
State [Member] | 2020 - 2024 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 55 |
State [Member] | 2025 - 2029 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 38 |
State [Member] | 2030 - 2034 | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | 0 |
State [Member] | Indefinite | ' |
Tax Credit Carryforward [Line Items] | ' |
Tax credit carryforwards | $31 |
Income_Taxes_Unrecognized_Tax_
Income Taxes - Unrecognized Tax Benefits (Details 4) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ' | ' | ' |
Beginning unrecognized tax benefits | $78 | $77 | $121 |
Increases related to tax positions taken during current year | 152 | 4 | 6 |
Foreign currency translation increases (decreases) to tax positions | 1 | 4 | ' |
Foreign currency translation increases (decreases) to tax positions | ' | ' | -9 |
Settlements with tax authorities | -1 | -8 | -29 |
Decreases related to tax positions from prior years | -1 | 0 | -14 |
Lapse of statute of limitations | -1 | 0 | 0 |
Increases related to tax positions from prior years | 0 | 0 | 2 |
Unrecognized tax benefits acquired in current year | 0 | 1 | 0 |
Ending unrecognized tax benefits | 228 | 78 | 77 |
Unrecognized tax benefits that affect our effective tax rate | 66 | 63 | 66 |
Income Tax Examination, Penalties and Interest Accrued [Abstract] | ' | ' | ' |
Accrued interest and penalties related to uncertain tax positions | $19 | $16 | $12 |
Income_Taxes_Income_Taxes_Esti
Income Taxes Income Taxes - Estimated Potential Changes to Unrecognized Tax Benefits (Details 5) (USD $) | Aug. 28, 2014 |
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] | ' |
Estimated potential reduction in our unrecognized tax benefits in the next 12 months, lower bound | $0 |
Estimated potential reduction in our unrecognized tax benefits in the next 12 months, upper bound | $77,000,000 |
Income_Taxes_Income_Tax_Holida
Income Taxes Income Tax Holiday (Details 6) (USD $) | 12 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Income Tax Holiday [Line Items] | ' | ' | ' |
Tax benefit due to arrangements allowing computation of tax provision at rates below local statutory rates | $286 | $141 | $52 |
Tax benefit per diluted share due to arrangements allowing computation of tax provision at rates below local statutory rates (in dollars per share) | $0.24 | $0.13 | $0.05 |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Earnings Per Share Reconciliation [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net income (loss) available to Micron shareholders b Basic | $1,150 | $806 | $731 | $358 | $1,708 | $43 | ($286) | ($275) | $3,045 | $1,190 | ($1,032) |
Dilutive effect related to equity method investment | ' | ' | ' | ' | ' | ' | ' | ' | -2 | 0 | 0 |
Net income (loss) available to Micron shareholders b Diluted | ' | ' | ' | ' | ' | ' | ' | ' | $3,043 | $1,190 | ($1,032) |
Weighted Average Number of Shares Outstanding Reconciliation [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average common shares outstanding - Basic (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | 1,060 | 1,022 | 991 |
Dilutive effect of equity plans and convertible notes (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | 138 | 35 | 0 |
Weighted-average common shares outstanding - Diluted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | 1,198 | 1,057 | 991 |
Earnings Per Share, Basic [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Basic (in dollars per share) | $1.08 | $0.76 | $0.69 | $0.34 | $1.65 | $0.04 | ($0.28) | ($0.27) | $2.87 | $1.16 | ($1.04) |
Earnings Per Share, Diluted [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Diluted (in dollars per share) | $0.96 | $0.68 | $0.61 | $0.30 | $1.51 | $0.04 | ($0.28) | ($0.27) | $2.54 | $1.13 | ($1.04) |
Earnings_Per_Share_Earnings_Pe
Earnings Per Share Earnings Per Share - Potential Common Shares Excluded in the Computation of Diluted Earnings Per Share Because They Would Have Been Antidilutive (Details) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Employee plans [Member] | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' | ' |
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares) | 7 | 40 | 105 |
Convertible notes [Member] | ' | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' | ' |
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares) | 26 | 186 | 258 |
Segment_Information_Details
Segment Information (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $4,227 | $3,982 | $4,107 | $4,042 | $2,843 | $2,318 | $2,078 | $1,834 | $16,358 | $9,073 | $8,234 |
Operating income (loss) | 828 | 839 | 869 | 551 | 207 | 149 | -23 | -97 | 3,087 | 236 | -612 |
Depreciation, Depletion and Amortization [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization expense included in operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 2,102 | 1,813 | 2,144 |
Other amortization | ' | ' | ' | ' | ' | ' | ' | ' | 168 | 113 | 78 |
Total depreciation and amortization expense | ' | ' | ' | ' | ' | ' | ' | ' | 2,270 | 1,926 | 2,222 |
Operating Segments [Member] | CNBU [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 7,333 | 3,462 | 2,667 |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 1,957 | 160 | -458 |
Depreciation, Depletion and Amortization [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization expense included in operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 878 | 687 | 755 |
Operating Segments [Member] | MBU [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 3,627 | 1,214 | 1,176 |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 683 | -265 | -371 |
Depreciation, Depletion and Amortization [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization expense included in operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 475 | 293 | 372 |
Operating Segments [Member] | SBU [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 3,480 | 2,824 | 2,842 |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 255 | 173 | 199 |
Depreciation, Depletion and Amortization [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization expense included in operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 512 | 551 | 649 |
Operating Segments [Member] | EBU [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 1,774 | 1,275 | 1,097 |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 331 | 227 | 129 |
Depreciation, Depletion and Amortization [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization expense included in operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 226 | 215 | 228 |
Operating Segments [Member] | All Other [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 144 | 298 | 452 |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 94 | -59 | -111 |
Depreciation, Depletion and Amortization [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization expense included in operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 11 | 67 | 140 |
Unallocated [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | ($233) | $0 | $0 |
Product_Sales_Product_Sales_De
Product Sales Product Sales (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Revenue from External Customer [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $4,227 | $3,982 | $4,107 | $4,042 | $2,843 | $2,318 | $2,078 | $1,834 | $16,358 | $9,073 | $8,234 |
DRAM [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue from External Customer [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 11,164 | 4,361 | 3,178 |
NAND Flash [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue from External Customer [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 4,468 | 3,589 | 3,627 |
NOR Flash [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue from External Customer [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 505 | 792 | 977 |
Other [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue from External Customer [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | $221 | $331 | $452 |
Certain_Concentrations_Details
Certain Concentrations (Details) (Sales Revenue, Goods, Net [Member]) | 12 Months Ended | ||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | |
Product Concentration Risk [Member] | Compute and graphics [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | 30.00% | 20.00% | 15.00% |
Product Concentration Risk [Member] | Mobile [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | 20.00% | 15.00% | 15.00% |
Product Concentration Risk [Member] | Solid state drives and other storage [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | 20.00% | 25.00% | 25.00% |
Product Concentration Risk [Member] | Automotive, industrial, medical and other embedded [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | 10.00% | 15.00% | 15.00% |
Product Concentration Risk [Member] | Server [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | 10.00% | 10.00% | 10.00% |
Customer Concentration Risk [Member] | Kingston [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | 10.00% | ' | ' |
Customer Concentration Risk [Member] | Intel [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | ' | 10.00% | 12.00% |
Customer Concentration Risk [Member] | Hewlett-Packard Company [Member] | ' | ' | ' |
Concentration Risk [Line Items] | ' | ' | ' |
Concentration risk, market concentrations, percentage of net sales (in hundreths) | ' | 10.00% | ' |
Geographic_Information_Details
Geographic Information (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $4,227 | $3,982 | $4,107 | $4,042 | $2,843 | $2,318 | $2,078 | $1,834 | $16,358 | $9,073 | $8,234 |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | 8,682 | ' | ' | ' | 7,626 | ' | ' | ' | 8,682 | 7,626 | ' |
CHINA | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 6,715 | 3,783 | 2,936 |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | 242 | ' | ' | ' | 350 | ' | ' | ' | 242 | 350 | ' |
UNITED STATES | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 2,551 | 1,512 | 1,262 |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | 3,282 | ' | ' | ' | 3,041 | ' | ' | ' | 3,282 | 3,041 | ' |
SINGAPORE | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | 3,101 | ' | ' | ' | 3,225 | ' | ' | ' | 3,101 | 3,225 | ' |
Taiwan [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 2,313 | 980 | 1,022 |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | 761 | ' | ' | ' | 307 | ' | ' | ' | 761 | 307 | ' |
Asia Pacific (excluding China, Taiwan and Japan) [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 1,791 | 946 | 1,327 |
JAPAN | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 1,253 | 589 | 460 |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | 1,221 | ' | ' | ' | 615 | ' | ' | ' | 1,221 | 615 | ' |
Europe [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 1,252 | 820 | 827 |
Other [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Geographic Areas, Revenues from External Customers [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 483 | 443 | 400 |
Geographic Areas, Long-Lived Assets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net | $75 | ' | ' | ' | $88 | ' | ' | ' | $75 | $88 | ' |
Quarterly_Financial_Informatio2
Quarterly Financial Information (Details) (USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | 0 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | |||||||||||||||||
In Millions, except Per Share data, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Nov. 28, 2013 | Aug. 28, 2014 | 15-May-14 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 29, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | |
mm | mm | MMJ Group [Member] | Rambus Settlement [Member] | Tessera, Inc. [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | |||||||||||
MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | MMJ Acquisition [Member] | |||||||||||||||||||||||
Net sales | $4,227 | $3,982 | $4,107 | $4,042 | $2,843 | $2,318 | $2,078 | $1,834 | $16,358 | $9,073 | $8,234 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Gross margin | 1,385 | 1,368 | 1,403 | 1,281 | 708 | 556 | 366 | 217 | 5,437 | 1,847 | 968 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Operating income (loss) | 828 | 839 | 869 | 551 | 207 | 149 | -23 | -97 | 3,087 | 236 | -612 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Net income (loss) | 1,151 | 806 | 741 | 381 | 1,710 | 43 | -284 | -275 | 3,079 | 1,194 | -1,031 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Net income (loss) attributable to Micron | 1,150 | 806 | 731 | 358 | 1,708 | 43 | -286 | -275 | 3,045 | 1,190 | -1,032 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Earnings (loss) per share: | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Basic (in dollars per share) | $1.08 | $0.76 | $0.69 | $0.34 | $1.65 | $0.04 | ($0.28) | ($0.27) | $2.87 | $1.16 | ($1.04) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Diluted (in dollars per share) | $0.96 | $0.68 | $0.61 | $0.30 | $1.51 | $0.04 | ($0.28) | ($0.27) | $2.54 | $1.13 | ($1.04) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Selected Quarterly Financial Information [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Rambus settlement | ' | ' | ' | ' | ' | ' | ' | ' | 233 | 0 | 0 | ' | 233 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Interest and debt expense incurred through restructure of debt | 17 | 16 | 80 | 92 | ' | ' | 31 | ' | 205 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Gain from issuance of Inotera shares | ' | ' | ' | ' | ' | ' | ' | ' | 93 | 48 | 0 | ' | ' | ' | ' | 93 | 48 | 93 | 48 | ' | ' | ' | ' | ' | ' | |
Inotera ownership percentage before transaction | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 35.00% | 35.00% | 40.00% | ' | 40.00% | ' | ' | ' | ' | ' | ' | |
Ownership percentage in Inotera after its stock sale transaction | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 33.00% | 33.00% | 35.00% | ' | 35.00% | ' | ' | ' | ' | ' | ' | |
Gain from disposition of interest in Aptina | ' | ' | ' | ' | ' | ' | ' | ' | 119 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Tessera license charge | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 66 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Changes in deferred tax assets expected to be realized | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 190 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Gain on MMJ Acquisition | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,484 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | 1,480 | 1,484 | ' | ' | ' | ' | |
(Gains) losses from currency hedges, net | ' | ' | ' | ' | ' | ' | ' | ' | 27 | 222 | 19 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | 47 | 120 | 58 | |
Diameter of Wafer Used in Production (in millimeters) | ' | ' | ' | ' | 200 | ' | ' | ' | ' | 200 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Restructure and asset impairments | ' | ' | ' | ' | $32 | $55 | $60 | ($21) | $40 | $126 | $10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
[1] | The loss on 2014 debt restructure activities was recorded as $184 million in other non-operating expense and $21B million in interest expense in 2014. |
Schedule_I_Condensed_Parent_Co2
Schedule I Condensed Parent Company Statement of Operations (Details) (USD $) | 3 Months Ended | 12 Months Ended | |||||||||
In Millions, unless otherwise specified | Aug. 28, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Aug. 29, 2013 | 30-May-13 | Feb. 28, 2013 | Nov. 29, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Condensed Income Statements, Captions [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | $4,227 | $3,982 | $4,107 | $4,042 | $2,843 | $2,318 | $2,078 | $1,834 | $16,358 | $9,073 | $8,234 |
Cost of goods sold | ' | ' | ' | ' | ' | ' | ' | ' | 10,921 | 7,226 | 7,266 |
Gross margin | 1,385 | 1,368 | 1,403 | 1,281 | 708 | 556 | 366 | 217 | 5,437 | 1,847 | 968 |
Selling, general and administrative | ' | ' | ' | ' | ' | ' | ' | ' | 707 | 562 | 620 |
Research and development | ' | ' | ' | ' | ' | ' | ' | ' | 1,371 | 931 | 918 |
Other operating (income) expense, net | ' | ' | ' | ' | ' | ' | ' | ' | 232 | -8 | 32 |
Operating income (loss) | 828 | 839 | 869 | 551 | 207 | 149 | -23 | -97 | 3,087 | 236 | -612 |
Adjustment to gain on MMJ Acquisition | ' | ' | ' | ' | ' | ' | ' | ' | -33 | ' | ' |
Gain on MMJ Acquisition | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,484 | 0 |
Other non-operating income (expense), net | ' | ' | ' | ' | ' | ' | ' | ' | 8 | -218 | 29 |
Income (loss) from continuing operations before equity method investments, income taxes, and noncontrolling interest | ' | ' | ' | ' | ' | ' | ' | ' | 2,733 | 1,285 | -754 |
Income tax (provision) benefit | ' | ' | ' | ' | ' | ' | ' | ' | -128 | -8 | 17 |
Equity in net income (loss) of equity method investees | ' | ' | ' | ' | ' | ' | ' | ' | 474 | -83 | -294 |
Net income (loss) attributable to Micron | 1,150 | 806 | 731 | 358 | 1,708 | 43 | -286 | -275 | 3,045 | 1,190 | -1,032 |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -7 | -16 | -58 |
Comprehensive income (loss) attributable to Micron | ' | ' | ' | ' | ' | ' | ' | ' | 3,038 | 1,173 | -1,084 |
Micron Technology, Inc. [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Income Statements, Captions [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | ' | ' | ' | ' | ' | ' | ' | 5,819 | 4,404 | 4,590 |
Cost of goods sold | ' | ' | ' | ' | ' | ' | ' | ' | 3,514 | 3,721 | 4,194 |
Gross margin | ' | ' | ' | ' | ' | ' | ' | ' | 2,305 | 683 | 396 |
Selling, general and administrative | ' | ' | ' | ' | ' | ' | ' | ' | 264 | 238 | 281 |
Research and development | ' | ' | ' | ' | ' | ' | ' | ' | 1,389 | 921 | 917 |
Other operating (income) expense, net | ' | ' | ' | ' | ' | ' | ' | ' | 251 | 77 | 18 |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 401 | -553 | -820 |
Adjustment to gain on MMJ Acquisition | ' | ' | ' | ' | ' | ' | ' | ' | -33 | ' | ' |
Gain on MMJ Acquisition | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,484 | 0 |
Interest income (expense), net | ' | ' | ' | ' | ' | ' | ' | ' | -209 | -189 | -160 |
Other non-operating income (expense), net | ' | ' | ' | ' | ' | ' | ' | ' | -86 | -248 | 17 |
Income (loss) from continuing operations before equity method investments, income taxes, and noncontrolling interest | ' | ' | ' | ' | ' | ' | ' | ' | 73 | 494 | -963 |
Income tax (provision) benefit | ' | ' | ' | ' | ' | ' | ' | ' | 18 | -1 | 8 |
Equity in earnings (loss) of subsidiaries | ' | ' | ' | ' | ' | ' | ' | ' | 2,956 | 703 | 29 |
Equity in net income (loss) of equity method investees | ' | ' | ' | ' | ' | ' | ' | ' | -2 | -6 | -106 |
Net income (loss) attributable to Micron | ' | ' | ' | ' | ' | ' | ' | ' | 3,045 | 1,190 | -1,032 |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -7 | -17 | -52 |
Comprehensive income (loss) attributable to Micron | ' | ' | ' | ' | ' | ' | ' | ' | $3,038 | $1,173 | ($1,084) |
Schedule_I_Condensed_Parent_Co3
Schedule I Condensed Parent Company Balance Sheets (Details) (USD $) | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Sep. 01, 2011 |
In Millions, except Per Share data, unless otherwise specified | ||||
Assets | ' | ' | ' | ' |
Cash and equivalents | $4,150 | $2,880 | $2,459 | $2,160 |
Short-term investments | 384 | 221 | ' | ' |
Receivables | 2,906 | 2,329 | ' | ' |
Finished goods | 898 | 796 | ' | ' |
Work in process | 1,372 | 1,719 | ' | ' |
Raw materials and supplies | 185 | 134 | ' | ' |
Other current assets | 350 | 276 | ' | ' |
Total current assets | 10,245 | 8,911 | ' | ' |
Long-term marketable investments | 819 | 499 | ' | ' |
Property, plant and equipment, net | 8,682 | 7,626 | ' | ' |
Equity method investments | 971 | 396 | ' | ' |
Other noncurrent assets | 497 | 439 | ' | ' |
Total assets | 22,498 | 19,118 | ' | ' |
Liabilities and equity | ' | ' | ' | ' |
Accounts payable and accrued expenses | 2,698 | 2,115 | ' | ' |
Current debt | 1,638 | 1,585 | ' | ' |
Total current liabilities | 4,811 | 4,125 | ' | ' |
Long-term debt | 4,955 | 4,452 | ' | ' |
Other noncurrent liabilities | 1,102 | 535 | ' | ' |
Total liabilities | 10,868 | 9,112 | ' | ' |
Commitments and contingencies | ' | ' | ' | ' |
Redeemable convertible notes | 57 | 0 | ' | ' |
Micron shareholders' equity: | ' | ' | ' | ' |
Common stock, $0.10 par value, 3,000 shares authorized, 1,073 shares issued and outstanding (1,044 as of August 29, 2013) | 107 | 104 | ' | ' |
Total Micron shareholders' equity | 10,771 | 9,142 | ' | ' |
Total liabilities and equity | 22,498 | 19,118 | ' | ' |
Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] | ' | ' | ' | ' |
Common stock, par value (in dollars per share) | $0.10 | $0.10 | ' | ' |
Common Stock, authorized shares (in shares) | 3,000 | 3,000 | ' | ' |
Common Stock, issued (in shares) | 1,073 | 1,044 | ' | ' |
Common Stock, outstanding (in shares) | 1,073 | 1,044 | ' | ' |
Micron Technology, Inc. [Member] | ' | ' | ' | ' |
Assets | ' | ' | ' | ' |
Cash and equivalents | 1,249 | 1,202 | 2,012 | 1,082 |
Short-term investments | 384 | 221 | ' | ' |
Receivables | 114 | 159 | ' | ' |
Notes and accounts receivable from subsidiaries | 1,767 | 826 | ' | ' |
Finished goods | 84 | 88 | ' | ' |
Work in process | 228 | 332 | ' | ' |
Raw materials and supplies | 68 | 43 | ' | ' |
Other current assets | 215 | 30 | ' | ' |
Total current assets | 4,109 | 2,901 | ' | ' |
Investment In subsidiaries | 10,149 | 7,465 | ' | ' |
Long-term marketable investments | 819 | 499 | ' | ' |
Noncurrent notes receivable from and prepaid expenses to subsidiaries | 111 | 573 | ' | ' |
Property, plant and equipment, net | 1,519 | 1,613 | ' | ' |
Equity method investments | 9 | 12 | ' | ' |
Other noncurrent assets | 595 | 472 | ' | ' |
Total assets | 17,311 | 13,535 | ' | ' |
Liabilities and equity | ' | ' | ' | ' |
Accounts payable and accrued expenses | 758 | 650 | ' | ' |
Short-term debt payable to subsidiaries | 619 | 416 | ' | ' |
Current debt | 1,077 | 646 | ' | ' |
Other current liabilities | 38 | 44 | ' | ' |
Total current liabilities | 2,492 | 1,756 | ' | ' |
Long-term debt | 3,231 | 2,438 | ' | ' |
Other noncurrent liabilities | 760 | 199 | ' | ' |
Total liabilities | 6,483 | 4,393 | ' | ' |
Commitments and contingencies | ' | ' | ' | ' |
Redeemable convertible notes | 57 | 0 | ' | ' |
Micron shareholders' equity: | ' | ' | ' | ' |
Common stock, $0.10 par value, 3,000 shares authorized, 1,073 shares issued and outstanding (1,044 as of August 29, 2013) | 107 | 104 | ' | ' |
Other equity | 10,664 | 9,038 | ' | ' |
Total Micron shareholders' equity | 10,771 | 9,142 | ' | ' |
Total liabilities and equity | $17,311 | $13,535 | ' | ' |
Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] | ' | ' | ' | ' |
Common stock, par value (in dollars per share) | $0.10 | $0.10 | ' | ' |
Common Stock, authorized shares (in shares) | 3,000 | 3,000 | ' | ' |
Common Stock, issued (in shares) | 1,073 | 1,044 | ' | ' |
Common Stock, outstanding (in shares) | 1,073 | 1,044 | ' | ' |
Schedule_I_Condensed_Parent_Co4
Schedule I Condensed Parent Company Cash Flows (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' | ' |
Net cash (used for) provided by operating activities | $5,699 | $1,811 | $2,114 |
Cash flows from investing activities | ' | ' | ' |
Purchases of available-for-sale securities | -1,063 | -924 | -564 |
Expenditures for property, plant and equipment | -2,658 | -1,244 | -1,699 |
Payments to settle hedging activities | -26 | -253 | -62 |
Additions to equity method investments | 0 | 0 | -187 |
Proceeds from sales and maturities of available-for-sale securities | 557 | 678 | 152 |
Cash received from disposition of interest in Aptina | 105 | 0 | 0 |
Other | 96 | 31 | 43 |
Net cash used for investing activities | -2,453 | -1,712 | -2,312 |
Cash flows from financing activities | ' | ' | ' |
Repayments of debt | -3,843 | -743 | -203 |
Cash paid to purchase common stock under equity plans | -76 | -5 | -6 |
Payments on equipment purchase contracts | -479 | -214 | -172 |
Proceeds from issuance of debt | 2,212 | 1,121 | 1,065 |
Proceeds from issuance of common stock under equity plans | 265 | 150 | 5 |
Proceeds from equipment sale-leaseback transactions | 14 | 126 | 609 |
Other | -115 | -87 | -141 |
Net cash provided by (used for) financing activities | -1,948 | 322 | 497 |
Effect of changes in currency exchange rates on cash and equivalents | -28 | 0 | 0 |
Net increase (decrease) in cash and equivalents | 1,270 | 421 | 299 |
Cash and equivalents at beginning of period | 2,880 | 2,459 | 2,160 |
Cash and equivalents at end of period | 4,150 | 2,880 | 2,459 |
Micron Technology, Inc. [Member] | ' | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' | ' |
Net cash (used for) provided by operating activities | 888 | -347 | -48 |
Cash flows from investing activities | ' | ' | ' |
Purchases of available-for-sale securities | -1,047 | -924 | -559 |
Expenditures for property, plant and equipment | -323 | -281 | -682 |
Cash contributions to subsidiaries | -121 | -23 | -84 |
Expenditures for intangible assets | -43 | -34 | -40 |
Payments to settle hedging activities | -27 | -256 | -51 |
Cash paid for the MMJ Acquisition | 0 | -596 | 0 |
Loan to equity method investee | 0 | -45 | 0 |
Cash paid to terminate lease to IMFT | 0 | 0 | -107 |
Additions to equity method investments | 0 | 0 | -17 |
Proceeds from sales and maturities of available-for-sale securities | 557 | 678 | 151 |
Proceeds from repayment of loans to subsidiaries, net | 379 | 851 | 556 |
Cash distributions from subsidiaries | 227 | 38 | 499 |
Cash received from disposition of interest in Aptina | 105 | 0 | 0 |
Proceeds from receipt of loan payments | 56 | 0 | 0 |
Proceeds from sales of property, plant and equipment | 45 | 38 | 63 |
Proceeds from settlement of hedging activities | 23 | 38 | 26 |
Other | 7 | 9 | -28 |
Net cash used for investing activities | -162 | -507 | -273 |
Cash flows from financing activities | ' | ' | ' |
Repayments of debt | -2,469 | -777 | -117 |
Cash paid to purchase common stock under equity plans | -76 | -5 | -6 |
Payments on equipment purchase contracts | -69 | -73 | -41 |
Payments of licensing obligations | -47 | -31 | -18 |
Debt issuance costs | -33 | -17 | -21 |
Cash paid for capped call transactions | 0 | -48 | -103 |
Proceeds from issuance of debt | 1,750 | 693 | 1,113 |
Proceeds from issuance of common stock under equity plans | 265 | 150 | 5 |
Proceeds from equipment sale-leaseback transactions | 0 | 126 | 439 |
Cash received for capped call transactions | 0 | 24 | 0 |
Other | 1 | 2 | 0 |
Net cash provided by (used for) financing activities | -678 | 44 | 1,251 |
Effect of changes in currency exchange rates on cash and equivalents | -1 | 0 | 0 |
Net increase (decrease) in cash and equivalents | 47 | -810 | 930 |
Cash and equivalents at beginning of period | 1,202 | 2,012 | 1,082 |
Cash and equivalents at end of period | $1,249 | $1,202 | $2,012 |
Schedule_I_Condensed_Parent_Co5
Schedule I Condensed Parent Company Debt Disclosures (Details) (USD $) | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Nov. 12, 2013 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 28, 2014 | |||||||||||||||||||||||||||||||||||||||||
Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Loans Payable [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | ||||||||||||||||||||||||||||||||||||||||||||
Sales-leaseback transactions [Member] | Sales-leaseback transactions [Member] | integer | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | Payment Guarantee of Subsidiary Debt [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Capital lease obligations [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Loans Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||
integer | Equipment [Member] | Equipment [Member] | Sales-leaseback transactions [Member] | Sales-leaseback transactions [Member] | integer | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2025 senior notes [Member] | 2025 senior notes [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Stated interest rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.88% | ' | 1.88% | ' | 1.50% | ' | 1.88% | ' | 2.38% | ' | 3.13% | ' | 1.63% | ' | 2.13% | ' | 3.00% | ' | ' | 5.88% | ' | 5.50% | ' | 2.29% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.88% | ' | 1.88% | ' | 1.50% | ' | 1.88% | ' | 2.38% | ' | 3.13% | ' | 1.63% | ' | 2.13% | ' | 3.00% | ' | 5.88% | ' | 5.50% | ' | 1.65% | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Effective interest rate (in hundredths) | ' | ' | ' | 4.30% | 4.10% | ' | ' | ' | ' | 7.88% | ' | 6.95% | ' | 6.55% | ' | 6.98% | ' | 5.95% | ' | 6.33% | ' | 4.50% | ' | 4.93% | ' | 6.76% | ' | ' | 6.14% | ' | 5.56% | ' | 3.40% | ' | ' | ' | ' | ' | ' | 4.70% | 4.70% | ' | ' | ' | ' | ' | 7.88% | ' | 6.95% | ' | 6.55% | ' | 6.98% | ' | 5.95% | ' | 6.33% | ' | 4.50% | ' | 4.93% | ' | 6.76% | ' | 6.14% | ' | 5.56% | ' | 1.65% | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Current debt | $1,638,000,000 | $1,585,000,000 | ' | $323,000,000 | [1] | $407,000,000 | [1] | ' | ' | ' | ' | $0 | [2] | $465,000,000 | [2] | $0 | [2] | $0 | [2] | $0 | [2] | $0 | [2] | $362,000,000 | [2],[3] | $0 | [2] | $0 | [2],[4] | $0 | [2] | $0 | [2],[4] | $0 | [2] | $278,000,000 | [2],[4],[5] | $0 | [2] | $265,000,000 | [2],[4],[5] | $0 | [2] | $0 | [2] | ' | $0 | [2] | $0 | $0 | $0 | $0 | $126,000,000 | $186,000,000 | ' | $1,077,000,000 | $646,000,000 | ' | ' | $172,000,000 | [6] | $156,000,000 | [6] | ' | ' | ' | ' | ' | $0 | [7] | $465,000,000 | [7] | $0 | [7] | $0 | [7] | $0 | [7] | $0 | [7] | $362,000,000 | [7],[8] | $0 | [7] | $0 | [7],[9] | $0 | [7],[9] | $0 | [7],[9] | $0 | [7],[9] | $278,000,000 | [10],[7],[9] | $0 | [10],[7],[9] | $265,000,000 | [10],[7],[9] | $0 | [10],[7],[9] | $0 | [7] | $0 | [7] | $0 | $0 | $0 | $0 | $0 | $25,000,000 | ' |
Long-term debt | 4,955,000,000 | 4,452,000,000 | ' | 588,000,000 | [1] | 845,000,000 | [1] | ' | ' | ' | ' | 0 | [2] | 0 | [2] | 0 | [2] | 147,000,000 | [2] | 0 | [2] | 277,000,000 | [2] | 0 | [2],[3] | 253,000,000 | [2] | 314,000,000 | [2],[4] | 463,000,000 | [2] | 288,000,000 | [2],[4] | 369,000,000 | [2] | 0 | [2],[4],[5] | 272,000,000 | [2] | 0 | [2],[4],[5] | 260,000,000 | [2] | 636,000,000 | [2] | ' | 0 | [2] | 600,000,000 | 0 | 1,150,000,000 | 0 | 116,000,000 | 449,000,000 | ' | 3,231,000,000 | 2,438,000,000 | ' | ' | 233,000,000 | [6] | 397,000,000 | [6] | ' | ' | ' | ' | ' | 0 | [7] | 0 | [7] | 0 | [7] | 147,000,000 | [7] | 0 | [7] | 277,000,000 | [7] | 0 | [7],[8] | 253,000,000 | [7] | 314,000,000 | [7],[9] | 463,000,000 | [7],[9] | 288,000,000 | [7],[9] | 369,000,000 | [7],[9] | 0 | [10],[7],[9] | 272,000,000 | [10],[7],[9] | 0 | [10],[7],[9] | 260,000,000 | [10],[7],[9] | 636,000,000 | [7] | 0 | [7] | 600,000,000 | 0 | 1,150,000,000 | 0 | 10,000,000 | 0 | ' |
Debt | 6,593,000,000 | 6,037,000,000 | ' | 911,000,000 | [1] | 1,252,000,000 | [1] | ' | ' | 2,143,000,000 | 2,506,000,000 | 0 | [2] | 465,000,000 | [2] | 0 | [2] | 147,000,000 | [2] | 0 | [2] | 277,000,000 | [2] | 362,000,000 | [11],[2],[3] | 253,000,000 | [2] | 314,000,000 | [2],[4] | 463,000,000 | [2] | 288,000,000 | [2],[4] | 369,000,000 | [2] | 278,000,000 | [2],[4],[5] | 272,000,000 | [2] | 265,000,000 | [2],[4],[5] | 260,000,000 | [2] | 636,000,000 | [2] | 627,000,000 | 0 | [2] | 600,000,000 | 0 | 1,150,000,000 | 0 | 242,000,000 | 635,000,000 | ' | 4,308,000,000 | 3,084,000,000 | ' | ' | 405,000,000 | [6] | 553,000,000 | [6] | ' | ' | ' | ' | ' | 0 | [7] | 465,000,000 | [7] | 0 | [7] | 147,000,000 | [7] | 0 | [7] | 277,000,000 | [7] | 362,000,000 | [7],[8] | 253,000,000 | [7] | 314,000,000 | [7],[9] | 463,000,000 | [7],[9] | 288,000,000 | [7],[9] | 369,000,000 | [7],[9] | 278,000,000 | [10],[7],[9] | 272,000,000 | [10],[7],[9] | 265,000,000 | [10],[7],[9] | 260,000,000 | [10],[7],[9] | 636,000,000 | [7] | 0 | [7] | 600,000,000 | 0 | 1,150,000,000 | 0 | 10,000,000 | 25,000,000 | ' |
Conversion rights, minimum number of trading days (in days) | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rights, consecutive trading period (in days) | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Conversion rights, threshold percentage of applicable conversion price (in hundredths) | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Other notes payable of Micron's subsidiaries and capital lease obligations | 1,570,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,570,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Maximum exposure from guarantees to subsidiaries | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 610,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Discounts and Interest, repectively | ' | ' | ' | -87,000,000 | ' | ' | ' | -577,000,000 | -444,000,000 | 0 | -20,000,000 | 0 | -28,000,000 | 0 | -68,000,000 | -27,000,000 | -92,000,000 | -48,000,000 | -87,000,000 | -56,000,000 | -81,000,000 | -22,000,000 | -28,000,000 | -35,000,000 | -40,000,000 | -389,000,000 | -398,000,000 | 0 | ' | ' | ' | ' | ' | ' | -707,000,000 | ' | ' | ' | ' | -25,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -468,000,000 | ||||||||||||||||||||||||||||||||||||||||
Leases, Capital [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Weighted Average Remaining Term (in years) | ' | ' | ' | '4 years 1 month | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '2 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Proceeds from equipment sale-leaseback transactions | 14,000,000 | 126,000,000 | 609,000,000 | ' | ' | ' | 126,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 126,000,000 | 439,000,000 | ' | ' | ' | ' | ' | ' | 126,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Capital leases, Current period additions | ' | ' | ' | ' | ' | ' | 126,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 126,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Imputed interest rate of sale leaseback additions (in hundredths) | ' | ' | ' | ' | ' | ' | 4.30% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4.30% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Due date | ' | ' | ' | ' | ' | 31-Jul-17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31-Jul-17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Collateral Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 305,000,000 | 458,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Long-term Debt, by Maturity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2015 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 803,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 389,000,000 | ||||||||||||||||||||||||||||||||||||||||
2016 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 352,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ||||||||||||||||||||||||||||||||||||||||
2017 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 320,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ||||||||||||||||||||||||||||||||||||||||
2018 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 602,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 300,000,000 | ||||||||||||||||||||||||||||||||||||||||
2019 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 684,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 362,000,000 | ||||||||||||||||||||||||||||||||||||||||
2020 and thereafter | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,628,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,320,000,000 | ||||||||||||||||||||||||||||||||||||||||
Notes Payable | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,682,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,903,000,000 | ||||||||||||||||||||||||||||||||||||||||
Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2015 | ' | ' | ' | 356,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 188,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2016 | ' | ' | ' | 301,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 200,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2017 | ' | ' | ' | 103,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 30,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2018 | ' | ' | ' | 60,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2019 | ' | ' | ' | 55,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
2020 and thereafter | ' | ' | ' | 123,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 6,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
Capital Lease Obligations | ' | ' | ' | $911,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $405,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||
[1] | Weighted-average imputed rate of 4.3% and 4.1% as of AugustB 28, 2014 and AugustB 29, 2013, respectively. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | We have either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[5] | As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[6] | Weighted-average imputed rate of 4.7% and 4.7% as of AugustB 28, 2014 and AugustB 29, 2013, respectively. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[7] | Micron has either the obligation or the option to pay cash for the aggregate amount due upon conversion for all of its convertible notes. Since it is Micron's current intent to settle in cash the principal amount of all of its convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[8] | Amount recorded for 2014 includes the debt and equity components, which was reclassified as a result of Micron's obligation to settle the conversions of the 2031B Notes. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[9] | Since the closing price of Micron's common stock for at least 20 trading days in the 30 trading day period ending on June 30, 2014 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended September 30, 2014. The closing price of Micron's common stock also exceeded the thresholds for the calendar quarter ended September 30, 2014; therefore, these notes are convertible by the holders through December 31, 2014. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[10] | As a result of these notes being convertible at the option of the holder through September 30, 2014, and because the terms of these notes would require Micron to pay cash for the principal amount of any converted notes, amounts are classified as current. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[11] | As holders had elected to convert these notes and we elected to settle the conversions in cash, net carrying amount for 2014 included the debt and equity components, which was reclassified as a result of our obligation to settle the conversions of the 2031B Notes. |
Schedule_I_Condensed_Parent_Co6
Schedule I Condensed Parent Company Other Disclosures (Details) (USD $) | 12 Months Ended | 0 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||
Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 15, 2014 | Aug. 28, 2014 | Mar. 01, 2012 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 | |
Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Securities Matter [Member] | Line of Credit [Member] | Aptina [Member] | Aptina [Member] | Aptina [Member] | Aptina [Member] | Aptina [Member] | Aptina [Member] | ||||
Payment Guarantee of Subsidiary Debt [Member] | Aptina [Member] | Aptina [Member] | Aptina [Member] | Transform [Member] | Former Shareholders of Elpida Memory, Inc [Member] | Micron Technology, Inc. [Member] | Other [Member] | Other [Member] | Other [Member] | ||||||||||||
Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Elpida Memories, Inc. now known as Micron Memory Japan, Inc. [Member] | Payment Guarantee of Subsidiary Debt [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | Micron Technology, Inc. [Member] | |||||||||||||
integer | |||||||||||||||||||||
Condensed Financial Statements, Captions [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Maximum exposure from guarantees to subsidiaries | ' | ' | ' | ' | ' | ' | $610,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 408,000,000 | ' | ' | ' | ' | ' | ' |
Number of plaintiffs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7 | ' | ' | ' | ' | ' | ' | ' |
Net sales to subsidiaries | ' | ' | ' | 5,640,000,000 | 4,190,000,000 | 4,150,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Ownership Percentage (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' |
Revenues from transactions with related party | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 43,000,000 | 182,000,000 | 372,000,000 | 43,000,000 | 182,000,000 | 372,000,000 |
Consideration ON Semiconductor paid to acquire Aptina | ' | ' | ' | ' | ' | ' | ' | ' | ' | 433,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Gain from disposition of interest in Aptina | 119,000,000 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | 119,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Diluted ownership interest held in Aptina (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | 27.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Equity method investments | $971,000,000 | $396,000,000 | ' | $9,000,000 | $12,000,000 | ' | ' | $9,000,000 | $12,000,000 | ' | ' | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Schedule_II_Valuation_and_Qual2
Schedule II Valuation and Qualifying Accounts (Details) (USD $) | 12 Months Ended | ||
In Millions, unless otherwise specified | Aug. 28, 2014 | Aug. 29, 2013 | Aug. 30, 2012 |
Allowance for Doubtful Accounts [Member] | ' | ' | ' |
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' | ' |
Balance at Beginning of Year | $5 | $5 | $3 |
Business Acquisition | 0 | 0 | 0 |
Charged (Credited) to Costs and Expenses | 0 | 1 | 5 |
Deductions/Write-Offs | -2 | -1 | -3 |
Balance at End of Year | 3 | 5 | 5 |
Deferred Tax Assets Valuation Allowance [Member] | ' | ' | ' |
Valuation and Qualifying Accounts Disclosure [Line Items] | ' | ' | ' |
Balance at Beginning of Year | 3,155 | 1,470 | 1,169 |
Business Acquisition | 0 | 1,292 | 0 |
Change in Deferred Tax Assets Valuation Allowance, Effect Of Income Tax Rate Reconciliation, Amount | -544 | 418 | 368 |
Deductions/Write-Offs | -168 | -25 | -67 |
Balance at End of Year | $2,443 | $3,155 | $1,470 |